data_4axp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4axp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.818 0.342 . . . . 74.05 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.15 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 64.45 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 71.34 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.11 111.156 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.739 0.225 . . . . 63.43 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 63.11 111.088 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 54.34 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.42 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 70.5 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 73.45 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 74.14 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.41 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.881 0.372 . . . . 73.5 110.929 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 74.41 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 61.33 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 75.13 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 71.43 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.52 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 64.14 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.1 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 73.21 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.826 0.346 . . . . 72.21 110.901 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.52 110.937 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 45.41 111.121 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 74.43 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.2 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.12 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 CA-C-O 120.736 0.223 . . . . 75.14 112.394 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 71.14 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.02 110.842 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 71.12 111.083 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 61.02 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.15 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 75.41 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 63.43 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 63.12 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.779 0.323 . . . . 74.23 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 54.3 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 55.34 112.457 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 75.45 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' VAL . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.03 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.31 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.573 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 65.43 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 74.44 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.573 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.1 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 72.34 110.855 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.817 0.342 . . . . 72.41 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 73.33 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 50.31 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 73.1 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 61.31 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.0 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.165 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.756 0.232 . . . . 73.54 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 52.12 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.877 0.37 . . . . 71.14 110.971 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 73.43 110.931 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 73.34 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.55 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.7 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.591 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 41.13 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.671 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 60.31 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.21 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 64.23 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.842 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.832 0.348 . . . . 74.31 110.9 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.43 110.901 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 72.34 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 54.24 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.484 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.163 0 CA-C-O 120.793 0.247 . . . . 73.42 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 70.13 111.133 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 22.13 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.85 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 75.0 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 75.31 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 74.13 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.844 0.354 . . . . 75.32 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.01 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 62.44 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.24 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.24 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.53 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 73.44 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.33 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 65.24 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 74.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.752 0.311 . . . . 72.54 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.12 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 71.2 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.51 110.861 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 30' ' ' LYS . 2.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.104 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.699 0.208 . . . . 54.22 112.301 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 75.51 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 72.24 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 64.14 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 65.35 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 71.21 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 70.31 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.42 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' N ' HD21 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.339 . . . . 63.21 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.33 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 64.13 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 72.41 110.873 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 73.14 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 73.32 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 73.24 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 75.13 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 65.24 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 65.54 110.794 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 73.33 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.52 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 64.33 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 61.11 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.44 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 72.31 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.698 0.208 . . . . 75.13 112.295 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.44 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 74.22 110.835 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 73.15 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.917 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 71.31 111.098 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 60.43 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.793 0.33 . . . . 75.22 110.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.15 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 75.42 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 71.54 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 64.13 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 72.31 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.603 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 64.33 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.62 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 73.24 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 74.31 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.697 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 63.13 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.41 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 72.42 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.855 0.359 . . . . 54.43 110.927 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.34 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.41 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 72.05 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.453 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.41 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.733 0.222 . . . . 75.55 112.331 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 73.02 111.081 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 72.54 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.3 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 73.12 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.113 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 73.41 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.33 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 71.12 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 74.25 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.41 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.53 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 74.24 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.584 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 71.25 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 71.45 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.347 . . . . 75.11 110.87 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.23 110.85 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 71.03 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HA ' HG23 ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.175 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.714 0.214 . . . . 74.41 112.281 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.928 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 74.33 111.116 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 70.23 110.888 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 62.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 72.0 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 75.43 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 71.13 110.904 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 75.04 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 75.34 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 62.33 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 73.23 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 71.12 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 74.0 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.681 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.31 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 73.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.681 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 70.43 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 72.44 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 74.31 110.958 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.447 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.2 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' CG2' ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 62.43 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 71.33 111.166 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.849 0.27 . . . . 73.42 112.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 74.3 111.075 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 74.01 111.135 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 75.34 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.11 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.52 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 65.1 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.21 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.34 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' N ' HD21 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 64.44 111.073 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.816 0.341 . . . . 74.42 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.901 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.6 t-20 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.12 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 70.44 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 71.43 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 65.32 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 73.53 110.879 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.45 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 CA-C-O 120.774 0.239 . . . . 72.25 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 72.4 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.5 110.844 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 74.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 75.31 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 70.11 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 73.45 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 74.1 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 74.41 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 62.44 111.059 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.895 0.378 . . . . 75.55 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.25 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 55.31 110.838 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.53 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 72.24 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 63.0 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 75.01 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 71.32 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 73.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.13 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 74.2 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 44.54 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.866 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 72.04 110.912 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 54.02 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 73.42 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 71.55 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.56 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 73.12 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 75.15 111.157 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.718 0.216 . . . . 74.35 112.273 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.91 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 73.2 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 71.11 111.099 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.34 111.158 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 74.43 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.23 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 74.12 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.5 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.13 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.3 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 74.33 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.41 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 75.15 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 73.43 110.894 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 73.21 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 71.33 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 31' ' ' GLU . 3.3 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.707 0.211 . . . . 75.12 112.305 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 75.21 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 75.23 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 70.12 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 73.51 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 71.01 111.07 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 73.33 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 75.12 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 50.43 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 70.24 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.503 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.32 110.854 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.888 0.375 . . . . 63.44 110.975 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.465 ' N ' HD11 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.1 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 6.0 mm-40 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.05 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 71.55 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 41.52 112.453 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 71.33 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 75.44 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.689 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 72.15 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.689 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.02 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 75.24 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 74.45 110.882 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 74.13 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 75.22 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 14.15 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 70.33 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.33 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.491 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.192 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.09 0 CA-C-O 120.777 0.24 . . . . 75.42 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 73.43 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 74.34 111.149 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 73.23 111.152 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.31 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 63.04 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.54 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.14 111.121 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.9 0.381 . . . . 73.14 110.999 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 70.11 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 75.14 112.483 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.24 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.648 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.45 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 75.21 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.648 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 74.22 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.781 0.325 . . . . 75.1 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 73.21 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' HG23 ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.085 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.23 0.107 0 CA-C-O 120.763 0.234 . . . . 75.22 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 72.4 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 74.13 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 60.12 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 72.22 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 64.54 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 64.31 110.855 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.496 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.773 0.321 . . . . 64.22 110.867 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.35 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 64.12 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.41 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 54.22 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.706 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.562 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 71.23 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.706 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.22 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.12 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.785 0.326 . . . . 73.01 110.916 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.877 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 75.42 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.135 0 CA-C-O 120.748 0.228 . . . . 64.25 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.25 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 71.04 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 73.35 111.115 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.31 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mm? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.756 0.312 . . . . 75.22 110.821 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 74.13 111.099 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 71.14 110.852 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.53 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 75.1 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 74.42 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 72.04 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 73.23 110.929 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 75.2 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 62.25 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 65.11 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 62.44 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 31' ' ' GLU . 1.6 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 CA-C-O 120.81 0.254 . . . . 73.13 112.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 72.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.551 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.129 179.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 75.1 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 62.43 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 74.34 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 73.21 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 75.45 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 52.24 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 75.24 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 72.45 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.44 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 75.43 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 71.43 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.4 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.11 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 1.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.527 0.134 0 CA-C-O 120.741 0.226 . . . . 73.41 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 74.24 111.121 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 52.42 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 74.01 111.116 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 70.33 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.41 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.42 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 73.32 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 72.22 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.44 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 64.21 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.792 0.33 . . . . 73.2 110.907 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.42 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 71.01 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.465 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 73.41 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.42 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 72.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.7 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 65.5 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 74.31 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.342 . . . . 62.13 110.887 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.44 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.42 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 CA-C-O 120.804 0.252 . . . . 71.32 112.297 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 75.3 111.11 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 65.32 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 75.01 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 51.1 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' N ' HD21 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.814 0.34 . . . . 75.14 110.925 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 72.41 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 75.21 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 50.22 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 73.43 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.76 0.314 . . . . 74.34 110.915 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 33' ' ' ILE . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 54.45 112.409 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.35 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.735 0.223 . . . . 74.52 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.22 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 60.41 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.44 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.876 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 75.32 111.097 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 64.41 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 74.41 111.072 179.837 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.815 0.34 . . . . 74.43 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 63.11 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 74.04 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.42 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 64.44 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.674 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 64.53 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 74.44 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.45 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 65.12 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.749 0.309 . . . . 75.12 110.879 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 72.11 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 71.44 112.484 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' HG23 ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.3 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.51 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.7 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 75.41 111.118 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.767 0.236 . . . . 64.51 112.316 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 71.02 110.923 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 72.03 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 75.33 111.096 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.921 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 61.12 111.138 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 50.44 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 71.24 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.3 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 65.34 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.111 179.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.785 0.326 . . . . 74.43 110.913 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 71.25 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 74.04 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 65.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.34 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 61.51 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 75.11 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 72.03 110.892 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.752 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 70.21 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -73.58 118.08 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.281 -0.418 . . . . 74.03 110.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -96.49 -26.78 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 74.01 110.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.63 -25.87 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 53.22 111.132 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.82 68.58 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.798 -0.715 . . . . 65.41 112.465 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -55.68 -41.87 74.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 74.22 110.937 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -17.41 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.864 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.16 -15.61 61.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 55.53 112.475 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.71 -20.89 52.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 75.51 110.903 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.62 -21.78 30.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 53.55 112.509 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.92 -22.92 20.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 70.35 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.96 -46.36 7.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.01 110.892 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.9 -35.55 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 65.25 111.045 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.8 t -76.3 -33.41 59.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 64.25 110.832 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.7 -27.31 23.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.912 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 -20.81 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.41 111.12 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.74 -13.43 20.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.888 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.2 mmtm -39.73 109.24 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 73.23 110.881 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.5 23.77 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.719 2.28 . . . . 64.24 112.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.4 t70 51.2 38.05 20.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 72.42 110.826 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 80.9 p -99.61 -16.27 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 65.42 110.864 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -116.83 -61.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 64.52 110.964 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.09 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 74.05 110.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 75.15 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 64.45 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 71.34 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.57 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.2 t -36.62 -46.98 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 74.11 111.156 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' H ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -64.16 -55.48 21.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.842 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.92 -45.96 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.902 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -58.72 -48.5 80.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.121 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -49.97 -22.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 41' ' ' ALA . 13.7 ttmt -95.31 -41.87 8.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.92 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.5 m -58.71 -7.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.34 111.172 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -91.69 -32.14 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 72.41 111.123 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.09 0.92 73.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.639 -0.791 . . . . 75.13 112.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -33.73 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 74.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -37.52 -47.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.108 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.53 111.93 4.81 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 73.34 110.849 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.02 35.48 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 63.43 112.363 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 75.11 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 63.11 111.088 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 54.34 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.42 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 70.5 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 73.45 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 74.14 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.41 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.42 -24.17 28.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.81 166.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 55.4 110.855 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.29 172.72 54.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 64.54 112.496 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -80.7 -179.31 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 72.33 110.897 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.47 -54.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 64.21 112.463 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.6 mm-40 -102.85 0.28 32.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 75.5 110.865 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 77.67 -48.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.876 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.05 -9.92 40.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 73.5 110.929 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 74.41 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 61.33 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 74.32 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 75.13 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 71.43 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.52 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 64.14 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 61.1 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 73.21 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -52.14 -31.88 33.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -85.78 -37.04 9.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -97.21 111.26 23.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 74.53 110.917 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -90.0 10.12 25.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 74.21 110.891 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.19 159.93 30.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.614 0.721 . . . . 75.21 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 100.37 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.693 2.262 . . . . 71.35 112.32 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -92.86 -26.84 17.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 74.45 111.156 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -121.76 51.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 73.14 110.901 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 73.42 110.958 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.832 0.349 . . . . 73.52 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.59 172.24 3.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 71.34 110.884 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.37 129.76 56.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 62.22 110.845 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.35 -24.33 11.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.2 111.12 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.8 156.49 10.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 72.03 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -109.93 10.26 24.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 74.2 110.902 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -21.22 62.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.883 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.22 -74.07 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 74.43 112.453 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -71.2 -9.76 58.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 73.12 110.926 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.04 -39.99 5.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 65.4 112.47 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.02 -21.96 66.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 73.32 110.892 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.82 -46.88 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.949 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.09 -35.49 78.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 73.32 111.037 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 t -76.04 -33.24 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.827 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -87.45 -26.89 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.55 110.906 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 -17.53 54.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.02 111.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 3.6 pp -100.24 -13.87 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.886 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -41.89 154.92 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 75.15 110.86 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -6.73 19.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 72.11 112.295 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 1.5 m-20 -136.76 53.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.03 110.818 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.534 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 5.5 m -98.98 -18.28 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 61.45 110.878 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -106.38 -13.93 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.925 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -101.17 -73.78 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.901 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.534 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.52 110.937 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 45.41 111.121 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.0 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 74.43 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.2 t -37.02 -46.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 75.12 111.146 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.92 -55.94 18.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.14 110.857 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.24 -46.76 88.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.53 110.904 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.475 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -56.75 -49.3 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.78 -22.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -95.33 -39.7 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.25 110.927 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.3 m -62.08 -5.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.22 111.15 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.82 -10.51 24.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 71.32 111.124 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.01 -7.76 59.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 74.12 112.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.38 2.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.753 0.311 . . . . 73.44 110.874 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -33.08 -48.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 75.34 111.17 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -60.29 111.89 4.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.519 0.676 . . . . 75.32 110.901 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -16.64 37.78 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.648 2.232 . . . . 75.14 112.394 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 71.14 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 72.02 110.842 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 74.12 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 71.12 111.083 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 61.02 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.15 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 75.41 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 63.43 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 63.12 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.67 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -61.83 145.96 51.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 74.33 110.921 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.3 -47.22 3.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 72.21 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -52.03 149.35 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 72.54 110.972 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.88 -64.83 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 45.24 112.447 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.5 pt-20 -100.55 -33.54 10.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 72.54 110.921 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 163.38 140.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 75.11 110.83 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.04 -9.32 58.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 74.23 110.922 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 54.3 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 55.34 112.457 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 75.45 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 93' ' ' VAL . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.03 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 64.31 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.573 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 65.43 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 74.44 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.573 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 74.1 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -55.07 -30.32 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 72.34 110.855 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.88 -125.34 4.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 64.35 112.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -97.78 129.31 44.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 71.44 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -99.93 10.11 41.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.946 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 144.8 86.01 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.622 0.725 . . . . 72.13 110.842 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 100.93 0.84 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.719 2.279 . . . . 70.53 112.356 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.69 20.0 12.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 73.21 111.16 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -110.7 173.73 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.923 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 75.01 110.84 179.882 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mmt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.803 0.335 . . . . 74.32 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -174.3 119.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.889 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -109.08 -30.62 7.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 62.33 110.889 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.3 -23.71 57.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.32 111.149 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.99 108.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 64.13 112.472 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -84.8 -44.24 13.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 72.04 110.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -17.48 36.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 64.42 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 102.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 75.42 112.483 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -89.48 -26.9 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 74.1 110.882 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.0 -16.18 45.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.78 -0.724 . . . . 70.43 112.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -86.08 -28.19 24.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.398 . . . . 74.23 110.877 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.21 -38.48 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 52.24 110.847 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 17' ' ' LEU . . . -73.02 -20.43 61.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 61.41 111.076 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 34.4 t -96.99 -25.39 15.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.884 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -99.74 -24.8 14.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 65.44 110.903 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -94.4 -17.21 22.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.35 111.096 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 ' CG ' ' O ' ' A' ' 13' ' ' ALA . 10.8 mt -113.31 -11.54 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.972 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.58 107.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.645 0.736 . . . . 71.01 110.909 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 67.48 1.74 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.683 2.255 . . . . 74.1 112.251 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.6 t0 52.67 29.15 6.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 51.23 110.848 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 49.2 m -102.41 -11.67 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.788 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -116.72 -63.08 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.4 110.901 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -39.04 -74.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 72.41 110.89 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 73.33 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 72.01 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 50.31 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' O ' HG21 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 73.1 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 61.31 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.0 t -36.7 -46.93 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.165 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' H ' HG21 ' A' ' 34' ' ' THR . 3.1 t0 -63.69 -56.05 18.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.54 110.863 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -45.92 90.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 75.33 110.854 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -58.37 -48.65 79.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 74.11 111.044 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -49.68 -22.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.849 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 -39.87 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.917 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.4 m -61.7 -6.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 73.35 111.152 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.0 -13.51 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.121 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.59 -12.17 59.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 61.24 112.487 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.24 -37.22 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 61.44 110.907 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.632 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -11.97 107.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 74.14 111.189 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.08 108.07 0.93 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.653 0.74 . . . . 75.31 110.933 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.07 32.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.628 2.219 . . . . 73.54 112.353 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 52.12 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 73.51 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 65.52 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -25.29 51.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -52.2 145.81 10.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.86 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.27 -50.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.495 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.76 120.02 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.877 0.37 . . . . 74.21 110.818 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.55 -44.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 60.41 112.468 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -102.92 -4.47 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 75.02 110.913 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER 80.01 -41.04 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.812 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.34 -13.61 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.971 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 73.43 110.931 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 73.34 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.55 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.43 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.671 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.7 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.591 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 41.13 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.671 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 60.31 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.21 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 64.23 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -103.88 29.41 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.842 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.09 -28.49 41.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.787 -0.721 . . . . 71.22 112.463 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.03 116.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 75.52 110.891 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -90.13 10.62 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 64.33 110.878 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.98 159.08 55.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.592 0.711 . . . . 74.35 110.887 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.64 2.227 . . . . 65.11 112.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -22.82 8.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 70.43 111.165 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -78.5 128.84 34.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 72.13 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.413 . . . . 72.33 110.879 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.857 0.36 . . . . 73.44 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -72.93 -57.74 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 73.55 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.17 127.47 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.876 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.62 -22.98 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 71.24 111.11 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.61 97.69 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.703 -0.76 . . . . 72.45 112.477 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.42 10.14 21.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 73.35 110.876 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -18.09 57.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.878 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.65 -16.84 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 73.4 112.53 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.16 -6.15 55.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 75.32 110.923 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.11 -29.3 17.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 70.32 112.463 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -58.55 -24.77 61.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.924 0.393 . . . . 74.33 110.898 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.61 -52.54 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 75.35 110.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.73 -41.36 95.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.146 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -70.99 -41.06 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.829 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.84 -24.87 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.926 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.47 -25.92 38.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 75.44 111.111 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.94 -11.57 16.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 75.33 110.942 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.69 157.22 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.549 0.69 . . . . 75.22 110.923 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -8.51 23.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.667 2.244 . . . . 71.2 112.341 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.9 t70 -58.66 -18.46 30.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.883 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.506 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 1.1 t -92.73 -5.56 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 55.3 110.924 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.12 -37.82 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 74.21 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -69.8 -71.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.31 110.9 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.457 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.506 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 74.43 110.901 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 72.34 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 54.24 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.484 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.484 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t -30.35 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.18 -66.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.839 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -44.87 79.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 71.54 110.867 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -45.41 -53.64 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.12 111.097 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.18 -25.88 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 74.41 110.863 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -95.46 -40.28 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.54 110.91 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.4 m -61.96 -5.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.156 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.36 -16.46 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 71.13 111.063 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.48 69.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.773 -0.727 . . . . 72.32 112.469 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -36.39 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 73.1 110.92 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.21 -45.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 73.24 111.156 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -56.94 110.79 2.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.541 0.686 . . . . 63.45 110.957 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -17.93 37.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 73.42 112.381 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 70.13 111.133 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 22.13 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 65.11 110.85 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 75.0 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 75.31 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 74.13 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.76 16.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -52.15 155.03 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 74.03 110.978 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.33 -145.26 17.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 75.4 112.495 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -57.21 120.09 7.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 72.35 110.917 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.76 -64.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 72.55 112.495 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.3 mp0 -100.82 -36.34 9.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 63.55 110.895 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.59 136.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.833 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.98 -12.6 61.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 75.32 110.921 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.01 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 71.11 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 62.44 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.24 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.24 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 63.23 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 74.53 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 73.44 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.33 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 65.24 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 74.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.14 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -54.69 -28.62 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.05 -21.08 44.67 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.442 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -78.16 175.44 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 72.41 110.866 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -98.16 -20.99 16.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.889 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.29 144.85 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 51.13 110.92 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 100.28 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.692 2.261 . . . . 65.05 112.407 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.4 p -119.77 20.03 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.129 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -112.03 153.63 26.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.188 -0.46 . . . . 74.43 110.911 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.875 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.812 0.339 . . . . 72.52 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 178.02 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.834 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.8 141.08 38.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.872 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.5 9.0 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 72.23 111.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.48 77.57 0.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 44.35 112.511 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -109.94 10.12 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 73.22 110.881 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -12.51 59.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.848 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.27 110.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.674 -0.774 . . . . 72.44 112.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.61 -7.73 53.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 74.43 110.896 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -32.5 8.33 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 41.6 mm-40 -57.1 -20.99 28.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 71.31 110.853 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -104.55 -46.46 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.926 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' O ' ' CG ' ' A' ' 17' ' ' LEU . . . -68.26 -19.45 64.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 44.22 111.109 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 26.0 t -94.67 -32.56 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.806 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 12.6 mm-40 -93.57 -23.0 18.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.846 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -90.96 -26.57 19.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 72.53 111.169 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' CG ' ' O ' ' A' ' 13' ' ' ALA . 10.7 mt -105.11 -3.68 22.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.958 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.88 151.09 0.2 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.569 0.7 . . . . 75.03 110.866 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -29.29 23.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.644 2.229 . . . . 75.23 112.295 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.25 -17.66 30.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.871 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.517 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 51.1 m -93.03 -5.74 49.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.33 110.88 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.02 -38.54 5.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 75.4 110.911 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt -69.48 -71.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 72.54 110.955 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.517 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 73.12 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 71.2 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.43 ' O ' HG21 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.51 110.861 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.557 ' O ' ' N ' ' A' ' 37' ' ' ALA . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 30' ' ' LYS . 2.9 t -36.28 -47.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.104 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -67.69 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.839 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -71.0 -12.9 61.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.86 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -69.74 -42.0 74.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.12 111.118 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -67.12 -19.79 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.886 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.73 -46.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 64.52 110.925 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 21.9 m -59.4 -8.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 73.53 111.125 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.43 30.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.096 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.32 -2.9 65.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.747 -0.739 . . . . 54.33 112.533 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.39 -37.58 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 73.45 110.9 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -36.26 -49.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.3 111.137 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -61.37 112.38 5.84 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.532 0.682 . . . . 73.32 110.898 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -18.94 36.52 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.739 2.293 . . . . 54.22 112.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 75.51 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 72.24 111.087 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 64.14 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 65.35 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 71.21 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 73.52 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 70.31 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.42 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' N ' HD21 ' A' ' 66' ' ' ASN . . . -60.44 -18.33 50.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -52.02 169.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.96 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.18 -30.18 16.89 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.774 -0.727 . . . . 73.13 112.472 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.29 120.06 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 73.31 110.956 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.59 -65.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.741 -0.742 . . . . 61.05 112.52 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' SER . 25.7 mm-40 -100.77 -35.59 9.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 73.34 110.922 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.52 137.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 63.34 110.835 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -70.46 -12.7 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 63.21 110.921 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 65.33 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 64.13 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.405 ' HG3' ' N ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 72.41 110.873 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 73.14 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 73.32 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 72.44 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 71.34 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 73.24 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.59 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 75.13 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 65.24 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 65.54 110.794 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -113.01 26.95 10.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.96 67.36 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 54.33 112.52 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.45 123.63 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 75.45 110.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -95.78 10.13 38.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 73.12 110.899 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.1 160.53 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.489 0.661 . . . . 61.23 110.934 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 98.51 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.248 . . . . 70.53 112.39 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -63.38 -25.86 68.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 54.45 111.131 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 171.15 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 74.31 110.883 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.903 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.754 0.311 . . . . 72.54 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 p -137.55 137.67 38.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 72.11 110.923 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -137.12 53.89 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.01 20.06 18.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 53.12 111.104 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.84 102.48 2.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.656 -0.783 . . . . 62.53 112.518 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -107.0 10.1 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.969 0.414 . . . . 73.42 110.959 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -16.28 62.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.919 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.37 -17.41 59.36 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.686 -0.769 . . . . 70.32 112.481 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -6.52 49.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 72.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -91.08 -37.55 6.27 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.693 -0.765 . . . . 64.22 112.426 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -49.03 -27.64 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.392 . . . . 65.24 110.811 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.83 -59.97 1.69 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.889 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 17' ' ' LEU . . . -58.69 -50.37 74.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.14 111.079 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' GLY . 2.1 t -59.77 -40.61 88.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.88 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -80.72 -22.78 39.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 72.43 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -84.51 -21.58 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 70.33 111.148 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 13' ' ' ALA . 3.2 mt -103.41 -18.06 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.55 110.843 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -41.83 108.98 0.64 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 73.42 110.862 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.57 37.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 54.43 112.319 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 58.43 19.83 6.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.951 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.45 -12.23 18.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 64.01 110.823 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -116.46 -62.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 73.24 110.926 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt -39.03 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 73.33 110.876 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.52 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 64.33 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 61.11 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.44 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.551 ' O ' ' N ' ' A' ' 37' ' ' ALA . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 72.31 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t -31.94 -47.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.52 -57.06 4.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.882 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -60.26 -55.54 32.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.836 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -46.47 -52.86 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.21 111.121 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.24 -25.45 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 71.22 110.866 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -40.3 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 75.51 110.948 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.4 m -61.83 -5.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.106 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.31 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 71.53 111.104 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -12.17 59.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 72.31 112.499 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.638 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.12 -37.45 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.761 0.315 . . . . 71.31 110.826 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.638 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.1 107.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.422 . . . . 72.11 111.081 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.03 108.02 0.92 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.533 0.683 . . . . 71.42 110.917 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.05 33.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.66 2.24 . . . . 75.13 112.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.44 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 74.22 110.835 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 73.15 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.917 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 71.31 111.098 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 60.43 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.22 -28.38 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.73 157.79 1.51 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 72.4 110.868 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.33 -141.94 29.65 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 65.14 112.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 178.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 72.44 110.936 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.39 -64.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 72.23 112.43 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 31.7 mt-10 -100.53 -33.48 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 71.43 110.888 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.58 140.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 72.13 110.812 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.38 -9.91 59.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 75.22 110.889 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 64.23 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.608 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.15 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 75.42 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 71.54 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 64.13 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 72.31 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.555 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.603 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 64.33 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.62 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 73.24 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 74.31 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.697 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 63.13 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.443 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.41 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 72.42 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -51.69 -31.78 27.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 113.19 3.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.749 . . . . 72.41 112.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -99.39 133.46 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.329 . . . . 72.55 110.933 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -99.95 10.21 41.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.881 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 160.57 75.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 63.11 110.861 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.625 2.217 . . . . 63.12 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 m -56.61 -23.92 44.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.19 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 120.97 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 73.52 110.871 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 74.24 110.936 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.749 0.309 . . . . 73.03 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -133.8 166.8 21.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.25 110.879 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.84 127.5 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 62.0 110.872 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.58 -23.15 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 73.52 111.055 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.35 121.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 70.14 112.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -93.67 10.14 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 74.21 110.901 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -4.88 59.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.892 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 -17.32 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 72.43 112.465 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.9 -13.77 35.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 74.04 110.825 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.62 -40.74 4.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 74.22 112.476 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -60.75 -22.75 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 72.43 110.875 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.08 -52.32 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 63.15 110.92 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.99 99.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 71.25 111.074 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -69.38 -36.57 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 75.4 110.881 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.45 -24.25 31.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 72.43 110.901 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -90.13 -13.7 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 63.23 111.108 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pp -110.84 -18.31 13.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 74.45 110.964 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 136.41 5.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.586 0.708 . . . . 72.41 110.891 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 61.18 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 72.44 112.323 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -13.81 5.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 72.32 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.98 -12.24 59.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.8 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -115.33 -64.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.943 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -41.32 -73.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 54.43 110.927 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 74.34 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 74.22 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 71.41 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' O ' HG21 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 72.05 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 71.42 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.41 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.497 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 t -41.32 -43.07 2.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.58 -52.16 66.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.841 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -20.3 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.923 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 40' ' ' VAL . . . -73.44 -40.47 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.099 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.62 -19.6 64.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.821 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.2 7.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 70.41 110.913 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 19.7 m -60.12 -8.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 75.44 111.079 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -94.25 -9.86 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 60.42 111.078 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.16 -8.61 58.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.806 -0.711 . . . . 61.2 112.529 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.4 -35.46 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 70.34 110.885 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.72 -49.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 64.43 111.113 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -63.64 112.72 7.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.12 110.921 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -14.28 35.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.628 2.219 . . . . 75.55 112.331 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 73.02 111.081 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 72.54 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 74.3 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 73.12 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.501 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.98 -48.82 10.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.113 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.22 166.94 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.889 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.16 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.683 -0.77 . . . . 73.41 112.583 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -66.69 120.46 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 65.04 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.71 -57.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.771 . . . . 74.12 112.525 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 76' ' ' ASP . 4.1 mm-40 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 65.5 110.886 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 72' ' ' GLU . 68.2 m -35.92 -53.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 73.02 110.863 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -95.11 -24.13 17.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 73.41 110.875 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 72' ' ' GLU . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.33 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 71.12 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 75.51 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 74.25 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.41 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.53 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 74.24 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.584 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 71.25 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 71.45 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -52.82 -33.95 51.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.87 -76.27 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 73.12 112.551 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.66 110.41 22.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 64.5 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -95.73 10.15 37.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 73.11 110.894 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.35 155.67 35.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 72.11 110.918 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 100.87 0.85 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.719 2.279 . . . . 55.01 112.391 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -95.64 20.04 10.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 74.33 111.13 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 -45.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 63.25 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 tttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 64.42 110.943 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.677 0.275 . . . . 74.23 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -142.38 134.21 27.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 64.44 110.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -53.29 127.75 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.52 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.02 -24.79 14.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 70.5 111.161 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.51 173.83 32.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 75.21 112.484 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -108.9 10.11 26.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 73.14 110.819 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -17.25 63.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 75.2 110.865 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.37 119.3 1.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.746 -0.74 . . . . 70.03 112.501 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -63.23 -16.06 59.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 74.31 110.856 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.5 -42.94 4.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 74.22 112.488 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -65.34 -20.4 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 74.42 110.834 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -47.19 6.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.823 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.55 -34.99 76.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 71.11 111.129 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 m -76.39 -32.98 58.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 64.33 110.878 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -87.77 -26.92 22.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 75.52 110.878 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.04 -17.74 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 75.54 111.069 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 3.6 pp -99.76 -14.65 18.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 74.34 110.841 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -41.3 153.42 0.25 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.59 0.709 . . . . 63.22 110.871 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 75.32 112.334 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.24 40.61 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.4 110.833 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 29.4 m -100.29 -18.98 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 71.2 110.862 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -115.48 -63.15 1.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.929 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -40.65 -71.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.87 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 75.23 110.85 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 71.03 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HA ' HG23 ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.481 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.481 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.5 t -30.01 -49.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -66.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.81 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -44.61 78.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 72.14 110.905 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -45.52 -53.78 8.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.065 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -49.69 -25.25 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 72.34 110.886 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 41' ' ' ALA . 2.3 ttpm? -95.59 -41.74 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 65.24 110.806 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.5 m -59.29 -7.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.14 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -90.23 -31.95 16.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 61.53 111.083 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.71 -3.28 66.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.683 -0.77 . . . . 61.41 112.42 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.93 -50.42 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 74.02 110.899 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER 33.83 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 74.34 111.156 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.91 108.66 1.05 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 74.55 110.916 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -16.62 37.52 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.748 2.299 . . . . 74.41 112.281 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.928 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 74.33 111.116 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 70.23 110.888 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 74.45 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 62.23 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 62.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 72.0 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 75.43 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.43 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.24 171.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.1 110.92 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.5 -59.58 7.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 73.0 112.475 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.46 121.58 9.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 73.33 110.87 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.08 -65.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 44.44 112.516 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 73' ' ' SER . 22.4 mt-10 -100.53 -35.49 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 75.24 110.879 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.79 138.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 62.43 110.858 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -71.12 -9.52 58.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.904 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 75.04 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 75.34 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 62.33 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 73.23 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 71.12 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.44 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 74.0 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.4 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.681 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.31 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 73.45 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.681 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.581 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 70.43 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -32.88 69.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 72.44 110.89 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.11 95.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.804 -0.713 . . . . 52.1 112.437 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.13 133.67 35.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 75.33 110.908 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -98.6 10.23 41.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 70.12 110.905 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.01 160.48 76.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.556 0.693 . . . . 73.42 110.9 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.7 90.78 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.694 2.263 . . . . 74.41 112.357 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 p -109.38 20.12 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 65.31 111.102 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -69.6 150.78 46.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 75.12 110.902 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 75.03 110.921 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.736 0.303 . . . . 73.23 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.33 106.66 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 63.52 110.836 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -67.67 -25.67 65.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.894 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 20.3 8.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 75.5 111.061 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.31 111.01 3.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 72.04 112.459 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -91.16 10.18 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 72.34 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -89.36 -1.15 57.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.911 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.92 -17.32 1.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.695 -0.764 . . . . 75.31 112.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.12 -9.97 59.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 73.4 110.843 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.97 -9.82 58.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 60.12 112.484 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.22 -28.29 25.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.938 0.399 . . . . 73.32 110.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.21 -38.24 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.932 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.44 -36.09 71.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.12 111.103 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -79.13 -29.25 43.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 65.04 110.867 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.42 -22.73 22.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.908 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -86.63 -21.69 26.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 61.54 111.059 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.86 -7.72 14.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.953 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -40.92 153.53 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.12 110.889 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 9.75 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.234 . . . . 72.21 112.303 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.89 8.95 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 72.54 110.86 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.544 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.84 -9.19 20.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 73.4 110.831 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -109.66 -37.44 5.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -70.64 -71.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 74.31 110.958 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.447 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.544 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.2 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' O ' ' CG2' ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 62.43 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.0 t -36.27 -46.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 71.33 111.166 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.402 ' H ' HG21 ' A' ' 34' ' ' THR . 0.4 OUTLIER -63.65 -56.12 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 70.2 110.834 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -46.68 88.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 71.14 110.944 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -57.16 -49.32 76.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.081 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -49.58 -22.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.856 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -95.36 -39.85 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 75.3 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.3 m -61.95 -5.68 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.076 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.83 -10.74 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 -7.8 59.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.818 -0.706 . . . . 43.43 112.532 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.32 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 72.24 110.929 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -32.74 -48.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.187 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.96 111.27 3.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 75.21 110.891 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -15.05 36.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 73.42 112.377 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 75.22 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 75.54 110.938 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 74.3 111.075 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 74.01 111.135 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 75.34 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 73.11 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 64.52 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 65.1 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.21 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.34 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' N ' HD21 ' A' ' 66' ' ' ASN . . . -67.34 -29.35 68.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 64.44 111.073 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.81 170.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 65.43 110.875 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.1 116.2 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 74.32 112.519 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -51.61 137.42 24.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 61.43 110.863 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.99 -63.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 62.54 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -102.02 -2.41 29.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.375 . . . . 54.53 110.873 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.0 OUTLIER 85.14 144.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.805 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.5 -14.82 14.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.874 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.0 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.901 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.6 t-20 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 75.12 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 70.44 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 71.43 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 65.32 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -52.79 -31.58 39.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.85 59.04 1.78 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 52.33 112.441 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -52.09 121.61 7.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 73.32 110.911 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.63 10.07 27.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 61.45 110.916 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -51.57 158.48 1.5 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.567 0.699 . . . . 65.04 110.865 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 88.74 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.622 2.215 . . . . 75.22 112.386 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.2 p -78.01 -24.88 47.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 74.52 111.115 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -135.32 82.45 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 71.22 110.903 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 75.1 110.88 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.724 0.297 . . . . 73.4 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.11 -170.21 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.814 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -110.59 150.23 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 75.53 110.876 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.17 -14.18 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.31 111.095 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.0 173.64 16.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.767 . . . . 73.43 112.475 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -109.28 10.2 25.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 74.13 110.911 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -18.21 65.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.878 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.86 -23.25 5.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.11 112.577 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -75.18 -6.6 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.932 0.396 . . . . 74.41 110.88 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.89 -27.95 17.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.1 112.53 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -60.09 -24.45 64.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.942 0.401 . . . . 75.32 110.868 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.53 -50.58 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 70.43 110.934 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.44 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 62.2 111.067 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 t -71.59 -35.88 70.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 71.45 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.05 -25.69 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 70.42 110.922 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.07 -15.48 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 60.2 111.05 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 pp -102.56 -11.31 18.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 64.41 110.933 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.5 mmtt -41.97 153.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.499 0.666 . . . . 65.41 110.87 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -8.71 24.31 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.681 2.254 . . . . 72.12 112.356 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.16 53.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.878 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.54 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 24.9 t -91.47 -15.31 29.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.822 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -110.08 -42.02 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 71.11 110.895 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.64 -71.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 73.53 110.879 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.423 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.555 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 74.45 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 75.2 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.7 t -39.09 -44.27 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.404 ' H ' HG21 ' A' ' 34' ' ' THR . 7.3 t0 -60.08 -52.57 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 72.41 110.844 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -20.52 59.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.838 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.532 ' HA ' ' CG2' ' A' ' 40' ' ' VAL . . . -74.53 -40.32 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 70.45 111.116 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.62 -19.41 64.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.37 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 74.41 110.888 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 19.2 m -60.11 -8.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 64.32 111.084 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -93.86 -9.52 37.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 71.14 111.163 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.23 -8.83 58.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 73.4 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.38 -35.47 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.326 . . . . 74.45 110.869 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.82 -48.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 72.31 111.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -58.93 111.24 3.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 74.22 110.891 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -16.55 37.61 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 72.25 112.372 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 74.55 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 72.4 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.5 110.844 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 74.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 75.31 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 70.11 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 73.45 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 74.1 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 74.41 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.97 -41.27 15.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 62.44 111.059 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -51.71 169.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.911 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.59 -117.08 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.653 -0.784 . . . . 62.03 112.461 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -52.15 121.58 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 63.34 110.861 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.59 -63.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 73.35 112.549 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 1.31 40.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 61.24 110.95 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.08 146.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 62.41 110.895 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.1 -14.44 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 75.55 110.923 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.25 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 55.31 110.838 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.53 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 72.24 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 63.0 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 75.01 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 71.32 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 73.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 73.13 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 74.2 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 44.54 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.52 -27.3 62.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 73.11 110.866 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 101.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 63.34 112.515 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.75 123.33 43.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 75.13 110.903 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -94.44 10.11 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 71.53 110.913 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 155.6 38.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 65.11 110.853 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 99.01 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 55.45 112.297 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -52.43 -29.59 25.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.212 -0.449 . . . . 72.13 111.093 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 153.3 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.922 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.918 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.336 . . . . 71.53 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 t 62.71 89.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 73.52 110.856 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -122.99 130.54 52.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 72.43 110.882 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.74 20.08 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 64.11 111.081 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.27 111.78 3.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 71.14 112.5 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -109.64 10.26 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 75.2 110.906 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -15.43 61.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.4 110.857 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.62 -17.36 0.98 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 53.01 112.457 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -81.21 -11.38 59.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 75.44 110.909 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.0 -40.38 4.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.43 112.508 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.65 -22.66 66.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 72.12 110.87 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.42 -43.2 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.1 110.865 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' CG ' ' A' ' 17' ' ' LEU . . . -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.139 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 41.2 t -95.35 -27.88 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.819 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -97.35 -26.1 15.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.34 110.872 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -92.1 -20.98 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 61.54 111.103 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CG ' ' O ' ' A' ' 13' ' ' ALA . 4.4 mt -114.06 -1.58 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 14' ' ' SER . 1.9 pttm -37.34 109.92 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.517 0.675 . . . . 75.12 110.862 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 62.5 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.261 . . . . 75.12 112.327 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.73 -14.09 5.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 65.05 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.7 -13.02 60.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.855 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -115.45 -64.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 73.4 110.865 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -41.46 -72.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 72.04 110.912 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.11 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 54.02 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 73.42 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 71.55 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.56 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.452 HG21 ' HA ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 73.12 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 2.4 t -36.7 -46.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 75.15 111.157 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -55.96 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.868 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -46.99 87.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.915 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -56.78 -49.24 75.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 63.04 111.11 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.41 -23.27 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.82 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -95.06 -39.45 10.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 75.35 110.945 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.2 m -63.05 -5.81 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.141 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.79 -16.52 25.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 70.25 111.113 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.26 69.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.682 -0.77 . . . . 52.34 112.519 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.08 -36.32 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 72.24 110.955 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.28 -45.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 74.23 111.114 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.07 111.56 3.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.51 0.672 . . . . 74.15 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -14.34 35.5 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 74.35 112.273 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 73.13 110.91 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 73.2 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 72.03 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 71.11 111.099 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.34 111.158 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.38 -29.67 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -67.37 147.65 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 74.44 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -102.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 52.52 112.492 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -63.22 161.94 12.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 62.51 110.866 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.85 -64.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.757 . . . . 64.02 112.493 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.6 -33.48 10.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 74.11 110.883 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.47 139.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.844 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.07 -9.81 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.43 110.93 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 73.23 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 74.12 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 75.5 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 65.13 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.688 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.3 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 74.33 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.41 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 75.15 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -95.94 26.84 3.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.28 -77.33 0.16 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.448 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.69 125.64 34.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 74.41 110.887 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.62 10.17 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.91 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.4 144.79 70.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.631 0.729 . . . . 64.52 110.818 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 101.06 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 72.02 112.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -26.18 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.21 111.143 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -80.44 -74.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.21 110.893 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 65.31 110.926 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.751 0.31 . . . . 71.23 110.86 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.8 t -173.82 168.91 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 65.42 110.902 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -137.72 127.25 25.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.62 -24.45 18.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 72.13 111.066 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.13 157.8 27.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 74.32 112.479 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.72 -49.56 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 75.44 110.932 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -19.57 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 73.45 110.873 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.21 100.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 73.31 112.493 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -85.12 -9.59 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 73.31 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -92.07 -37.39 6.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.679 -0.772 . . . . 61.43 112.491 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mt-10 -48.09 -26.6 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 72.34 110.87 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -102.68 -60.72 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.9 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.0 -46.24 91.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 51.15 111.107 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -66.35 -36.87 83.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 74.22 110.779 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 18.2 mm-40 -82.18 -23.13 35.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.977 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -94.1 -10.71 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 74.44 111.07 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 pp -112.72 -22.43 10.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.15 110.922 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -42.81 106.3 0.47 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 74.21 110.84 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 65.17 1.87 Allowed 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.71 2.273 . . . . 73.43 112.313 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.8 t70 51.34 42.97 29.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.889 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 87.9 p -104.93 -17.2 14.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 64.35 110.808 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -110.47 -39.48 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 74.4 110.962 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.07 -73.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.894 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.51 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 73.21 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' O ' HG21 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' HG23 ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.569 ' O ' ' N ' ' A' ' 37' ' ' ALA . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 71.33 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 31' ' ' GLU . 3.3 t -35.48 -48.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -61.5 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 64.2 110.811 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.27 -16.49 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.916 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -68.75 -41.59 78.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 45.02 111.069 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.5 -20.04 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 71.33 110.872 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 41' ' ' ALA . 2.7 ttmt -95.69 -48.26 5.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 75.32 110.896 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 29.9 m -56.65 -9.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 70.02 111.168 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -90.99 -32.32 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.41 111.137 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.54 0.92 71.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 74.34 112.508 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.71 -34.54 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.803 0.335 . . . . 72.3 110.905 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -34.86 -48.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.092 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -58.71 111.53 3.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 63.24 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.38 37.64 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 75.12 112.305 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 75.21 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 75.23 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 70.12 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 73.51 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 71.01 111.07 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 73.33 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 75.12 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 50.43 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 70.24 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.503 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.32 110.854 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.58 -58.35 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.58 151.76 21.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.07 -60.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.829 -0.7 . . . . 72.01 112.529 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -52.28 122.75 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 64.41 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.7 -64.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 73.41 112.488 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -100.58 -33.67 10.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.916 0.389 . . . . 74.54 110.905 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.75 139.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 73.2 110.874 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -69.77 -8.17 45.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.504 . . . . 63.44 110.975 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.465 ' N ' HD11 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.1 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 6.0 mm-40 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.05 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 71.55 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 41.52 112.453 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 74.44 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 71.33 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 75.44 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.689 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 73.14 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.458 HG11 ' HA ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 72.15 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.689 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.02 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 75.24 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -52.04 -34.33 42.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 74.45 110.882 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.31 112.54 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 72.24 112.489 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -96.72 159.66 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 75.11 110.871 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -87.46 -22.29 25.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.908 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.6 158.43 1.53 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.56 0.695 . . . . 73.33 110.911 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 101.0 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.697 2.265 . . . . 73.4 112.31 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.6 p -85.13 -25.52 27.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 72.1 111.162 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -101.77 -175.26 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.89 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 62.42 110.872 179.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 72.22 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -55.89 163.0 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 65.35 110.9 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.94 121.87 17.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.832 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.95 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 74.35 111.079 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.59 30.29 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.764 -0.731 . . . . 63.54 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.14 8.88 21.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 74.3 110.871 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -51.94 -31.33 28.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 75.52 110.889 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.82 -26.85 65.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 72.21 112.42 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -6.92 50.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 74.25 110.843 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.5 -36.21 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 74.55 112.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mm-40 -51.11 -24.38 3.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 72.14 110.898 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -103.07 -57.53 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 73.2 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.63 92.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 71.13 111.105 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -67.66 -42.22 82.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 74.53 110.841 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 67.4 mm-40 -76.85 -24.75 52.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -81.9 -24.44 35.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.2 111.115 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 pp -107.0 -10.99 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.53 110.913 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -43.0 106.72 0.5 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.6 0.714 . . . . 75.2 110.892 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 69.8 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 73.01 112.364 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.86 -8.28 10.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.41 110.845 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -79.32 -13.5 59.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.22 110.845 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -114.08 -64.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 73.04 110.923 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -43.02 -72.03 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.878 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 75.22 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 14.15 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 70.33 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HA ' HG23 ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.33 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.491 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t -29.92 -48.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.192 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -64.85 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.849 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -42.89 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 63.33 110.844 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 40' ' ' VAL . . . -44.78 -52.43 8.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.133 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -53.89 -25.97 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.51 110.859 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 41' ' ' ALA . 6.3 tttp -93.08 -59.67 1.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.884 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 m -55.75 -5.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 72.34 111.174 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -98.4 -30.92 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 60.52 111.067 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.29 -22.59 24.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 65.14 112.49 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.81 -46.41 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.846 0.355 . . . . 74.32 110.892 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -42.54 -39.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 74.35 111.091 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -40.87 102.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 73.31 110.925 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -18.59 37.11 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.702 2.268 . . . . 75.42 112.344 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 73.43 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 74.34 111.149 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.43 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 73.23 111.152 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 72.21 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.31 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 63.04 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.54 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.48 -29.39 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 62.14 111.121 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.94 141.73 28.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.871 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.86 -35.84 2.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 71.54 112.511 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -52.12 160.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 72.5 110.933 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.92 -64.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.519 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -100.51 -33.28 10.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.855 0.36 . . . . 72.24 110.883 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 t 162.53 140.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.869 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -25.85 59.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 73.14 110.999 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 70.11 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.598 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.34 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 75.43 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 75.14 112.483 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.24 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.648 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 74.45 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 75.21 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.648 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 74.22 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.552 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -94.96 -39.28 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.83 38.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.732 . . . . 70.42 112.474 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.47 118.68 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 64.21 110.882 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.23 10.11 33.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.866 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.47 160.56 32.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.629 0.728 . . . . 72.52 110.828 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 85.01 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.251 . . . . 74.43 112.36 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -31.98 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.45 111.133 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.61 154.28 9.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 71.22 110.895 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 70.35 110.865 179.832 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.803 0.335 . . . . 75.23 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.45 178.95 9.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 64.42 110.86 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.28 130.12 12.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 73.14 110.859 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.32 -21.28 66.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 71.5 111.11 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.01 -118.56 5.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.642 -0.789 . . . . 75.43 112.52 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -69.86 -44.15 70.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.924 0.392 . . . . 74.01 110.821 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.43 -1.57 37.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.895 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.38 69.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.539 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -90.34 -5.61 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 74.12 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.98 -30.76 19.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 73.31 112.491 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -25.98 63.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 73.43 110.865 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.93 -52.38 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 73.24 110.882 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.22 -43.99 97.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.23 111.118 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 t -68.39 -37.96 80.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 72.34 110.85 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -81.42 -23.97 37.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 72.15 110.9 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.25 -13.8 32.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 74.04 111.095 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 pp -111.48 -17.56 13.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 72.32 110.889 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.5 107.08 0.58 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.524 0.678 . . . . 74.41 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 65.33 1.79 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.676 2.251 . . . . 74.21 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.45 39.08 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 71.12 110.89 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -98.62 -15.53 19.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 60.25 110.881 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -116.79 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.9 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.02 -74.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 75.1 110.89 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 73.21 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' HG23 ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.486 ' O ' ' C ' ' A' ' 34' ' ' THR . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.486 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t -30.38 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.085 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -66.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 73.41 110.91 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -44.78 79.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.821 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -45.23 -53.7 7.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 70.13 111.151 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.29 -25.86 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -95.43 -40.26 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 74.4 110.829 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.4 m -61.79 -6.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 74.52 111.075 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 -17.05 23.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.34 111.116 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.59 0.23 70.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.794 -0.717 . . . . 75.15 112.536 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -36.28 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 74.0 110.824 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.29 -45.92 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 73.02 111.122 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -57.09 110.26 2.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 75.35 110.949 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -16.8 37.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.624 2.216 . . . . 75.22 112.335 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.21 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 74.35 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 72.4 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 74.13 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 60.12 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 72.22 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 64.54 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 64.31 110.855 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.91 25.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.18 169.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 54.21 110.888 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.62 -95.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.792 -0.718 . . . . 71.42 112.449 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.61 155.0 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.4 110.881 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.28 -64.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 72.03 112.438 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 -33.68 10.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.37 . . . . 75.11 110.928 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.55 139.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 71.13 110.844 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.496 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -70.14 -8.26 48.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 64.22 110.867 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' N ' HD11 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 71.35 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 64.12 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 75.41 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 71.2 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 54.22 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.706 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 73.21 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.562 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 71.23 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.706 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.22 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 74.12 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -71.22 -29.98 65.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.82 179.19 0.43 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 61.21 112.519 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -75.89 121.77 23.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 73.44 110.908 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.47 10.09 29.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 75.33 110.874 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -51.65 158.56 1.51 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 72.31 110.885 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 92.15 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.615 2.21 . . . . 62.43 112.322 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -99.24 20.07 14.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.33 111.166 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -153.91 -175.87 5.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.927 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 74.41 110.954 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.768 0.318 . . . . 73.44 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -73.61 137.08 44.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 74.45 110.87 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.88 -26.47 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 72.44 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.69 20.14 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 71.4 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.18 73.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.81 -0.71 . . . . 71.44 112.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -109.76 10.11 24.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 73.31 110.881 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -18.16 57.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 71.41 110.864 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.43 103.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.812 -0.709 . . . . 63.5 112.482 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -57.17 -23.75 49.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 65.44 110.929 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.17 3.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 75.11 112.491 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -61.9 -19.9 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.33 110.833 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.59 -52.91 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.443 . . . . 74.11 110.912 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.8 92.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 75.54 111.097 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 t -71.4 -35.75 71.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.02 110.895 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -85.26 -25.45 27.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.899 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.43 -14.36 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.14 111.058 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 3.6 pp -102.05 -13.18 17.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.929 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -42.84 155.91 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 63.31 110.835 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.721 2.281 . . . . 73.12 112.359 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.1 m-20 -135.25 52.8 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.869 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.533 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 75.2 p -89.38 -14.54 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.85 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -110.16 -41.47 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.894 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.94 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.916 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.418 ' H ' ' CG ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 71.2 110.877 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.533 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 37' ' ' ALA . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 75.42 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.4 t -32.15 -47.84 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.58 -56.95 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.814 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -60.11 -55.52 32.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.11 110.937 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -46.49 -52.96 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.128 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -48.42 -25.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.55 110.897 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -40.17 9.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 71.11 110.93 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.5 m -61.88 -5.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.142 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.14 -14.0 24.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.092 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.33 -13.47 60.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 63.11 112.515 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.76 -39.72 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 71.31 110.91 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 27.14 93.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 73.3 111.121 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.1 108.22 0.92 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.654 0.74 . . . . 74.13 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -20.39 35.18 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.732 2.288 . . . . 64.25 112.338 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.25 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 71.04 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 73.35 111.115 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.31 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.91 153.8 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.894 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.44 -150.26 5.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 64.42 112.544 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -55.68 122.76 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 71.33 110.854 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.53 -62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 55.22 112.51 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -100.25 13.32 34.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 75.05 110.95 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.474 ' C ' ' O ' ' A' ' 72' ' ' GLU . 73.6 m -32.42 -64.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.2 110.911 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -95.06 -21.85 18.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 75.22 110.821 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 74.13 111.099 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.672 ' N ' ' O ' ' A' ' 72' ' ' GLU . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 71.14 110.852 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 72.53 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 75.1 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 74.42 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 72.04 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -52.02 -32.36 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.16 -60.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 63.11 112.479 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.04 165.85 11.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 74.03 110.898 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -95.31 -20.38 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 62.22 110.9 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.81 144.79 18.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 73.45 110.852 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 101.37 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.606 2.204 . . . . 75.14 112.37 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -75.05 -25.06 58.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.33 111.147 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -115.07 -178.67 3.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.02 110.963 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 74.13 110.912 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.83 0.348 . . . . 75.11 110.925 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.12 123.9 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 65.34 110.853 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.52 129.32 56.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 70.11 110.873 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.93 -24.83 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 55.55 111.115 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.99 -168.21 12.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 73.15 112.494 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -80.42 -44.35 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 74.04 110.799 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -18.15 26.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.879 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.56 103.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 74.11 112.479 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -87.78 -13.02 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.918 0.389 . . . . 72.13 110.896 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.35 -45.03 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.659 -0.781 . . . . 75.44 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.51 -20.37 59.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 74.45 110.967 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.17 -54.18 3.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 72.32 110.917 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.38 98.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 64.41 111.062 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -69.22 -36.22 77.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 74.22 110.862 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -84.73 -22.79 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.886 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.87 -11.3 36.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 72.45 111.133 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 pp -110.55 -25.19 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.949 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -47.27 154.06 0.85 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 74.42 110.925 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.86 22.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.738 2.292 . . . . 73.25 112.35 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -126.23 43.72 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 75.14 110.878 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 6.3 p -80.24 -15.63 56.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 63.32 110.883 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -115.53 -61.79 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 74.15 110.919 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.12 -71.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.929 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 75.2 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 62.25 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 65.11 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 62.44 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HA ' HG23 ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.13 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.488 HG23 ' HA ' ' A' ' 31' ' ' GLU . 1.6 t -32.24 -47.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 -56.02 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.944 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -60.26 -54.78 41.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.863 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.546 ' HA ' ' CG2' ' A' ' 40' ' ' VAL . . . -46.11 -53.71 9.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 73.41 111.066 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -51.37 -24.22 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 74.03 110.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 41' ' ' ALA . 3.6 ttpm? -94.79 -58.87 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.841 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 37' ' ' ALA . 2.0 m -58.78 -5.78 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 74.24 111.134 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -92.27 -16.55 25.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 64.33 111.115 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.13 -6.22 65.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 70.42 112.483 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.13 -37.12 2.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 72.24 110.885 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.569 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -21.71 106.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.44 111.213 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -50.03 108.27 0.97 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.537 0.684 . . . . 74.23 110.939 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -19.21 36.37 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.745 2.297 . . . . 73.13 112.36 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 74.44 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 72.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 73.41 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 72.44 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.551 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.96 -48.34 43.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 71.32 111.129 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -53.63 141.53 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.836 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.0 -18.78 30.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 72.43 112.422 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.75 169.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 73.5 110.845 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.49 -65.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 73.32 112.504 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 4.4 mm-40 -100.57 -34.15 10.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 72.35 110.954 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 162.76 139.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 73.53 110.847 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.81 -12.71 61.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 75.1 110.926 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 62.43 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 74.34 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 75.21 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.52 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 73.21 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 75.45 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 52.24 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 75.24 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 75.11 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 72.45 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.44 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 75.43 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.67 25.69 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.27 74.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.69 -0.767 . . . . 53.52 112.458 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -78.96 119.51 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 74.05 110.875 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -95.38 10.07 37.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 65.32 110.92 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -51.55 158.44 1.5 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.647 0.737 . . . . 72.01 110.848 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 101.05 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 71.2 112.375 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.7 p -94.35 20.15 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 73.41 111.102 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -89.35 179.31 6.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.4 110.878 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.5 110.918 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.786 0.327 . . . . 72.52 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -142.4 174.42 10.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.54 110.896 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.83 128.25 21.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 63.04 110.838 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.44 -24.61 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 74.04 111.127 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.45 143.17 13.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 70.34 112.524 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.54 10.12 23.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 72.23 110.863 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -17.45 59.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 65.2 110.88 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.88 -16.92 4.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 64.33 112.438 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -86.66 -9.98 54.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 63.42 110.842 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.86 -43.28 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.439 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -64.66 -19.86 65.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 74.4 110.894 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.97 -47.04 6.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 72.2 110.894 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.91 -33.98 74.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 75.22 111.114 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.7 t -77.83 -32.86 52.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.826 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -87.73 -25.58 23.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 73.12 110.913 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 -30.18 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.12 111.106 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -96.2 -10.88 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 65.4 110.871 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -39.44 108.76 0.51 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.529 0.681 . . . . 73.45 110.856 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 79.96 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.644 2.229 . . . . 74.44 112.317 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -90.9 19.85 5.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 72.02 110.925 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 7.9 t -85.89 -19.34 30.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 74.42 110.865 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -114.86 -63.57 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 75.13 110.871 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt -42.0 -70.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.953 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.4 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.494 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 30' ' ' LYS . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.11 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 31' ' ' GLU . 1.9 t -36.09 -46.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' H ' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -63.71 -56.16 17.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 71.25 110.853 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -47.86 84.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.841 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 40' ' ' VAL . . . -55.49 -49.83 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 71.35 111.114 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -49.69 -23.16 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 54.23 110.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -95.42 -39.82 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 37' ' ' ALA . 2.2 m -61.95 -5.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 75.31 111.135 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -98.49 -11.16 22.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.14 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.77 -7.5 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 62.25 112.544 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.47 -35.57 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 74.13 110.857 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -32.77 -48.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 62.43 111.121 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -61.89 111.68 4.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 61.22 110.915 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -18.23 36.91 Favored 'Trans proline' 0 CA--C 1.527 0.134 0 C-N-CA 122.684 2.256 . . . . 73.41 112.288 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 70.34 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 74.24 111.121 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 52.42 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 74.01 111.116 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.22 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 70.33 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.41 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.42 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 73.32 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 74.54 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 72.22 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.44 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 64.21 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.91 -31.58 12.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.75 170.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.882 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.46 -83.14 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 72.13 112.504 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.52 121.5 17.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 72.43 110.889 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.9 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.711 -0.756 . . . . 62.31 112.46 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 73' ' ' SER . 13.4 mm-40 -100.92 0.95 39.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 62.54 110.882 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.24 147.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.883 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -14.76 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 73.2 110.907 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 74.42 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 71.01 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 74.44 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 74.24 112.465 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 73.41 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.42 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.409 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.43 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.472 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 72.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.7 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 65.5 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.432 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.7 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.55 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 74.31 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -39.23 85.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.0 175.77 17.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 71.31 112.477 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.57 123.44 39.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 74.02 110.83 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -91.35 9.9 29.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 64.33 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.57 158.49 1.49 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 75.44 110.879 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 92.44 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.678 2.252 . . . . 52.25 112.351 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -52.14 -29.89 24.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 75.33 111.099 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -109.64 -170.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.892 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.41 110.892 179.916 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 74.23 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.5 m -133.64 -175.56 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.853 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.4 115.11 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.864 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -53.55 -27.93 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.3 111.111 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.41 -110.41 1.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 74.13 112.507 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -109.69 -23.92 11.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 72.13 110.883 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -3.45 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.911 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.57 -17.26 47.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 62.22 112.512 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -73.27 -13.39 61.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.003 0.43 . . . . 64.54 110.92 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.33 -42.75 3.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.714 . . . . 72.55 112.449 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.53 -20.67 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.35 110.905 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.3 -53.6 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 71.33 110.873 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.82 -41.77 99.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 73.42 111.092 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -69.17 -36.52 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 62.03 110.823 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.72 -24.12 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.898 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -90.46 -13.17 35.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 54.2 111.084 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pp -111.01 -19.33 12.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 72.13 110.942 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.49 107.59 0.68 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 75.41 110.928 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 63.72 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 75.54 112.353 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 46.47 55.71 7.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.948 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 47.8 p -76.8 -18.22 58.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.802 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -115.7 -60.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 64.35 110.843 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.08 -72.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 62.13 110.887 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' O ' ' CG2' ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.44 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.42 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.6 t -32.56 -47.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -57.23 4.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.87 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -59.41 -55.4 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 72.51 110.918 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -46.87 -52.84 13.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 72.44 111.101 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -48.51 -25.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.855 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -96.46 -40.05 9.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.5 m -61.98 -5.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 75.03 111.057 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.68 -13.8 22.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 64.52 111.061 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.48 -11.97 60.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 74.41 112.468 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.14 -37.39 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 72.34 110.88 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.64 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.18 107.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.125 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.19 108.03 0.92 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 75.54 110.934 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -22.31 31.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.32 112.297 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 74.41 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 70.31 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 75.3 111.11 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 65.32 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 75.01 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 51.1 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' N ' HD21 ' A' ' 66' ' ' ASN . . . -55.72 -22.93 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.84 167.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 62.14 110.926 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.37 -82.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 72.33 112.553 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.53 124.66 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 70.23 110.956 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.27 -64.63 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.677 -0.773 . . . . 71.05 112.42 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.7 -0.04 38.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 74.12 110.863 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.1 t 86.33 147.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.845 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.68 -14.57 8.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 75.14 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.595 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 74.33 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 72.41 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 74.14 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 75.21 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 50.22 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 73.43 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.5 30.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.31 -103.49 0.54 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 71.03 112.462 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.86 115.74 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 74.32 110.896 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.4 10.04 29.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.79 155.69 3.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 72.33 110.912 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.74 100.71 0.84 Allowed 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.756 2.304 . . . . 73.3 112.383 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 72.34 111.178 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -63.92 -178.75 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.88 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 62.4 110.931 179.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.716 0.293 . . . . 74.13 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -166.38 170.21 13.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 74.11 110.874 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.86 130.12 18.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.05 110.84 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.12 20.06 19.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 73.54 111.096 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.25 -164.15 20.83 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 62.42 112.466 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 9.75 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 70.14 110.884 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -79.26 -9.99 59.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.95 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.2 103.55 0.21 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 72.2 112.419 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.75 -9.54 58.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 63.52 110.911 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.17 -40.67 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 62.02 112.501 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.74 -20.48 65.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 73.01 110.873 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.37 -44.22 7.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.892 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.423 ' O ' ' CG ' ' A' ' 17' ' ' LEU . . . -71.82 -20.86 61.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.52 111.131 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 18.5 p -93.49 -29.54 15.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.04 110.85 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -94.46 -26.99 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -86.44 -26.34 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 51.24 111.128 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' CG ' ' O ' ' A' ' 13' ' ' ALA . 18.3 mt -102.24 -7.39 22.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.76 151.37 0.19 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.657 0.742 . . . . 72.24 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.79 26.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.637 2.225 . . . . 61.51 112.347 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.03 26.73 10.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.889 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 1.4 p -88.15 -20.29 25.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.831 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -115.09 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 61.01 110.89 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -42.06 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.34 110.915 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' O ' HD11 ' A' ' 33' ' ' ILE . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 54.45 112.409 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.35 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 37' ' ' ALA . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.43 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.5 t -32.03 -48.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -57.1 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.847 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 tptt -59.95 -55.66 31.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.961 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -46.37 -52.6 12.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 72.35 111.076 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -48.01 -25.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.88 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.881 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.21 -5.25 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 74.04 111.136 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.73 -13.65 29.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 74.41 111.119 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.72 -7.83 59.84 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 64.42 112.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.52 -28.35 7.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 75.13 110.921 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -34.63 -44.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.21 111.133 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -38.35 101.01 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 54.2 110.935 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.06 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.264 . . . . 74.52 112.391 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 73.23 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 74.22 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 60.41 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 75.44 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.52 110.876 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 73.13 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 75.32 111.097 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 64.41 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.03 -70.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 74.41 111.072 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.97 141.55 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.874 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.39 -63.05 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 75.34 112.467 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -52.27 127.59 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 72.33 110.906 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.9 -71.38 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 74.35 112.555 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.98 12.86 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 74.03 110.877 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 t -63.01 -133.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.912 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.93 -7.18 57.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.882 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 74.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 63.11 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 74.04 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.588 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.42 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 64.44 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.674 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 64.53 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 74.44 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 63.45 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 65.12 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.82 27.61 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.99 -17.17 69.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.707 -0.759 . . . . 72.34 112.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.08 179.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 62.42 110.832 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -89.96 10.11 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 54.04 110.905 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.93 160.61 1.1 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.685 0.755 . . . . 73.54 110.847 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 101.42 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.714 2.276 . . . . 74.02 112.374 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -109.84 20.11 18.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.13 111.079 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -132.14 69.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 73.13 110.868 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.2 110.908 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.773 0.321 . . . . 73.22 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.1 p -167.76 -172.4 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 44.33 110.808 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.14 112.29 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 70.54 110.841 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.81 -24.25 56.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 54.44 111.133 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.49 -80.34 0.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 74.41 112.519 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -110.06 10.24 24.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.367 . . . . 73.54 110.854 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.52 -15.81 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.919 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.37 97.38 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.3 112.454 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.37 -7.69 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 74.13 110.827 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.96 -29.74 11.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 73.14 112.45 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 16.4 mm-40 -57.72 -19.98 31.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 74.21 110.902 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -103.88 -46.27 4.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 75.04 110.877 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 17' ' ' LEU . . . -68.69 -19.51 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.23 111.147 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 34.2 t -94.51 -32.28 13.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.22 110.818 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 23.3 mm-40 -93.87 -22.89 18.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 55.13 110.946 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -91.0 -27.37 18.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 75.3 111.087 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' CG ' ' O ' ' A' ' 13' ' ' ALA . 10.6 mt -104.07 -4.88 22.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 65.42 110.96 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -38.82 150.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 72.44 110.87 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -6.98 19.9 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.722 2.281 . . . . 72.53 112.305 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.9 m-20 -137.61 54.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 63.43 110.825 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.549 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -101.81 -20.11 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 52.34 110.855 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -105.24 -12.64 15.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 70.12 110.876 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -102.07 -72.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.879 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 72.11 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 71.44 112.484 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' HG23 ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 74.3 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 74.51 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 33' ' ' ILE . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.467 ' C ' ' O ' ' A' ' 33' ' ' ILE . 1.7 t -32.5 -48.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 75.41 111.118 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -57.27 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.879 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -59.29 -55.24 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.893 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' ILE . . . -47.07 -52.72 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 50.45 111.107 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.65 -24.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.836 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -96.57 -40.16 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.872 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 37' ' ' ALA . 1.5 m -61.95 -5.88 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 70.12 111.103 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.16 -13.9 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.113 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.3 -13.44 60.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.716 -0.754 . . . . 73.11 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.77 -39.65 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.794 0.33 . . . . 73.24 110.884 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER 26.72 93.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 74.43 111.132 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -48.89 108.22 0.91 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 72.05 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.88 31.39 Favored 'Trans proline' 0 N--CA 1.466 -0.096 0 C-N-CA 122.741 2.294 . . . . 64.51 112.316 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 71.02 110.923 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 72.03 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 75.33 111.096 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.43 110.921 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 61.12 111.138 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 50.44 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 72.44 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 71.24 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 74.3 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 65.34 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.83 -57.99 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 74.42 111.111 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -52.08 170.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 73.12 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.28 167.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 71.25 112.474 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.98 179.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 63.02 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.93 -64.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 75.44 112.484 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.1 mm-40 -100.47 1.97 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.44 110.906 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.12 148.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 65.34 110.881 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -13.86 7.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.913 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.32 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 71.25 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 74.04 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 65.24 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.34 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 61.51 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 75.11 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.25 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 72.03 110.892 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 71.34 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -85.18 -31.01 23.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.12 110.752 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.95 119.41 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 71.21 112.438 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.06 126.18 46.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.299 . . . . 62.41 110.888 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -71.03 -20.29 62.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.41 160.5 33.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.589 0.709 . . . . 63.43 110.886 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.677 2.251 . . . . 75.52 112.352 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -29.61 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 63.41 111.172 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -57.16 138.95 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 75.43 110.944 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 72.5 110.916 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.818 0.342 . . . . 73.4 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.21 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 63.34 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 54.21 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.008 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 61.1 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.008 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 70.42 111.156 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.739 0.225 . . . . 63.43 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 62.52 111.088 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' HG23 ' A' ' 52' ' ' VAL . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 23.15 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.3 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 53.52 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 54.13 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 73.35 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 72.43 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.881 0.372 . . . . 62.5 110.929 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 70.31 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 40.34 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 43.14 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 65.53 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.24 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 54.45 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 62.44 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.826 0.346 . . . . 72.21 110.901 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 64.54 110.937 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 41.23 111.121 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 65.2 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.983 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 71.35 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.983 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 CA-C-O 120.736 0.223 . . . . 71.52 112.394 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 70.43 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 50.13 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 53' ' ' PHE . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 54.05 111.083 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' VAL . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 51.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 34.23 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 62.43 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 55.11 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 62.45 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.7 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.779 0.323 . . . . 73.24 110.922 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 53.41 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 71.54 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 53.32 112.457 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 50.33 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 71.02 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.25 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 72.4 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.69 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 54.34 110.855 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.817 0.342 . . . . 72.01 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 65.14 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 54.53 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 44.44 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.997 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 50.13 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.997 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.165 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.756 0.232 . . . . 73.54 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 52' ' ' VAL . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 60.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 50.5 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 48' ' ' ASP . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.34 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 45.13 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.877 0.37 . . . . 71.14 110.971 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 60.12 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 62.33 110.931 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.24 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 64.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 32.45 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 50.32 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.05 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 54.13 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.842 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.832 0.348 . . . . 53.25 110.9 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 71.11 110.901 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.965 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 44.34 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.59 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.163 0 CA-C-O 120.793 0.247 . . . . 73.42 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 63.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.45 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 64.04 111.133 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 52' ' ' VAL . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 13.02 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' N ' HG12 ' A' ' 56' ' ' VAL . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 50.43 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 72.2 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 63.44 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 62.14 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.844 0.354 . . . . 75.32 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 30.2 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 45.41 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.1 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 42.22 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 71.43 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 73.3 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 61.31 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.707 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 61.35 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 63.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.03 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.752 0.311 . . . . 72.54 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 52.15 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 63.23 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 64.43 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.888 ' O ' HG22 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.14 110.861 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.579 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.579 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 44.41 111.104 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.699 0.208 . . . . 51.42 112.301 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 60.55 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 72.4 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 71.25 111.087 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 54.35 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.44 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 40.41 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 64.3 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.339 . . . . 62.11 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 41.4 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 61.52 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.03 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 65.31 110.873 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 72.4 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.41 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 53.32 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.708 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 72.02 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 64.35 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 64.31 110.794 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 73.33 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 61.34 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 53.02 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.14 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 63.15 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.698 0.208 . . . . 65.31 112.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.04 110.835 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 49' ' ' ASN . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 50.2 110.917 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 61.14 111.098 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 62.54 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 44.22 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.793 0.33 . . . . 71.44 110.889 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 63.33 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 55.33 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 51.11 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 34.04 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 1.066 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 44.41 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.695 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 1.066 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 70.13 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.51 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.695 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 62.45 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.545 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.25 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 70.13 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.855 0.359 . . . . 53.32 110.927 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 65.54 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 65.21 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.969 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 55.31 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.969 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.733 0.222 . . . . 75.55 112.331 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 64.14 111.081 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 41.21 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 52.22 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 62.43 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 45.2 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 65.13 111.113 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 71.4 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.14 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 70.11 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 64.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 33.3 112.467 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 73.45 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.31 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 73.44 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 50.22 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 52.15 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.347 . . . . 75.11 110.87 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 71.2 110.85 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.979 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 62.25 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 53.24 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.175 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.714 0.214 . . . . 61.33 112.281 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.608 ' O ' HG22 ' A' ' 52' ' ' VAL . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 73.32 110.928 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 49' ' ' ASN . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 44.44 111.116 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.671 ' HA ' HG22 ' A' ' 56' ' ' VAL . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 64.44 110.888 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 34.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 64.22 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 62.25 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 51.23 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 64.35 110.904 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 53.31 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.15 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 62.53 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 61.5 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.584 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 61.23 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 54.14 110.958 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.021 ' O ' HG22 ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 45.12 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.021 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 70.4 111.166 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.849 0.27 . . . . 73.42 112.377 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 49' ' ' ASN . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.51 111.075 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HA ' HG22 ' A' ' 56' ' ' VAL . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 71.51 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 53' ' ' PHE . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 73.34 111.135 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.03 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.03 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 52.4 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.15 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.33 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 61.11 111.073 179.855 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.816 0.341 . . . . 64.12 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.53 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.32 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 52.32 110.901 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.7 t30 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 62.55 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 55.22 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 70.31 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 64.04 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 71.12 110.879 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.047 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.35 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.047 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 CA-C-O 120.774 0.239 . . . . 71.52 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 70.54 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 44.15 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 53' ' ' PHE . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' HG23 ' A' ' 52' ' ' VAL . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 64.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 72.5 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 55.33 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 64.14 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 73.34 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 43.32 111.059 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.895 0.378 . . . . 62.3 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 61.33 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 52.13 110.838 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 44.22 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 54.44 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 73.15 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 65.14 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 62.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 64.21 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 24.44 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 63.44 110.866 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 72.04 110.912 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 70.43 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 44.41 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 63.33 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 41.25 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.981 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 61.21 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.981 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 43.02 111.157 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.718 0.216 . . . . 74.35 112.273 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.689 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 70.5 110.91 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 63.11 110.877 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 48' ' ' ASP . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 51.52 111.099 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' N ' HG23 ' A' ' 52' ' ' VAL . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.3 111.158 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.416 ' N ' HG12 ' A' ' 56' ' ' VAL . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 73.51 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 73.42 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.686 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 41.2 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.686 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 63.35 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 73.45 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 53.54 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.22 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 62.25 110.894 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 62.43 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 65.21 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.664 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.664 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 62.31 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.3 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.707 0.211 . . . . 61.33 112.305 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.33 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 72.42 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 63.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 70.43 111.07 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 56' ' ' VAL . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 65.32 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 44.34 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 60.42 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.854 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.888 0.375 . . . . 63.44 110.975 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.02 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.1 mm100 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 65.43 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 64.04 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 25.13 112.453 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.21 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.687 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 72.13 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 64.11 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.591 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.01 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 73.43 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.4 110.882 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 63.32 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 70.43 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 73.04 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 11.21 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 60.4 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.594 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.974 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 65.05 111.192 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.09 0 CA-C-O 120.777 0.24 . . . . 75.42 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 52' ' ' VAL . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 52' ' ' VAL . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 41.14 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 48' ' ' ASP . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 51.01 111.149 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 64.33 111.152 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' N ' HG12 ' A' ' 56' ' ' VAL . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 71.52 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 61.43 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 33.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.22 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.13 111.121 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.9 0.381 . . . . 73.14 110.999 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 60.14 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 61.11 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 34.41 112.483 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.04 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.23 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.781 0.325 . . . . 63.12 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.966 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 72.14 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 64.54 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.586 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.34 111.085 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.23 0.107 0 CA-C-O 120.763 0.234 . . . . 75.22 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.11 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 53.11 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 65.24 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 24.41 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 64.35 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 63.22 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 62.04 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 63.1 110.855 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.77 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.773 0.321 . . . . 61.14 110.867 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 65.33 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 23.11 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.43 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 54.22 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 41.44 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 64.03 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 65.44 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 62.44 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.785 0.326 . . . . 73.01 110.916 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 45.44 110.877 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 53.55 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 64.11 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.135 0 CA-C-O 120.748 0.228 . . . . 64.25 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.2 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 60.51 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 53' ' ' PHE . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 72.24 111.115 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HA ' HG22 ' A' ' 56' ' ' VAL . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 53' ' ' PHE . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 42.34 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.04 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.12 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.756 0.312 . . . . 75.22 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 42.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 64.21 110.852 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 44.21 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 52.52 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.684 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 72.3 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 34.21 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 73.23 110.929 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 60.33 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 54.43 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 34.35 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 54.42 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.656 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.11 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 CA-C-O 120.81 0.254 . . . . 64.12 112.36 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 52' ' ' VAL . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 50.21 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 53' ' ' PHE . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HA ' HG22 ' A' ' 56' ' ' VAL . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 71.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.661 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 60.01 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 65.51 111.129 179.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 64.05 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 51.15 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 65.44 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.04 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 65.32 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 74.44 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 43.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 41.34 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.42 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 55.41 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 71.11 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 65.23 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.32 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 1.045 ' O ' HG22 ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 1.045 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.527 0.134 0 CA-C-O 120.741 0.226 . . . . 73.41 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 52' ' ' VAL . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 53' ' ' PHE . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 61.43 111.121 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 56' ' ' VAL . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 45.52 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 72.4 111.116 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 63.15 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 45.22 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 63.43 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 73.21 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 54.5 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.04 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 62.33 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 74' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.792 0.33 . . . . 73.2 110.907 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 62.22 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.21 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 43.22 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 35.41 112.465 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 72.43 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 32.33 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 63.43 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 51.3 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.342 . . . . 61.44 110.887 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.22 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 CA-C-O 120.804 0.252 . . . . 71.24 112.297 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 64.32 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 54.32 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 72.05 111.11 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.401 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 62.11 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 44.53 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.814 0.34 . . . . 74.22 110.925 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 70.55 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 61.21 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 52.34 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 60.52 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 73.01 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 97' ' ' SER . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 63.32 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 55.1 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 45.33 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.76 0.314 . . . . 71.05 110.915 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 44.3 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 44.0 112.409 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.96 ' O ' HG22 ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 HD12 ' HD1' ' A' ' 32' ' ' TYR . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.01 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.735 0.223 . . . . 71.51 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 50.31 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 71.12 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 42.31 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 43.12 111.097 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 43.31 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 73.22 111.072 179.837 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.815 0.34 . . . . 62.44 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 51.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 32.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 71.42 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 1.094 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.592 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 1.094 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 45.23 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 54.31 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 97' ' ' SER . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.587 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 50.14 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 63.13 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 64.32 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.749 0.309 . . . . 75.12 110.879 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 64.23 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 53.44 112.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 70.53 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 29' ' ' GLY . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.7 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.118 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.767 0.236 . . . . 64.51 112.316 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 52' ' ' VAL . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.24 110.923 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 72.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 53.45 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' ASN . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 60.5 111.096 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.921 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 34.23 111.138 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 45.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 64.54 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 54.5 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 61.52 111.111 179.861 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.785 0.326 . . . . 74.43 110.913 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 63.45 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 60.02 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.14 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 52.01 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 63.22 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 72.43 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 94' ' ' GLU . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 70.33 110.892 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 41.2 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 65.35 110.752 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 42.35 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -73.58 118.08 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.281 -0.418 . . . . 74.03 110.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -96.49 -26.78 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 74.01 110.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.63 -25.87 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 53.22 111.132 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.82 68.58 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.798 -0.715 . . . . 65.41 112.465 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -55.68 -41.87 74.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 74.02 110.937 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -17.41 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.864 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.16 -15.61 61.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 53.12 112.475 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.71 -20.89 52.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 75.51 110.903 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.62 -21.78 30.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 53.55 112.509 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.92 -22.92 20.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 70.35 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -93.96 -46.36 7.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.892 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -67.9 -35.55 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 65.25 111.045 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 17.8 t -76.3 -33.41 59.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 64.25 110.832 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 9.9 pt-20 -86.7 -27.31 23.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.912 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 -20.81 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.41 111.12 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.9 pp -98.74 -13.43 20.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 64.33 110.888 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 14' ' ' SER . 26.2 mmtm -39.73 109.24 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 60.11 110.881 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.5 23.77 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.719 2.28 . . . . 64.24 112.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 23.4 t70 51.2 38.05 20.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 70.15 110.826 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 80.9 p -99.61 -16.27 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 50.52 110.864 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 58.5 mt-30 -116.83 -61.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 54.23 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.09 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.4 110.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.21 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 63.34 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 54.21 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.008 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 61.1 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.008 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t -36.62 -46.98 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 70.42 111.156 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -64.16 -55.48 21.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.842 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.779 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -59.92 -45.96 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.902 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -58.72 -48.5 80.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.121 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -49.97 -22.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -95.31 -41.87 8.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.92 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.5 m -58.71 -7.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 53.32 111.172 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.69 -32.14 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 71.41 111.123 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.09 0.92 73.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.639 -0.791 . . . . 75.13 112.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -33.73 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 74.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -37.52 -47.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 72.21 111.108 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.53 111.93 4.81 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 61.43 110.849 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.02 35.48 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 63.43 112.363 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 62.52 111.088 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' HG23 ' A' ' 52' ' ' VAL . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 23.15 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.3 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 53.52 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 54.13 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 73.35 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 72.43 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.42 -24.17 28.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.81 166.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 55.4 110.855 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.29 172.72 54.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 64.54 112.496 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -80.7 -179.31 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 72.33 110.897 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.47 -54.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 64.21 112.463 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' O ' HD22 ' A' ' 74' ' ' LEU . 5.6 mm-40 -102.85 0.28 32.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 75.03 110.865 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 77.67 -48.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.54 110.876 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -92.05 -9.92 40.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 62.5 110.929 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 70.31 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 40.34 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 43.14 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 65.53 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.24 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 54.45 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 62.44 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -52.14 -31.88 33.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -85.78 -37.04 9.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -97.21 111.26 23.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.21 110.917 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -90.0 10.12 25.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 74.21 110.891 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.19 159.93 30.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.614 0.721 . . . . 62.42 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 100.37 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.693 2.262 . . . . 63.13 112.32 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -92.86 -26.84 17.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 73.22 111.156 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -121.76 51.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 73.14 110.901 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 60.25 110.958 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.832 0.349 . . . . 73.52 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.59 172.24 3.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 71.34 110.884 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.37 129.76 56.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 61.21 110.845 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.35 -24.33 11.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.2 111.12 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.8 156.49 10.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 50.41 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -109.93 10.26 24.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 74.2 110.902 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -21.22 62.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.883 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.22 -74.07 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 24.33 112.453 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -71.2 -9.76 58.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 73.12 110.926 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.04 -39.99 5.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 65.4 112.47 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.02 -21.96 66.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 72.02 110.892 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -93.82 -46.88 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.949 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -68.09 -35.49 78.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.22 111.037 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 18.9 t -76.04 -33.24 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.827 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 9.6 pt-20 -87.45 -26.89 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.906 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 -17.53 54.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -100.24 -13.87 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 62.42 110.886 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' N ' HD12 ' A' ' 17' ' ' LEU . 33.1 mmtt -41.89 154.92 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 73.43 110.86 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -6.73 19.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 63.54 112.295 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 1.5 m-20 -136.76 53.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.03 110.818 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 5.5 m -98.98 -18.28 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 61.45 110.878 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.763 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 50.5 mt-30 -106.38 -13.93 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.925 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -101.17 -73.78 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.901 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 64.54 110.937 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 22' ' ' GLN . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 41.23 111.121 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 65.2 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.983 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 71.35 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.983 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t -37.02 -46.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.92 -55.94 18.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 64.0 110.857 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.793 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -60.24 -46.76 88.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.53 110.904 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -56.75 -49.3 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.78 -22.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -95.33 -39.7 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 64.25 110.927 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.3 m -62.08 -5.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.12 111.15 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.82 -10.51 24.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 63.55 111.124 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.01 -7.76 59.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 74.12 112.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.38 2.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.753 0.311 . . . . 73.44 110.874 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -33.08 -48.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 74.01 111.17 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.2 mt-30 -60.29 111.89 4.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.519 0.676 . . . . 74.44 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 54.1 Cg_endo -69.73 -16.64 37.78 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.648 2.232 . . . . 71.52 112.394 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 70.43 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 50.13 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 53' ' ' PHE . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 54.05 111.083 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' VAL . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 51.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 34.23 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 62.43 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 55.11 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 62.45 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.67 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -61.83 145.96 51.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 74.33 110.921 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.3 -47.22 3.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 72.21 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -52.03 149.35 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 72.54 110.972 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.88 -64.83 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 45.24 112.447 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.5 pt-20 -100.55 -33.54 10.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 72.54 110.921 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 163.38 140.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 75.11 110.83 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 74' ' ' LEU . 1.7 mm? -72.04 -9.32 58.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.922 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 53.41 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 71.54 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 53.32 112.457 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 50.33 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 71.02 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.25 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 72.4 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.69 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -55.07 -30.32 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 54.34 110.855 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.88 -125.34 4.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 62.41 112.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -97.78 129.31 44.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 71.44 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -99.93 10.11 41.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.946 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 144.8 86.01 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.622 0.725 . . . . 72.13 110.842 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 100.93 0.84 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.719 2.279 . . . . 70.33 112.356 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.69 20.0 12.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 72.42 111.16 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -110.7 173.73 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.923 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.3 110.84 179.882 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mmt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.803 0.335 . . . . 72.53 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -174.3 119.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.889 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -109.08 -30.62 7.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 62.33 110.889 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.3 -23.71 57.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 73.13 111.149 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.99 108.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 64.13 112.472 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -84.8 -44.24 13.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 72.04 110.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -17.48 36.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 43.01 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 102.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 75.42 112.483 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -89.48 -26.9 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 72.21 110.882 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.0 -16.18 45.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.78 -0.724 . . . . 70.43 112.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -86.08 -28.19 24.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.398 . . . . 74.23 110.877 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.21 -38.48 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 52.24 110.847 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -73.02 -20.43 61.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.076 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 34.4 t -96.99 -25.39 15.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.884 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.6 pt-20 -99.74 -24.8 14.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 65.44 110.903 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -94.4 -17.21 22.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.35 111.096 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.8 mt -113.31 -11.54 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.972 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.58 107.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.645 0.736 . . . . 44.42 110.909 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.2 Cg_endo -69.76 67.48 1.74 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.683 2.255 . . . . 63.5 112.251 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.6 t0 52.67 29.15 6.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 51.23 110.848 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 49.2 m -102.41 -11.67 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.788 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.3 mp0 -116.72 -63.08 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.4 110.901 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -39.04 -74.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 72.01 110.89 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 65.14 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 54.53 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 44.44 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.997 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 50.13 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.997 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t -36.7 -46.93 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.165 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.69 -56.05 18.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.54 110.863 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.777 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.86 -45.92 90.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 75.33 110.854 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -58.37 -48.65 79.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 53.42 111.044 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -49.68 -22.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.849 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 -39.87 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.917 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.4 m -61.7 -6.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 63.34 111.152 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.0 -13.51 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.121 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.59 -12.17 59.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 61.24 112.487 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.24 -37.22 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 61.44 110.907 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.632 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -11.97 107.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 71.23 111.189 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.08 108.07 0.93 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.653 0.74 . . . . 74.4 110.933 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.07 32.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.628 2.219 . . . . 73.54 112.353 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 52' ' ' VAL . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 60.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 50.5 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 48' ' ' ASP . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.34 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 45.13 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.438 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -25.29 51.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -52.2 145.81 10.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.86 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.27 -50.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.495 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.76 120.02 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.877 0.37 . . . . 74.21 110.818 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.55 -44.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 60.41 112.468 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -102.92 -4.47 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 75.02 110.913 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER 80.01 -41.04 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.812 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.34 -13.61 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.971 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 60.12 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 62.33 110.931 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.24 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 64.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 32.45 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 50.32 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.05 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 54.13 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -103.88 29.41 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.842 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.09 -28.49 41.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.787 -0.721 . . . . 65.43 112.463 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.03 116.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 75.52 110.891 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -90.13 10.62 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 64.33 110.878 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.98 159.08 55.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.592 0.711 . . . . 74.35 110.887 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.64 2.227 . . . . 65.11 112.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -22.82 8.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.165 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -78.5 128.84 34.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 55.21 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.413 . . . . 72.33 110.879 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.857 0.36 . . . . 73.44 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -72.93 -57.74 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 73.55 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.17 127.47 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.876 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.62 -22.98 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 64.2 111.11 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.61 97.69 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.703 -0.76 . . . . 72.45 112.477 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.42 10.14 21.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 53.24 110.876 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -18.09 57.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.878 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.65 -16.84 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 73.4 112.53 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.16 -6.15 55.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 75.32 110.923 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.11 -29.3 17.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 63.41 112.463 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -58.55 -24.77 61.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.924 0.393 . . . . 74.33 110.898 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -96.61 -52.54 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.932 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -60.73 -41.36 95.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.146 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -70.99 -41.06 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.829 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 12.1 pt-20 -77.84 -24.87 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.47 -25.92 38.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 70.24 111.111 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -105.94 -11.57 16.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 75.33 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.69 157.22 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.549 0.69 . . . . 75.22 110.923 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -8.51 23.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.667 2.244 . . . . 60.52 112.341 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.9 t70 -58.66 -18.46 30.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.883 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 1.1 t -92.73 -5.56 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 55.3 110.924 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.12 -37.82 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 70.1 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -69.8 -71.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.25 110.9 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 71.11 110.901 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.965 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 44.34 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.59 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -30.35 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.18 -66.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.839 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.764 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -66.83 -44.87 79.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.867 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.41 -53.64 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.097 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.18 -25.88 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.33 110.863 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -95.46 -40.28 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.96 -5.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 61.31 111.156 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.36 -16.46 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.34 111.063 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.48 69.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.773 -0.727 . . . . 72.32 112.469 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -36.39 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 73.1 110.92 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.21 -45.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 52.51 111.156 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 17.4 mt-30 -56.94 110.79 2.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.541 0.686 . . . . 63.24 110.957 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.9 Cg_endo -69.82 -17.93 37.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 73.42 112.381 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 63.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.45 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 64.04 111.133 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 52' ' ' VAL . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 13.02 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.408 ' N ' HG12 ' A' ' 56' ' ' VAL . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 50.43 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 72.2 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 63.44 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 62.14 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.76 16.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -52.15 155.03 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 72.45 110.978 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.33 -145.26 17.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 72.03 112.495 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -57.21 120.09 7.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 72.35 110.917 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.76 -64.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 72.55 112.495 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.3 mp0 -100.82 -36.34 9.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 63.55 110.895 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.59 136.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.833 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.98 -12.6 61.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 75.32 110.921 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 30.2 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 45.41 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.1 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 42.22 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 71.43 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 73.3 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 61.31 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.707 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 61.35 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 63.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.03 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -54.69 -28.62 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.05 -21.08 44.67 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.442 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -78.16 175.44 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 72.41 110.866 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -98.16 -20.99 16.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.889 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.666 ' OD1' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -56.29 144.85 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 35.51 110.92 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 100.28 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.692 2.261 . . . . 65.05 112.407 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.666 HG23 ' OD1' ' A' ' 105' ' ' ASP . 5.4 p -119.77 20.03 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.129 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -112.03 153.63 26.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.911 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.875 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.812 0.339 . . . . 72.52 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 178.02 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.834 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.8 141.08 38.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.872 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.5 9.0 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 61.01 111.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.48 77.57 0.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 42.54 112.511 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -109.94 10.12 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 73.22 110.881 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -12.51 59.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.32 110.848 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.27 110.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.674 -0.774 . . . . 72.44 112.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.61 -7.73 53.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 74.43 110.896 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -32.5 8.33 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 41.6 mm-40 -57.1 -20.99 28.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 71.31 110.853 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -104.55 -46.46 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.926 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -68.26 -19.45 64.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 43.24 111.109 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 26.0 t -94.67 -32.56 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.806 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 12.6 mm-40 -93.57 -23.0 18.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.846 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -90.96 -26.57 19.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 52.14 111.169 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.7 mt -105.11 -3.68 22.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.13 110.958 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.88 151.09 0.2 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.569 0.7 . . . . 75.03 110.866 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -29.29 23.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.644 2.229 . . . . 75.23 112.295 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 23.7 m-20 -59.25 -17.66 30.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.871 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 51.1 m -93.03 -5.74 49.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.33 110.88 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.02 -38.54 5.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.44 110.911 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt -69.48 -71.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 72.54 110.955 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 52.15 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 63.23 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 64.43 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.888 ' O ' HG22 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.14 110.861 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.579 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.579 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.9 t -36.28 -47.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 44.41 111.104 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -54.23 -67.69 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.839 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.0 -12.9 61.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.86 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -69.74 -42.0 74.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 52.34 111.118 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -67.12 -19.79 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.886 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.73 -46.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 54.05 110.925 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' A' ' 37' ' ' ALA . 21.9 m -59.4 -8.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 73.53 111.125 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.43 30.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.096 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.32 -2.9 65.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.747 -0.739 . . . . 42.45 112.533 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.39 -37.58 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 72.51 110.9 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -36.26 -49.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.3 111.137 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -61.37 112.38 5.84 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.532 0.682 . . . . 73.32 110.898 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -18.94 36.52 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.739 2.293 . . . . 51.42 112.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 60.55 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 72.4 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 71.25 111.087 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 54.35 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.44 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 40.41 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 64.3 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.44 -18.33 50.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -52.02 169.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.96 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.18 -30.18 16.89 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.774 -0.727 . . . . 64.15 112.472 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -54.29 120.06 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 71.03 110.956 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.59 -65.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.741 -0.742 . . . . 55.22 112.52 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' SER . 25.7 mm-40 -100.77 -35.59 9.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 73.34 110.922 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.52 137.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 62.43 110.835 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.505 HD21 ' CD ' ' A' ' 70' ' ' GLN . 25.4 mt -70.46 -12.7 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.921 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 41.4 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 61.52 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.03 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 65.31 110.873 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 72.4 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.41 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 53.32 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.708 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 72.02 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 64.35 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 64.31 110.794 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -113.01 26.95 10.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.96 67.36 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 54.33 112.52 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.45 123.63 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 75.45 110.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -95.78 10.13 38.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 73.12 110.899 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.1 160.53 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.489 0.661 . . . . 60.44 110.934 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 98.51 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.248 . . . . 70.53 112.39 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -63.38 -25.86 68.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 51.2 111.131 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 171.15 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.883 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 71.33 110.903 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.754 0.311 . . . . 53.31 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 p -137.55 137.67 38.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 72.11 110.923 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -137.12 53.89 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.01 20.06 18.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 53.12 111.104 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.84 102.48 2.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.656 -0.783 . . . . 62.53 112.518 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -107.0 10.1 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.969 0.414 . . . . 73.42 110.959 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -16.28 62.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.919 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.37 -17.41 59.36 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.686 -0.769 . . . . 70.32 112.481 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -6.52 49.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 72.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.55 6.27 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.693 -0.765 . . . . 32.14 112.426 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -49.03 -27.64 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.392 . . . . 65.24 110.811 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.83 -59.97 1.69 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.889 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 17' ' ' LEU . . . -58.69 -50.37 74.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 43.43 111.079 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -59.77 -40.61 88.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.88 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -80.72 -22.78 39.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 61.13 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -84.51 -21.58 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 70.33 111.148 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 13' ' ' ALA . 3.2 mt -103.41 -18.06 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.843 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -41.83 108.98 0.64 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 70.12 110.862 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.57 37.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 54.43 112.319 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 58.43 19.83 6.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.951 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.45 -12.23 18.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 64.01 110.823 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -116.46 -62.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 65.5 110.926 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt -39.03 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 73.33 110.876 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 61.34 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 53.02 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.14 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 63.15 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -31.94 -47.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.52 -57.06 4.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.882 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.6 tptt -60.26 -55.54 32.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.836 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.47 -52.86 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.21 111.121 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.24 -25.45 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 65.13 110.866 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -40.3 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 72.33 110.948 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.83 -5.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.106 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.31 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.104 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -12.17 59.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 72.31 112.499 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.638 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.12 -37.45 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.761 0.315 . . . . 63.31 110.826 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.638 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.1 107.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.422 . . . . 72.11 111.081 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.03 108.02 0.92 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.533 0.683 . . . . 71.42 110.917 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.05 33.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.66 2.24 . . . . 65.31 112.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.04 110.835 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 49' ' ' ASN . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 50.2 110.917 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 61.14 111.098 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 62.54 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 44.22 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.22 -28.38 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.73 157.79 1.51 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.868 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.33 -141.94 29.65 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 65.14 112.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 178.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 72.44 110.936 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.39 -64.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 53.44 112.43 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 31.7 mt-10 -100.53 -33.48 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 64.35 110.888 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.58 140.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 72.13 110.812 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.1 mm? -72.38 -9.91 59.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 71.44 110.889 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 63.33 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 55.33 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 51.11 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 34.04 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 1.066 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 44.41 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.695 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 1.066 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 70.13 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.51 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.695 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 62.45 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.545 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.25 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 70.13 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -51.69 -31.78 27.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 113.19 3.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.749 . . . . 63.44 112.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -99.39 133.46 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.329 . . . . 72.55 110.933 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -99.95 10.21 41.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.881 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 160.57 75.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 63.11 110.861 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.625 2.217 . . . . 63.12 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 m -56.61 -23.92 44.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.19 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 120.97 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 73.52 110.871 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 74.24 110.936 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.749 0.309 . . . . 73.03 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -133.8 166.8 21.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.25 110.879 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.84 127.5 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 62.0 110.872 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.58 -23.15 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.055 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.35 121.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 70.14 112.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -93.67 10.14 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 72.53 110.901 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -4.88 59.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.892 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 -17.32 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 72.43 112.465 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.9 -13.77 35.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 73.35 110.825 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.62 -40.74 4.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 74.22 112.476 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -60.75 -22.75 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 72.41 110.875 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.08 -52.32 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 63.03 110.92 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.72 -41.99 99.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 63.54 111.074 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -69.38 -36.57 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.881 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.45 -24.25 31.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 64.01 110.901 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -90.13 -13.7 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 63.23 111.108 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -110.84 -18.31 13.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.964 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 136.41 5.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.586 0.708 . . . . 72.41 110.891 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 61.18 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 71.14 112.323 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -13.81 5.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 53.22 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.98 -12.24 59.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.8 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 6.7 mm100 -115.33 -64.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -41.32 -73.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 53.32 110.927 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 65.54 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 65.21 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.969 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 55.31 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.969 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.4 t -41.32 -43.07 2.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.58 -52.16 66.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.841 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.8 -20.3 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.923 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -73.44 -40.47 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.099 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.62 -19.6 64.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.821 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.2 7.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 54.31 110.913 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 19.7 m -60.12 -8.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 44.3 111.079 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -94.25 -9.86 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 54.54 111.078 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.16 -8.61 58.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.806 -0.711 . . . . 61.2 112.529 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.4 -35.46 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 70.34 110.885 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.72 -49.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 64.02 111.113 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 23.6 mt-30 -63.64 112.72 7.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.12 110.921 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.5 Cg_endo -69.82 -14.28 35.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.628 2.219 . . . . 75.55 112.331 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 64.14 111.081 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 41.21 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 52.22 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 62.43 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 45.2 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.98 -48.82 10.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 65.13 111.113 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.22 166.94 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.889 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.16 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.683 -0.77 . . . . 73.41 112.583 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -66.69 120.46 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 63.14 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.71 -57.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.771 . . . . 45.13 112.525 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 76' ' ' ASP . 4.1 mm-40 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 65.5 110.886 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.47 ' HB2' HD22 ' A' ' 74' ' ' LEU . 68.2 m -35.92 -53.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.863 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? -95.11 -24.13 17.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 71.4 110.875 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 72' ' ' GLU . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.14 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 70.11 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 64.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 33.3 112.467 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 73.45 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.31 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 73.44 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 50.22 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 52.15 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -52.82 -33.95 51.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.87 -76.27 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 73.12 112.551 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.66 110.41 22.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 52.21 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -95.73 10.15 37.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 73.11 110.894 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.35 155.67 35.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 72.11 110.918 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 100.87 0.85 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.719 2.279 . . . . 50.45 112.391 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -95.64 20.04 10.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 74.33 111.13 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 -45.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 63.25 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 tttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 62.41 110.943 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.677 0.275 . . . . 74.23 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -142.38 134.21 27.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 61.43 110.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -53.29 127.75 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.52 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.02 -24.79 14.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 70.5 111.161 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.51 173.83 32.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.484 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -108.9 10.11 26.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 72.35 110.819 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -17.25 63.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 61.24 110.865 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.37 119.3 1.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.746 -0.74 . . . . 70.03 112.501 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -63.23 -16.06 59.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 74.31 110.856 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.5 -42.94 4.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 74.22 112.488 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -65.34 -20.4 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 74.2 110.834 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -47.19 6.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 72.31 110.823 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.55 -34.99 76.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 45.11 111.129 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 44.3 m -76.39 -32.98 58.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 64.1 110.878 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 10.7 pt-20 -87.77 -26.92 22.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 75.52 110.878 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.04 -17.74 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 71.55 111.069 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -99.76 -14.65 18.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 74.34 110.841 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' N ' HD12 ' A' ' 17' ' ' LEU . 26.0 mmtt -41.3 153.42 0.25 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.59 0.709 . . . . 63.13 110.871 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 75.32 112.334 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.24 40.61 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.4 110.833 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.412 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 29.4 m -100.29 -18.98 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 60.22 110.862 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -115.48 -63.15 1.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.929 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -40.65 -71.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.87 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 71.2 110.85 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.979 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 62.25 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 53.24 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t -30.01 -49.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -66.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.81 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.77 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -67.26 -44.61 78.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 72.14 110.905 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.696 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.52 -53.78 8.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.065 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -49.69 -25.25 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 72.34 110.886 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -95.59 -41.74 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 65.24 110.806 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -59.29 -7.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.14 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.23 -31.95 16.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 31.12 111.083 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.71 -3.28 66.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.683 -0.77 . . . . 60.33 112.42 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.93 -50.42 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 51.22 110.899 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER 33.83 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 74.34 111.156 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.91 108.66 1.05 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 74.55 110.916 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -16.62 37.52 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.748 2.299 . . . . 61.33 112.281 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.608 ' O ' HG22 ' A' ' 52' ' ' VAL . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 73.32 110.928 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 49' ' ' ASN . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 44.44 111.116 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.671 ' HA ' HG22 ' A' ' 56' ' ' VAL . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 64.44 110.888 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 34.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 64.22 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 62.25 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 51.23 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.43 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.24 171.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.1 110.92 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.5 -59.58 7.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 43.4 112.475 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.46 121.58 9.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 73.33 110.87 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.08 -65.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 44.44 112.516 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 73' ' ' SER . 22.4 mt-10 -100.53 -35.49 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 75.24 110.879 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.79 138.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 54.5 110.858 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.563 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.0 mm? -71.12 -9.52 58.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.904 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 53.31 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.15 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 62.53 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 61.5 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.584 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -32.88 69.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 61.23 110.89 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.11 95.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.804 -0.713 . . . . 52.1 112.437 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.13 133.67 35.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 42.41 110.908 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -98.6 10.23 41.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 70.12 110.905 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.01 160.48 76.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.556 0.693 . . . . 73.42 110.9 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.7 90.78 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.694 2.263 . . . . 52.13 112.357 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 p -109.38 20.12 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 64.35 111.102 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -69.6 150.78 46.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 75.12 110.902 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 71.15 110.921 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.736 0.303 . . . . 73.23 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.33 106.66 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 63.52 110.836 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -67.67 -25.67 65.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.894 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 20.3 8.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 75.5 111.061 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.31 111.01 3.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 72.04 112.459 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -91.16 10.18 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 72.31 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -89.36 -1.15 57.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 52.13 110.911 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.92 -17.32 1.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.695 -0.764 . . . . 75.31 112.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.12 -9.97 59.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 73.4 110.843 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.97 -9.82 58.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 60.12 112.484 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.22 -28.29 25.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.938 0.399 . . . . 73.12 110.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.21 -38.24 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.932 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -71.44 -36.09 71.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 70.24 111.103 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -79.13 -29.25 43.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 63.4 110.867 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 13.3 pt-20 -89.42 -22.73 22.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.908 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -86.63 -21.69 26.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 61.54 111.059 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.627 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.7 pp -110.86 -7.72 14.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.953 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -40.92 153.53 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.12 110.889 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 9.75 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.234 . . . . 72.21 112.303 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.89 8.95 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 72.54 110.86 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.84 -9.19 20.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 73.4 110.831 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -109.66 -37.44 5.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 63.34 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -70.64 -71.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 54.14 110.958 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.556 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.021 ' O ' HG22 ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 45.12 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.021 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t -36.27 -46.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 70.4 111.166 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -63.65 -56.12 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 70.2 110.834 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' O ' HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -60.08 -46.68 88.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 71.04 110.944 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -57.16 -49.32 76.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.081 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -49.58 -22.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.856 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -95.36 -39.85 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.3 m -61.95 -5.68 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.076 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.83 -10.74 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 -7.8 59.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.818 -0.706 . . . . 43.43 112.532 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.32 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 54.51 110.929 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -32.74 -48.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.187 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.96 111.27 3.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 75.21 110.891 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -15.05 36.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 73.42 112.377 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 49' ' ' ASN . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.51 111.075 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HA ' HG22 ' A' ' 56' ' ' VAL . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 71.51 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 53' ' ' PHE . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 73.34 111.135 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.03 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.03 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 52.4 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.15 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.33 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.34 -29.35 68.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 61.11 111.073 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.81 170.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 65.43 110.875 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.1 116.2 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 74.32 112.519 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -51.61 137.42 24.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 61.43 110.863 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.99 -63.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 54.43 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -102.02 -2.41 29.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.375 . . . . 54.53 110.873 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.0 OUTLIER 85.14 144.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.31 110.805 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.5 -14.82 14.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 64.12 110.874 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.53 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.32 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 52.32 110.901 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.7 t30 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 62.55 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 55.22 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 70.31 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 64.04 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -52.79 -31.58 39.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.85 59.04 1.78 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 44.22 112.441 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -52.09 121.61 7.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 73.32 110.911 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.63 10.07 27.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 61.45 110.916 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -51.57 158.48 1.5 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.567 0.699 . . . . 65.04 110.865 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 88.74 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.622 2.215 . . . . 75.13 112.386 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.2 p -78.01 -24.88 47.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 74.52 111.115 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -135.32 82.45 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 71.22 110.903 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 71.44 110.88 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.724 0.297 . . . . 64.41 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.11 -170.21 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.814 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -110.59 150.23 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 75.53 110.876 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.17 -14.18 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.31 111.095 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.0 173.64 16.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.767 . . . . 63.13 112.475 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -109.28 10.2 25.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 74.13 110.911 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -18.21 65.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.878 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.86 -23.25 5.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.11 112.577 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -75.18 -6.6 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.932 0.396 . . . . 74.41 110.88 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.89 -27.95 17.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.1 112.53 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -60.09 -24.45 64.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.942 0.401 . . . . 75.32 110.868 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.53 -50.58 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 70.43 110.934 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.58 -40.44 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 61.22 111.067 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 4.8 t -71.59 -35.88 70.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 54.43 110.875 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 8.7 pt-20 -84.05 -25.69 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 70.42 110.922 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.07 -15.48 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 54.03 111.05 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.7 pp -102.56 -11.31 18.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 64.41 110.933 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 14' ' ' SER . 56.5 mmtt -41.97 153.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.499 0.666 . . . . 65.41 110.87 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -8.71 24.31 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.681 2.254 . . . . 72.12 112.356 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.16 53.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.878 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.549 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 24.9 t -91.47 -15.31 29.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 70.34 110.822 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -110.08 -42.02 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 71.11 110.895 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.64 -71.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 71.12 110.879 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.047 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.35 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.047 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.7 t -39.09 -44.27 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.08 -52.57 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 72.41 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.14 -20.52 59.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.838 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -74.53 -40.32 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 70.45 111.116 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.62 -19.41 64.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.37 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 45.4 110.888 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 37' ' ' ALA . 19.2 m -60.11 -8.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 64.32 111.084 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -93.86 -9.52 37.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 64.23 111.163 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.23 -8.83 58.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 73.4 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.38 -35.47 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.326 . . . . 74.45 110.869 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.82 -48.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 72.31 111.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -58.93 111.24 3.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 74.22 110.891 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -16.55 37.61 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 71.52 112.372 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 70.54 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 44.15 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 53' ' ' PHE . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' HG23 ' A' ' 52' ' ' VAL . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 64.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 72.5 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 55.33 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 64.14 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 73.34 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.97 -41.27 15.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 43.32 111.059 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -51.71 169.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.911 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.59 -117.08 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.653 -0.784 . . . . 62.03 112.461 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -52.15 121.58 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 63.34 110.861 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.59 -63.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 73.35 112.549 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 1.31 40.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 61.24 110.95 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.08 146.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 62.41 110.895 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.1 -14.44 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 62.3 110.923 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 61.33 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 52.13 110.838 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 44.22 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 54.44 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 73.15 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 65.14 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 62.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 64.21 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 24.44 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.52 -27.3 62.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 63.44 110.866 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 101.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 63.34 112.515 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.75 123.33 43.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 75.13 110.903 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -94.44 10.11 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 52.21 110.913 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 155.6 38.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 65.11 110.853 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 99.01 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 55.45 112.297 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -52.43 -29.59 25.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.093 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 153.3 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.922 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.918 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.336 . . . . 71.0 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 t 62.71 89.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 52.53 110.856 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -122.99 130.54 52.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 61.11 110.882 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.74 20.08 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 64.11 111.081 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.27 111.78 3.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 71.14 112.5 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -109.64 10.26 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 75.2 110.906 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -15.43 61.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 63.52 110.857 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.62 -17.36 0.98 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 53.01 112.457 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -81.21 -11.38 59.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 75.44 110.909 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.0 -40.38 4.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.43 112.508 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.65 -22.66 66.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 63.3 110.87 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.42 -43.2 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.1 110.865 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 55.42 111.139 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 41.2 t -95.35 -27.88 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.819 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 12.1 pt-20 -97.35 -26.1 15.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.34 110.872 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -92.1 -20.98 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 51.15 111.103 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 13' ' ' ALA . 4.4 mt -114.06 -1.58 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' SER . 1.9 pttm -37.34 109.92 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.517 0.675 . . . . 75.12 110.862 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 62.5 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.261 . . . . 75.12 112.327 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.73 -14.09 5.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 65.05 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.7 -13.02 60.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.855 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 19.8 mm-40 -115.45 -64.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 55.13 110.865 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -41.46 -72.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 72.04 110.912 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 70.43 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 44.41 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 63.33 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 41.25 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.981 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 61.21 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.981 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.4 t -36.7 -46.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 43.02 111.157 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -55.96 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.868 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -59.9 -46.99 87.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 64.21 110.915 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -56.78 -49.24 75.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 51.54 111.11 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.41 -23.27 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.82 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -95.06 -39.45 10.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 75.35 110.945 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.2 m -63.05 -5.81 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.44 111.141 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.79 -16.52 25.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 53.4 111.113 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.26 69.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.682 -0.77 . . . . 52.34 112.519 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.08 -36.32 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 72.24 110.955 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.28 -45.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 52.01 111.114 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -59.07 111.56 3.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.51 0.672 . . . . 74.15 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -14.34 35.5 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 74.35 112.273 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.689 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 70.5 110.91 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 63.11 110.877 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 48' ' ' ASP . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 51.52 111.099 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' N ' HG23 ' A' ' 52' ' ' VAL . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.3 111.158 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' N ' HG12 ' A' ' 56' ' ' VAL . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.38 -29.67 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -67.37 147.65 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -102.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 52.52 112.492 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -63.22 161.94 12.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 62.11 110.866 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.85 -64.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.757 . . . . 64.02 112.493 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.6 -33.48 10.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 74.11 110.883 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.47 139.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.844 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.2 mm? -72.07 -9.81 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 73.51 110.93 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 73.42 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.686 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 41.2 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.686 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 63.35 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 73.45 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 53.54 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.22 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -95.94 26.84 3.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.28 -77.33 0.16 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.448 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.69 125.64 34.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 74.41 110.887 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.62 10.17 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.91 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.4 144.79 70.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.631 0.729 . . . . 64.52 110.818 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 101.06 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 72.02 112.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -26.18 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.21 111.143 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -80.44 -74.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.21 110.893 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 61.1 110.926 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.751 0.31 . . . . 63.23 110.86 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.8 t -173.82 168.91 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 65.42 110.902 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -137.72 127.25 25.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.62 -24.45 18.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 44.24 111.066 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.13 157.8 27.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 44.22 112.479 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.72 -49.56 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 75.44 110.932 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -19.57 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.873 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.21 100.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.34 112.493 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -85.12 -9.59 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 73.31 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -92.07 -37.39 6.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.679 -0.772 . . . . 43.34 112.491 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mt-10 -48.09 -26.6 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 61.12 110.87 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -102.68 -60.72 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.9 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -61.0 -46.24 91.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 44.23 111.107 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -66.35 -36.87 83.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 54.24 110.779 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 18.2 mm-40 -82.18 -23.13 35.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.977 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -94.1 -10.71 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.07 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.4 pp -112.72 -22.43 10.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.15 110.922 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -42.81 106.3 0.47 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 74.21 110.84 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 65.17 1.87 Allowed 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.71 2.273 . . . . 70.14 112.313 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.8 t70 51.34 42.97 29.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.889 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.521 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 87.9 p -104.93 -17.2 14.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 63.45 110.808 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -110.47 -39.48 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 65.24 110.962 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.07 -73.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 62.25 110.894 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 62.43 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 65.21 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.664 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.664 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 62.31 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.3 t -35.48 -48.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -58.77 -61.5 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 64.2 110.811 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.27 -16.49 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.916 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -68.75 -41.59 78.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 20.54 111.069 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.5 -20.04 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.872 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -95.69 -48.26 5.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 75.32 110.896 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 37' ' ' ALA . 29.9 m -56.65 -9.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.34 111.168 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.32 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 70.44 111.137 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.54 0.92 71.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 64.44 112.508 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.71 -34.54 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.803 0.335 . . . . 72.3 110.905 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -34.86 -48.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.092 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -58.71 111.53 3.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 62.11 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.38 37.64 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 61.33 112.305 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.33 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 72.42 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 63.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 70.43 111.07 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 56' ' ' VAL . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 65.32 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 44.34 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 60.42 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.854 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.58 -58.35 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.58 151.76 21.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.07 -60.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.829 -0.7 . . . . 72.01 112.529 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -52.28 122.75 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 64.41 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.7 -64.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 63.41 112.488 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -100.58 -33.67 10.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.916 0.389 . . . . 42.44 110.905 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.75 139.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 73.2 110.874 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -69.77 -8.17 45.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.504 . . . . 63.44 110.975 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.02 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.1 mm100 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 65.43 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 64.04 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 25.13 112.453 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.21 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.687 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 72.13 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 64.11 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.591 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.01 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 73.43 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -52.04 -34.33 42.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.31 112.54 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 72.24 112.489 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -96.72 159.66 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 75.03 110.871 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -87.46 -22.29 25.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.908 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.6 158.43 1.53 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.56 0.695 . . . . 73.33 110.911 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 101.0 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.697 2.265 . . . . 62.34 112.31 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.6 p -85.13 -25.52 27.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 72.1 111.162 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -101.77 -175.26 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.89 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 62.42 110.872 179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 72.22 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -55.89 163.0 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 63.53 110.9 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.94 121.87 17.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.832 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.95 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 74.35 111.079 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.59 30.29 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.764 -0.731 . . . . 63.54 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.14 8.88 21.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 74.1 110.871 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -51.94 -31.33 28.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 75.52 110.889 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.82 -26.85 65.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 64.43 112.42 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -6.92 50.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 74.25 110.843 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.5 -36.21 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 74.55 112.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mm-40 -51.11 -24.38 3.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 72.14 110.898 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -103.07 -57.53 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 73.2 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.63 92.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 64.01 111.105 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -67.66 -42.22 82.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 73.44 110.841 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 67.4 mm-40 -76.85 -24.75 52.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 62.24 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -81.9 -24.44 35.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.14 111.115 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.5 pp -107.0 -10.99 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.53 110.913 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 3.8 mttm -43.0 106.72 0.5 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.6 0.714 . . . . 75.2 110.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.8 Cg_endo -69.8 69.8 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 73.01 112.364 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 1.3 m-20 -63.86 -8.28 10.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 64.33 110.845 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -79.32 -13.5 59.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 61.25 110.845 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -114.08 -64.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 73.04 110.923 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -43.02 -72.03 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.32 110.878 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 70.43 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 73.04 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 11.21 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 60.4 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.974 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -29.92 -48.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 65.05 111.192 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -64.85 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.849 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -68.46 -42.89 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 55.11 110.844 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -44.78 -52.43 8.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.133 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -53.89 -25.97 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.51 110.859 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 41' ' ' ALA . 6.3 tttp -93.08 -59.67 1.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.884 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 36' ' ' LYS . 1.6 m -55.75 -5.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.174 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -98.4 -30.92 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 53.11 111.067 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.29 -22.59 24.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 43.41 112.49 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.81 -46.41 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.846 0.355 . . . . 64.34 110.892 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -42.54 -39.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 74.35 111.091 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 14.2 mt-30 -40.87 102.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 70.32 110.925 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.8 Cg_endo -69.72 -18.59 37.11 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.702 2.268 . . . . 75.42 112.344 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 52' ' ' VAL . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 52' ' ' VAL . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 41.14 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 48' ' ' ASP . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 51.01 111.149 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 64.33 111.152 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' N ' HG12 ' A' ' 56' ' ' VAL . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 71.52 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 61.43 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 33.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.22 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.48 -29.39 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.13 111.121 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.94 141.73 28.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.871 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.86 -35.84 2.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 71.54 112.511 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -52.12 160.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 65.24 110.933 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.92 -64.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.519 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -100.51 -33.28 10.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.855 0.36 . . . . 63.44 110.883 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 t 162.53 140.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.869 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -25.85 59.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 73.14 110.999 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 60.14 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 61.11 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 34.41 112.483 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.04 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.23 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -94.96 -39.28 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.83 38.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.732 . . . . 70.42 112.474 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.47 118.68 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 64.21 110.882 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.23 10.11 33.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.866 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.47 160.56 32.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.629 0.728 . . . . 70.51 110.828 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 85.01 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.251 . . . . 74.43 112.36 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -31.98 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.45 111.133 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.61 154.28 9.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 53.32 110.895 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 70.35 110.865 179.832 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.803 0.335 . . . . 74.25 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.45 178.95 9.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 34.13 110.86 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.28 130.12 12.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 64.22 110.859 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.688 ' HB3' ' CA ' ' A' ' 8' ' ' GLY . . . -64.32 -21.28 66.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 63.33 111.11 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.01 -118.56 5.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.642 -0.789 . . . . 73.5 112.52 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -69.86 -44.15 70.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.924 0.392 . . . . 73.31 110.821 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.43 -1.57 37.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 65.12 110.895 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.688 ' CA ' ' HB3' ' A' ' 4' ' ' ALA . . . -94.38 69.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.539 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -90.34 -5.61 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 74.12 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.98 -30.76 19.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 73.31 112.491 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -25.98 63.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 73.43 110.865 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -96.93 -52.38 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 62.14 110.882 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -61.22 -43.99 97.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.23 111.118 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 t -68.39 -37.96 80.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 52.34 110.85 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 8.1 pt-20 -81.42 -23.97 37.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 72.15 110.9 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.25 -13.8 32.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 53.42 111.095 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.4 pp -111.48 -17.56 13.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 53.55 110.889 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -44.5 107.08 0.58 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.524 0.678 . . . . 70.21 110.86 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 54.6 Cg_endo -69.75 65.33 1.79 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.676 2.251 . . . . 74.21 112.366 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 25.9 t70 51.45 39.08 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.1 110.89 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -98.62 -15.53 19.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 60.23 110.881 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 56.7 mm-40 -116.79 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.9 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.02 -74.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.89 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.966 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 72.14 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 64.54 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.586 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.711 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -30.38 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.34 111.085 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -66.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 73.41 110.91 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -66.9 -44.78 79.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.821 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.23 -53.7 7.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 45.33 111.151 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.29 -25.86 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -95.43 -40.26 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 71.13 110.829 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.79 -6.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 64.24 111.075 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 -17.05 23.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 54.33 111.116 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.59 0.23 70.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.794 -0.717 . . . . 75.15 112.536 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -36.28 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 71.33 110.824 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.29 -45.92 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 71.42 111.122 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -57.09 110.26 2.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 75.24 110.949 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -16.8 37.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.624 2.216 . . . . 75.22 112.335 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.11 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 53.11 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 65.24 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 24.41 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 64.35 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 63.22 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 62.04 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 63.1 110.855 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.91 25.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.18 169.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 54.21 110.888 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.62 -95.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.792 -0.718 . . . . 65.1 112.449 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.61 155.0 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.4 110.881 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.28 -64.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 71.23 112.438 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 -33.68 10.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.37 . . . . 75.11 110.928 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.55 139.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 71.13 110.844 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.77 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -70.14 -8.26 48.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 61.14 110.867 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 65.33 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 23.11 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.43 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 54.22 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 41.44 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 64.03 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 65.44 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 62.44 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -71.22 -29.98 65.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.82 179.19 0.43 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 44.52 112.519 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -75.89 121.77 23.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 73.44 110.908 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.47 10.09 29.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 75.33 110.874 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -51.65 158.56 1.51 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 72.31 110.885 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 92.15 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.615 2.21 . . . . 62.43 112.322 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -99.24 20.07 14.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.33 111.166 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -153.91 -175.87 5.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.927 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 65.24 110.954 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.768 0.318 . . . . 73.44 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -73.61 137.08 44.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 74.45 110.87 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.88 -26.47 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 72.44 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.69 20.14 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 71.4 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.18 73.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.81 -0.71 . . . . 71.44 112.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -109.76 10.11 24.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 72.55 110.881 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -18.16 57.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 54.23 110.864 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.43 103.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.812 -0.709 . . . . 63.5 112.482 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -57.17 -23.75 49.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 65.44 110.929 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.17 3.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 75.11 112.491 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -61.9 -19.9 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.01 110.833 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.59 -52.91 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.443 . . . . 74.11 110.912 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.8 92.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.097 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.0 t -71.4 -35.75 71.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.02 110.895 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -85.26 -25.45 27.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.899 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.43 -14.36 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.14 111.058 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -102.05 -13.18 17.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.929 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 17' ' ' LEU . 15.7 mmtp -42.84 155.91 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 63.31 110.835 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.721 2.281 . . . . 73.12 112.359 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.1 m-20 -135.25 52.8 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.869 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 75.2 p -89.38 -14.54 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.85 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -110.16 -41.47 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.894 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.94 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.916 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 45.44 110.877 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 53.55 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 64.11 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -32.15 -47.84 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.58 -56.95 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.814 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.763 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.5 tptt -60.11 -55.52 32.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.11 110.937 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.49 -52.96 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.128 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -48.42 -25.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.55 110.897 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -40.17 9.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 71.11 110.93 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.88 -5.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.142 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.14 -14.0 24.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.092 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.33 -13.47 60.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 63.11 112.515 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.76 -39.72 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 71.31 110.91 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER 27.14 93.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 73.3 111.121 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.1 108.22 0.92 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.654 0.74 . . . . 74.13 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -20.39 35.18 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.732 2.288 . . . . 64.25 112.338 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.2 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 60.51 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 53' ' ' PHE . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 72.24 111.115 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HA ' HG22 ' A' ' 56' ' ' VAL . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 53' ' ' PHE . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 42.34 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.04 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.12 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.91 153.8 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 62.15 110.894 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.44 -150.26 5.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 63.31 112.544 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -55.68 122.76 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 62.42 110.854 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.53 -62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 45.22 112.51 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -100.25 13.32 34.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 75.05 110.95 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.523 ' HB2' HD22 ' A' ' 74' ' ' LEU . 73.6 m -32.42 -64.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 64.02 110.911 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.3 mm? -95.06 -21.85 18.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 75.22 110.821 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 42.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.615 ' N ' ' O ' ' A' ' 72' ' ' GLU . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 64.21 110.852 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 44.21 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 52.52 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.684 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 72.3 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 34.21 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -52.02 -32.36 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.16 -60.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 63.11 112.479 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.04 165.85 11.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 74.03 110.898 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -95.31 -20.38 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 43.44 110.9 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.81 144.79 18.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 73.45 110.852 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 101.37 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.606 2.204 . . . . 72.4 112.37 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -75.05 -25.06 58.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 62.22 111.147 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -115.07 -178.67 3.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.02 110.963 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 65.55 110.912 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.83 0.348 . . . . 65.24 110.925 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.12 123.9 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.14 110.853 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.52 129.32 56.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 70.11 110.873 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.93 -24.83 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 53.3 111.115 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.99 -168.21 12.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 73.15 112.494 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -80.42 -44.35 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 72.42 110.799 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -18.15 26.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.879 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.56 103.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 74.11 112.479 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -87.78 -13.02 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.918 0.389 . . . . 72.13 110.896 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.35 -45.03 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.659 -0.781 . . . . 71.31 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.51 -20.37 59.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 74.45 110.967 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.17 -54.18 3.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 72.32 110.917 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.43 -41.38 98.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 64.41 111.062 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -69.22 -36.22 77.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 74.22 110.862 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -84.73 -22.79 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.886 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.87 -11.3 36.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 55.13 111.133 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.7 pp -110.55 -25.19 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.949 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -47.27 154.06 0.85 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 71.44 110.925 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.86 22.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.738 2.292 . . . . 73.25 112.35 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -126.23 43.72 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 75.14 110.878 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 6.3 p -80.24 -15.63 56.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 63.32 110.883 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -115.53 -61.79 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 72.43 110.919 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.12 -71.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.929 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 60.33 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 54.43 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 34.35 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 54.42 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.656 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.11 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t -32.24 -47.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 -56.02 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.944 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' O ' HG22 ' A' ' 40' ' ' VAL . 2.4 tptm -60.26 -54.78 41.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.863 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.11 -53.71 9.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 72.41 111.066 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -51.37 -24.22 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 73.41 110.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 41' ' ' ALA . 3.6 ttpm? -94.79 -58.87 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.841 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 36' ' ' LYS . 2.0 m -58.78 -5.78 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 73.15 111.134 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -92.27 -16.55 25.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 51.13 111.115 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.13 -6.22 65.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 70.42 112.483 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.13 -37.12 2.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 72.24 110.885 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.569 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -21.71 106.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.213 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.2 mt-30 -50.03 108.27 0.97 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.537 0.684 . . . . 74.23 110.939 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.6 Cg_endo -69.77 -19.21 36.37 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.745 2.297 . . . . 64.12 112.36 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 52' ' ' VAL . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 50.21 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 53' ' ' PHE . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HA ' HG22 ' A' ' 56' ' ' VAL . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 71.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.661 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 60.01 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.96 -48.34 43.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 65.51 111.129 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -53.63 141.53 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.836 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.0 -18.78 30.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 72.43 112.422 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.75 169.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 73.5 110.845 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.49 -65.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 73.32 112.504 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 4.4 mm-40 -100.57 -34.15 10.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 63.24 110.954 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 162.76 139.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 62.32 110.847 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.81 -12.71 61.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 64.05 110.926 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 51.15 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 65.44 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.04 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 65.32 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 74.44 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 43.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 41.34 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.42 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 55.41 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 71.11 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.67 25.69 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.27 74.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.69 -0.767 . . . . 53.52 112.458 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -78.96 119.51 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 74.05 110.875 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -95.38 10.07 37.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 65.32 110.92 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -51.55 158.44 1.5 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.647 0.737 . . . . 71.43 110.848 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 101.05 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 71.2 112.375 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.7 p -94.35 20.15 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 72.35 111.102 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -89.35 179.31 6.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.4 110.878 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 65.32 110.918 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.786 0.327 . . . . 63.32 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -142.4 174.42 10.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.54 110.896 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.83 128.25 21.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 54.1 110.838 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.44 -24.61 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 71.43 111.127 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.45 143.17 13.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 65.44 112.524 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.54 10.12 23.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 70.42 110.863 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -17.45 59.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 63.45 110.88 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.88 -16.92 4.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 64.33 112.438 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -86.66 -9.98 54.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 63.42 110.842 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.86 -43.28 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.439 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -64.66 -19.86 65.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 74.4 110.894 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -94.97 -47.04 6.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 72.2 110.894 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -68.91 -33.98 74.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 65.12 111.114 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.7 t -77.83 -32.86 52.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 63.52 110.826 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 15.8 pt-20 -87.73 -25.58 23.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.53 110.913 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 -30.18 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.12 111.106 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 17' ' ' LEU . 4.1 pp -96.2 -10.88 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 65.4 110.871 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 14' ' ' SER . 6.8 mmtm -39.44 108.76 0.51 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.529 0.681 . . . . 72.41 110.856 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 79.96 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.644 2.229 . . . . 71.22 112.317 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -90.9 19.85 5.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 72.02 110.925 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 7.9 t -85.89 -19.34 30.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 65.14 110.865 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -114.86 -63.57 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 75.13 110.871 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt -42.0 -70.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 65.23 110.953 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.32 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 1.045 ' O ' HG22 ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 1.045 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.9 t -36.09 -46.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -56.16 17.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 71.25 110.853 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.78 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -60.42 -47.86 84.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.841 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -55.49 -49.83 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 71.35 111.114 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -49.69 -23.16 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 54.23 110.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -95.42 -39.82 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.2 m -61.95 -5.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 62.13 111.135 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -98.49 -11.16 22.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.14 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.77 -7.5 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 54.23 112.544 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.47 -35.57 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.35 110.857 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -32.77 -48.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 55.42 111.121 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mt-30 -61.89 111.68 4.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 55.33 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 52.7 Cg_endo -69.81 -18.23 36.91 Favored 'Trans proline' 0 CA--C 1.527 0.134 0 C-N-CA 122.684 2.256 . . . . 73.41 112.288 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 52' ' ' VAL . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 53' ' ' PHE . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 61.43 111.121 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 56' ' ' VAL . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 45.52 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 72.4 111.116 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 63.15 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 45.22 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 63.43 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 73.21 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 54.5 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.04 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 62.33 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.91 -31.58 12.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.75 170.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.882 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.46 -83.14 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 72.13 112.504 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.52 121.5 17.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 72.43 110.889 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.9 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.711 -0.756 . . . . 54.42 112.46 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 73' ' ' SER . 13.4 mm-40 -100.92 0.95 39.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 62.54 110.882 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.24 147.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.883 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -57.73 -14.76 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 73.2 110.907 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 62.22 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.21 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 43.22 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 35.41 112.465 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 72.43 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 32.33 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 63.43 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 51.3 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -39.23 85.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.0 175.77 17.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 71.31 112.477 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.57 123.44 39.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 74.02 110.83 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -91.35 9.9 29.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 64.33 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.57 158.49 1.49 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 73.33 110.879 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 92.44 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.678 2.252 . . . . 52.25 112.351 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -52.14 -29.89 24.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 72.03 111.099 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -109.64 -170.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.892 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 70.13 110.892 179.916 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 73.15 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.5 m -133.64 -175.56 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.853 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.4 115.11 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.864 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.624 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -53.55 -27.93 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.3 111.111 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.41 -110.41 1.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 52.2 112.507 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -109.69 -23.92 11.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 72.13 110.883 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -3.45 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.911 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.624 ' HA3' ' HB1' ' A' ' 4' ' ' ALA . . . -60.57 -17.26 47.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 44.35 112.512 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -73.27 -13.39 61.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.003 0.43 . . . . 63.02 110.92 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.33 -42.75 3.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.714 . . . . 72.01 112.449 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.53 -20.67 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.35 110.905 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -53.6 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 63.15 110.873 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.82 -41.77 99.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 45.45 111.092 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -69.17 -36.52 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 55.32 110.823 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.7 pt-20 -83.72 -24.12 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.898 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.17 35.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 51.14 111.084 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -111.01 -19.33 12.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 72.13 110.942 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -45.49 107.59 0.68 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 75.41 110.928 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.6 Cg_endo -69.75 63.72 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 35.32 112.353 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 46.47 55.71 7.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.948 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 47.8 p -76.8 -18.22 58.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.802 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -115.7 -60.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 64.35 110.843 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.08 -72.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 61.44 110.887 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.22 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t -32.56 -47.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -57.23 4.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.87 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 11.1 tptp -59.41 -55.4 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 72.34 110.918 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.87 -52.84 13.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.101 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -48.51 -25.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.855 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -96.46 -40.05 9.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 55.32 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.98 -5.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 75.03 111.057 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.68 -13.8 22.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 43.52 111.061 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.48 -11.97 60.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 74.41 112.468 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.14 -37.39 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 72.34 110.88 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.64 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.18 107.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.125 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.19 108.03 0.92 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 74.5 110.934 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -22.31 31.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.24 112.297 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 64.32 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 54.32 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 72.05 111.11 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.401 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 62.11 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 44.53 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.72 -22.93 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.84 167.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 52.3 110.926 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.37 -82.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 72.33 112.553 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.53 124.66 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 61.22 110.956 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.27 -64.63 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.677 -0.773 . . . . 70.22 112.42 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.7 -0.04 38.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 54.23 110.863 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.1 t 86.33 147.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 63.14 110.845 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.68 -14.57 8.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 74.22 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 70.55 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 61.21 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 52.34 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 60.52 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 73.01 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 97' ' ' SER . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 63.32 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 55.1 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 45.33 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.5 30.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.31 -103.49 0.54 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 54.44 112.462 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.86 115.74 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 74.32 110.896 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.4 10.04 29.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.79 155.69 3.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 72.33 110.912 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.74 100.71 0.84 Allowed 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.756 2.304 . . . . 71.21 112.383 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 72.34 111.178 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -63.92 -178.75 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.88 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 62.4 110.931 179.847 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.716 0.293 . . . . 54.53 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -166.38 170.21 13.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 74.11 110.874 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.86 130.12 18.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.05 110.84 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.12 20.06 19.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 53.11 111.096 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.25 -164.15 20.83 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 45.4 112.466 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 9.75 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 70.14 110.884 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -79.26 -9.99 59.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.95 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.2 103.55 0.21 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 52.34 112.419 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.75 -9.54 58.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 51.01 110.911 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.17 -40.67 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 62.02 112.501 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.74 -20.48 65.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 73.01 110.873 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.37 -44.22 7.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.892 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -71.82 -20.86 61.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.52 111.131 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 18.5 p -93.49 -29.54 15.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.04 110.85 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 13.3 pt-20 -94.46 -26.99 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.922 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -86.44 -26.34 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 41.14 111.128 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 13' ' ' ALA . 18.3 mt -102.24 -7.39 22.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.76 151.37 0.19 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.657 0.742 . . . . 50.02 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.79 26.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.637 2.225 . . . . 61.51 112.347 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.03 26.73 10.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.889 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 1.4 p -88.15 -20.29 25.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 60.34 110.831 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -115.09 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 54.11 110.89 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -42.06 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.915 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 44.3 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 44.0 112.409 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.96 ' O ' HG22 ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.01 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t -32.03 -48.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -57.1 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 64.44 110.847 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.767 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.6 tptt -59.95 -55.66 31.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.961 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.37 -52.6 12.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 44.25 111.076 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -48.01 -25.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.88 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.43 110.881 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.3 m -63.21 -5.25 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 73.52 111.136 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.73 -13.65 29.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.72 -7.83 59.84 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 64.42 112.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.52 -28.35 7.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 75.13 110.921 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -34.63 -44.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.21 111.133 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -38.35 101.01 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 54.2 110.935 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.06 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.264 . . . . 71.51 112.391 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 50.31 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 71.12 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 42.31 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 43.12 111.097 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 43.31 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.03 -70.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 73.22 111.072 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.97 141.55 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.874 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.39 -63.05 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 75.34 112.467 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -52.27 127.59 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 72.33 110.906 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.9 -71.38 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 74.35 112.555 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -90.98 12.86 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 74.03 110.877 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.684 ' OG ' HD22 ' A' ' 74' ' ' LEU . 7.8 t -63.01 -133.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.912 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.684 HD22 ' OG ' ' A' ' 73' ' ' SER . 1.1 mm? -87.93 -7.18 57.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 62.44 110.882 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 51.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 32.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 71.42 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 1.094 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.592 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 1.094 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 45.23 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 54.31 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 97' ' ' SER . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.587 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 50.14 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 63.13 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 64.32 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.82 27.61 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.99 -17.17 69.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.707 -0.759 . . . . 72.34 112.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.08 179.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 62.42 110.832 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -89.96 10.11 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 44.22 110.905 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.93 160.61 1.1 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.685 0.755 . . . . 73.54 110.847 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 101.42 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.714 2.276 . . . . 72.11 112.374 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -109.84 20.11 18.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.13 111.079 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -132.14 69.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 52.5 110.868 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.908 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.773 0.321 . . . . 73.22 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.1 p -167.76 -172.4 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 44.33 110.808 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.14 112.29 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 70.54 110.841 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 7' ' ' LYS . . . -57.81 -24.25 56.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 54.44 111.133 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.49 -80.34 0.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 65.04 112.519 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -110.06 10.24 24.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.367 . . . . 50.45 110.854 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -63.52 -15.81 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.919 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.37 97.38 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.12 112.454 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.37 -7.69 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 63.52 110.827 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.96 -29.74 11.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 21.03 112.45 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 16.4 mm-40 -57.72 -19.98 31.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 71.44 110.902 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -103.88 -46.27 4.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.877 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -68.69 -19.51 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.147 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 34.2 t -94.51 -32.28 13.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.22 110.818 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 23.3 mm-40 -93.87 -22.89 18.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 55.13 110.946 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -91.0 -27.37 18.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 75.3 111.087 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.6 mt -104.07 -4.88 22.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 65.42 110.96 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -38.82 150.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 72.14 110.87 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -6.98 19.9 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.722 2.281 . . . . 72.53 112.305 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.9 m-20 -137.61 54.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 63.43 110.825 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.56 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -101.81 -20.11 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 52.34 110.855 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.76 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 mt-30 -105.24 -12.64 15.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.876 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -102.07 -72.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.879 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 22' ' ' GLN . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 64.23 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 53.44 112.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 70.53 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.7 t -32.5 -48.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.118 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -57.27 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 61.11 110.879 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.3 tptt -59.29 -55.24 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.893 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -47.07 -52.72 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 50.45 111.107 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.65 -24.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.836 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -96.57 -40.16 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.872 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.95 -5.88 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 70.12 111.103 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.16 -13.9 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.113 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.3 -13.44 60.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.716 -0.754 . . . . 73.11 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.77 -39.65 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.794 0.33 . . . . 73.24 110.884 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER 26.72 93.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 74.43 111.132 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -48.89 108.22 0.91 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 53.15 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.88 31.39 Favored 'Trans proline' 0 N--CA 1.466 -0.096 0 C-N-CA 122.741 2.294 . . . . 64.51 112.316 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 52' ' ' VAL . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.24 110.923 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 72.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 53.45 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' ASN . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 60.5 111.096 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.921 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 34.23 111.138 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 45.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 64.54 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 54.5 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.83 -57.99 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 61.52 111.111 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -52.08 170.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 73.12 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.28 167.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 71.25 112.474 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.98 179.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 60.51 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.93 -64.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 75.44 112.484 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.1 mm-40 -100.47 1.97 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.44 110.906 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.12 148.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 65.34 110.881 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -58.74 -13.86 7.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.913 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 63.45 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 60.02 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.14 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 52.01 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 63.22 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 72.43 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 94' ' ' GLU . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 70.33 110.892 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 41.2 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -85.18 -31.01 23.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 65.35 110.752 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.95 119.41 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 51.33 112.438 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG3' HG23 ' A' ' 107' ' ' THR . 0.9 OUTLIER -100.06 126.18 46.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.299 . . . . 62.41 110.888 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -71.03 -20.29 62.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.41 160.5 33.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.589 0.709 . . . . 62.2 110.886 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.677 2.251 . . . . 75.52 112.352 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -51.84 -29.61 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 62.4 111.172 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -57.16 138.95 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 64.14 110.944 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 72.5 110.916 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.818 0.342 . . . . 73.4 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.21 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 63.34 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 54.21 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.008 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 61.1 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.008 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 70.42 111.156 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.739 0.225 . . . . 63.43 112.363 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 62.52 111.088 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' HG23 ' A' ' 52' ' ' VAL . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 23.15 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.3 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 53.52 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 54.13 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 73.35 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 72.43 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 74' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.881 0.372 . . . . 62.5 110.929 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 70.31 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 40.34 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 43.14 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 65.53 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.24 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 54.45 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 62.44 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.826 0.346 . . . . 72.21 110.901 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 64.54 110.937 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 41.23 111.121 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 65.2 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.983 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 71.35 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.983 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.146 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.105 0 CA-C-O 120.736 0.223 . . . . 71.52 112.394 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 70.43 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 50.13 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 53' ' ' PHE . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 54.05 111.083 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' VAL . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 51.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 34.23 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 62.43 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 55.11 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 62.45 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 74' ' ' LEU . 1.7 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.779 0.323 . . . . 73.24 110.922 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 53.41 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 71.54 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 53.32 112.457 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 50.33 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 71.02 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.25 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 72.4 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.69 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 54.34 110.855 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.817 0.342 . . . . 72.01 110.89 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 65.14 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 54.53 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 44.44 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.997 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 50.13 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.997 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.165 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.756 0.232 . . . . 73.54 112.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 52' ' ' VAL . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 60.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 50.5 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 48' ' ' ASP . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.34 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 45.13 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.877 0.37 . . . . 71.14 110.971 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 60.12 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 62.33 110.931 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.24 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 64.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 32.45 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 50.32 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.05 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 54.13 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.842 179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.832 0.348 . . . . 53.25 110.9 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 71.11 110.901 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.965 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 44.34 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.59 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.59 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.465 -0.163 0 CA-C-O 120.793 0.247 . . . . 73.42 112.381 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 63.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.45 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 64.04 111.133 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 52' ' ' VAL . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 13.02 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' N ' HG12 ' A' ' 56' ' ' VAL . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 50.43 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 72.2 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 63.44 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 62.14 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.844 0.354 . . . . 75.32 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 30.2 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 45.41 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.1 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 42.22 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 71.43 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 73.3 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 61.31 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.707 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 61.35 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 63.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.03 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.752 0.311 . . . . 72.54 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 52.15 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 63.23 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 64.43 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.888 ' O ' HG22 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.14 110.861 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.579 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.579 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.9 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 44.41 111.104 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.134 0 CA-C-O 120.699 0.208 . . . . 51.42 112.301 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 60.55 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 72.4 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 71.25 111.087 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 54.35 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.44 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 40.41 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 64.3 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' N ' HD22 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.813 0.339 . . . . 62.11 110.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 41.4 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 61.52 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.03 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 65.31 110.873 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 72.4 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.41 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 53.32 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.708 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 72.02 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 64.35 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 64.31 110.794 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.787 0.327 . . . . 73.33 110.876 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 61.34 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 53.02 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.14 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 63.15 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.698 0.208 . . . . 65.31 112.295 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.04 110.835 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 49' ' ' ASN . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 50.2 110.917 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 61.14 111.098 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 62.54 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 44.22 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.793 0.33 . . . . 71.44 110.889 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 63.33 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 55.33 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 51.11 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 34.04 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 1.066 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 44.41 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.695 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 1.066 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 70.13 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.51 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.695 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 62.45 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.545 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.25 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 70.13 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.855 0.359 . . . . 53.32 110.927 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 65.54 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 65.21 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.969 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 55.31 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.969 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.4 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.733 0.222 . . . . 75.55 112.331 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 64.14 111.081 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 41.21 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 52.22 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 62.43 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 45.2 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 65.13 111.113 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.764 0.316 . . . . 71.4 110.875 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.14 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 70.11 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 64.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 33.3 112.467 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 73.45 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.31 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 73.44 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 50.22 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 52.15 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.83 0.347 . . . . 75.11 110.87 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 71.2 110.85 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.979 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 62.25 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.591 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 53.24 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.175 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.23 0.104 0 CA-C-O 120.714 0.214 . . . . 61.33 112.281 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.608 ' O ' HG22 ' A' ' 52' ' ' VAL . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 73.32 110.928 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 49' ' ' ASN . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 44.44 111.116 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.671 ' HA ' HG22 ' A' ' 56' ' ' VAL . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 64.44 110.888 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 34.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 64.22 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 62.25 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 51.23 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.425 ' N ' HD22 ' A' ' 74' ' ' LEU . 2.0 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.781 0.324 . . . . 64.35 110.904 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 53.31 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.15 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 62.53 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 61.5 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.584 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 61.23 110.89 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.822 0.344 . . . . 54.14 110.958 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.021 ' O ' HG22 ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 45.12 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.021 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 70.4 111.166 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 N--CA 1.465 -0.149 0 CA-C-O 120.849 0.27 . . . . 73.42 112.377 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 49' ' ' ASN . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.51 111.075 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HA ' HG22 ' A' ' 56' ' ' VAL . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 71.51 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 53' ' ' PHE . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 73.34 111.135 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.03 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.03 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 52.4 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.15 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.33 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' N ' HD22 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 61.11 111.073 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.816 0.341 . . . . 64.12 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.53 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.32 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 52.32 110.901 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.6 t-20 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 62.55 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 55.22 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 70.31 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 64.04 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 71.12 110.879 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.047 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.35 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.047 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.7 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 N--CA 1.466 -0.137 0 CA-C-O 120.774 0.239 . . . . 71.52 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 70.54 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 44.15 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 53' ' ' PHE . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' HG23 ' A' ' 52' ' ' VAL . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 64.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 72.5 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 55.33 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 64.14 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 73.34 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 43.32 111.059 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.458 -0.039 0 CA-C-O 120.895 0.378 . . . . 62.3 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 61.33 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 52.13 110.838 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 44.22 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 54.44 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 73.15 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 65.14 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 62.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 64.21 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 24.44 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 63.44 110.866 179.917 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 72.04 110.912 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 70.43 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 44.41 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 63.33 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 41.25 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.981 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 61.21 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.981 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 43.02 111.157 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.718 0.216 . . . . 74.35 112.273 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.689 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 70.5 110.91 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 63.11 110.877 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 48' ' ' ASP . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 51.52 111.099 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' N ' HG23 ' A' ' 52' ' ' VAL . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.3 111.158 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.416 ' N ' HG12 ' A' ' 56' ' ' VAL . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.784 0.326 . . . . 73.51 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 73.42 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.686 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 41.2 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.686 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 63.35 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 73.45 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 53.54 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.22 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.788 0.328 . . . . 62.25 110.894 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 62.43 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 65.21 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.664 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.664 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 62.31 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.3 t . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.707 0.211 . . . . 61.33 112.305 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.33 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 72.42 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 63.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 70.43 111.07 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 56' ' ' VAL . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 65.32 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 44.34 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 60.42 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.854 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.888 0.375 . . . . 63.44 110.975 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.474 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.02 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 6.0 mm-40 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 65.43 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 64.04 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 25.13 112.453 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.21 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.687 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 72.13 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 64.11 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.591 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.01 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 73.43 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.4 110.882 179.927 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.786 0.327 . . . . 63.32 110.878 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 70.43 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 73.04 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 11.21 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 60.4 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.594 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.974 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 65.05 111.192 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.23 0.09 0 CA-C-O 120.777 0.24 . . . . 75.42 112.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 52' ' ' VAL . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 52' ' ' VAL . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 41.14 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 48' ' ' ASP . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 51.01 111.149 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 64.33 111.152 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.426 ' N ' HG12 ' A' ' 56' ' ' VAL . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 71.52 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 61.43 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 33.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.22 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.13 111.121 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.9 0.381 . . . . 73.14 110.999 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 60.14 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 61.11 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 34.41 112.483 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.04 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.23 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.781 0.325 . . . . 63.12 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.966 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 72.14 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 64.54 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.586 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.34 111.085 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.23 0.107 0 CA-C-O 120.763 0.234 . . . . 75.22 112.335 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.11 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 53.11 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 65.24 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 24.41 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 64.35 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 63.22 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 62.04 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.543 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 63.1 110.855 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.77 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.773 0.321 . . . . 61.14 110.867 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 65.33 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 23.11 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.43 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 54.22 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 41.44 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 64.03 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 65.44 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 62.44 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.785 0.326 . . . . 73.01 110.916 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 45.44 110.877 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 53.55 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 34' ' ' THR . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 64.11 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.135 0 CA-C-O 120.748 0.228 . . . . 64.25 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.2 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 60.51 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 53' ' ' PHE . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 72.24 111.115 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HA ' HG22 ' A' ' 56' ' ' VAL . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 53' ' ' PHE . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 42.34 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.04 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.12 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.756 0.312 . . . . 75.22 110.821 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 42.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 64.21 110.852 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 44.21 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 52.52 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.684 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 72.3 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 34.21 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.805 0.336 . . . . 73.23 110.929 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 60.33 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 54.43 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 34.35 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 54.42 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.656 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.11 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.465 -0.175 0 CA-C-O 120.81 0.254 . . . . 64.12 112.36 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 52' ' ' VAL . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 50.21 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 53' ' ' PHE . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HA ' HG22 ' A' ' 56' ' ' VAL . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 71.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.661 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 60.01 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 65.51 111.129 179.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 64.05 110.926 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 51.15 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 65.44 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.04 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 65.32 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 74.44 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 43.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 41.34 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.42 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 55.41 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 71.11 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 65.23 110.953 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.32 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 1.045 ' O ' HG22 ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 1.045 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.9 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo . . . . . 0 CA--C 1.527 0.134 0 CA-C-O 120.741 0.226 . . . . 73.41 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 52' ' ' VAL . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 53' ' ' PHE . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 61.43 111.121 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 56' ' ' VAL . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 45.52 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 72.4 111.116 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 63.15 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 45.22 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 63.43 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 73.21 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 54.5 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.04 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 62.33 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 74' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.792 0.33 . . . . 73.2 110.907 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 62.22 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.21 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 43.22 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 35.41 112.465 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 72.43 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 32.33 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 63.43 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 51.3 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.817 0.342 . . . . 61.44 110.887 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.22 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.627 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.466 -0.131 0 CA-C-O 120.804 0.252 . . . . 71.24 112.297 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 64.32 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 54.32 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 72.05 111.11 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.401 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 62.11 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 44.53 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' N ' HD22 ' A' ' 66' ' ' ASN . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.814 0.34 . . . . 74.22 110.925 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 70.55 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 61.21 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 52.34 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 60.52 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 73.01 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 97' ' ' SER . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 63.32 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 55.1 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 45.33 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.76 0.314 . . . . 71.05 110.915 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 44.3 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 44.0 112.409 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.96 ' O ' HG22 ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.514 HD12 ' HD1' ' A' ' 32' ' ' TYR . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.01 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.735 0.223 . . . . 71.51 112.391 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 50.31 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 71.12 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 42.31 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 43.12 111.097 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 43.31 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 73.22 111.072 179.837 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.815 0.34 . . . . 62.44 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 51.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 32.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 71.42 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 1.094 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.592 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 1.094 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 45.23 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 54.31 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 97' ' ' SER . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.587 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 50.14 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 63.13 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 64.32 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.749 0.309 . . . . 75.12 110.879 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 64.23 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 53.44 112.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 70.53 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.68 HD13 ' O ' ' A' ' 29' ' ' GLY . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.7 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.118 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.096 0 CA-C-O 120.767 0.236 . . . . 64.51 112.316 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 52' ' ' VAL . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.24 110.923 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 72.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 53.45 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' ASN . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 60.5 111.096 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.921 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 34.23 111.138 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 45.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 64.54 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 54.5 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 61.52 111.111 179.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.785 0.326 . . . . 74.43 110.913 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 63.45 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 60.02 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.14 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 52.01 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 63.22 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 72.43 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 94' ' ' GLU . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 70.33 110.892 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 41.2 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 65.35 110.752 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 mtt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.736 0.303 . . . . 42.35 110.91 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -73.58 118.08 16.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.281 -0.418 . . . . 74.03 110.848 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -96.49 -26.78 15.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 74.01 110.896 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.63 -25.87 41.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 53.22 111.132 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.82 68.58 1.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.798 -0.715 . . . . 65.41 112.465 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -55.68 -41.87 74.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.901 0.381 . . . . 74.02 110.937 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.23 -17.41 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.864 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 92.16 -15.61 61.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 53.12 112.475 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -58.71 -20.89 52.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 75.51 110.903 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.62 -21.78 30.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 53.55 112.509 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.92 -22.92 20.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 70.35 110.89 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -93.96 -46.36 7.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.43 110.892 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.486 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -67.9 -35.55 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 65.25 111.045 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 17.8 t -76.3 -33.41 59.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.301 -0.409 . . . . 64.25 110.832 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 9.9 pt-20 -86.7 -27.31 23.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 73.11 110.912 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.96 -20.81 52.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.41 111.12 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.9 pp -98.74 -13.43 20.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 64.33 110.888 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 14' ' ' SER . 26.2 mmtm -39.73 109.24 0.55 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.603 0.716 . . . . 60.11 110.881 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -8.5 23.77 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.719 2.28 . . . . 64.24 112.308 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 23.4 t70 51.2 38.05 20.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 70.15 110.826 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 80.9 p -99.61 -16.27 18.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.454 . . . . 50.52 110.864 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 58.5 mt-30 -116.83 -61.57 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 54.23 110.964 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.09 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 73.4 110.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.46 -31.19 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 64.54 110.85 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.4 m-85 -83.47 -57.23 3.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 63.15 110.918 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.52 -49.36 48.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.21 111.085 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -48.47 -56.62 7.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.11 110.912 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -48.45 -35.77 13.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 63.34 110.959 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.66 -43.13 30.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.672 -0.775 . . . . 54.21 112.446 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.008 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -67.86 -51.25 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.732 0.301 . . . . 72.43 110.841 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.72 -28.05 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 73.35 110.87 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.94 -36.09 59.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 73.21 110.954 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.06 3.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 61.1 111.161 179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.008 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t -36.62 -46.98 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.112 -0.494 . . . . 70.42 111.156 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.406 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -64.16 -55.48 21.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.842 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.779 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -59.92 -45.96 90.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.02 110.902 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.622 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -58.72 -48.5 80.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.121 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -49.97 -22.52 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 74.22 110.908 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -95.31 -41.87 8.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 75.43 110.92 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.5 m -58.71 -7.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 53.32 111.172 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -91.69 -32.14 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 71.41 111.123 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.09 0.92 73.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.639 -0.791 . . . . 75.13 112.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -33.73 3.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.809 0.338 . . . . 74.5 110.886 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -37.52 -47.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 72.21 111.108 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -60.53 111.93 4.81 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 61.43 110.849 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -20.02 35.48 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 63.43 112.363 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -89.6 0.25 57.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.1 110.89 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -63.34 -15.3 56.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.03 110.883 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -57.15 -24.09 51.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.876 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -96.39 -20.19 18.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.03 -30.49 77.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.771 . . . . 45.43 112.519 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.0 m -63.23 -39.02 83.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.865 0.364 . . . . 62.52 111.088 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' HG23 ' A' ' 52' ' ' VAL . 47.3 m-85 -90.4 -10.95 41.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.912 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -65.37 -43.07 91.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.78 -14.14 57.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.654 -0.784 . . . . 23.15 112.498 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.16 -52.84 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.802 0.335 . . . . 73.3 111.093 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -53.64 -27.0 24.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 74.11 110.862 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -54.83 -26.33 34.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.42 110.846 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -63.87 -25.57 68.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 53.52 110.869 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.15 24.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 54.13 111.097 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -51.65 -30.9 23.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.897 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.6 ttmm -70.94 -48.51 53.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.903 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.02 9.84 70.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.755 . . . . 74.35 112.469 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.7 29.1 4.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 73.35 110.946 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -102.24 13.44 34.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 55.44 110.776 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.68 -23.55 1.81 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 72.43 110.94 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.42 -24.17 28.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.123 -0.49 . . . . 74.2 111.102 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.81 166.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 55.4 110.855 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.29 172.72 54.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 64.54 112.496 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -80.7 -179.31 7.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 72.33 110.897 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -172.47 -54.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 64.21 112.463 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' O ' HD22 ' A' ' 74' ' ' LEU . 5.6 mm-40 -102.85 0.28 32.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.856 0.36 . . . . 75.03 110.865 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER 77.67 -48.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.54 110.876 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 72' ' ' GLU . 0.9 OUTLIER -92.05 -9.92 40.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 62.5 110.929 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.78 -38.34 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 60.15 111.066 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -53.5 -43.11 68.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 71.22 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -77.2 -42.23 38.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.248 -0.433 . . . . 70.31 110.909 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.39 -32.67 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 40.34 111.151 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -75.16 -64.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.847 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -73.13 -51.2 18.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.867 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -43.36 -63.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.852 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -33.79 4.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 43.14 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -77.07 -61.35 2.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.799 -0.715 . . . . 63.31 112.485 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.94 -23.2 4.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 65.53 111.043 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -77.26 -76.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.262 -0.426 . . . . 72.23 111.129 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.0 OUTLIER -55.02 -38.11 67.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.825 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.0 t -64.87 -65.76 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 71.24 110.835 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -62.55 -47.22 84.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 71.22 110.937 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 7.3 tp -56.28 -48.02 77.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.875 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 8.0 t-20 -75.39 -44.38 45.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.91 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.694 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 90.8 m-20 -69.6 -24.19 63.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.441 . . . . 72.32 110.87 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.557 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -93.46 -31.27 14.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.086 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -103.36 -65.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.173 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -41.98 57.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.471 . . . . 70.25 110.855 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 48.8 t80 -76.5 -51.38 11.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 75.53 110.858 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -80.99 -66.83 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.34 111.122 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' VAL . 2.8 t -51.95 -28.95 18.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 54.45 110.885 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.46 -32.19 35.08 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.644 -0.789 . . . . 62.22 112.473 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -77.91 -30.82 50.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.902 0.382 . . . . 62.44 110.916 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.12 -23.12 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 74.21 111.162 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -52.14 -31.88 33.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.895 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -85.78 -37.04 9.7 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 71.04 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -97.21 111.26 23.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.858 0.361 . . . . 72.21 110.917 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -90.0 10.12 25.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.501 . . . . 74.21 110.891 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.19 159.93 30.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.614 0.721 . . . . 62.42 110.838 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.69 100.37 0.81 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.693 2.262 . . . . 63.13 112.32 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.4 t -92.86 -26.84 17.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 73.22 111.156 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.2 mmtm -121.76 51.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 73.14 110.901 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 60.25 110.958 179.904 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.832 0.349 . . . . 73.52 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.59 172.24 3.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 71.34 110.884 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.37 129.76 56.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 61.21 110.845 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.35 -24.33 11.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 72.2 111.12 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.8 156.49 10.15 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.808 -0.711 . . . . 50.41 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 28.3 mtt180 -109.93 10.26 24.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.928 0.394 . . . . 74.2 110.902 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -21.22 62.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 74.02 110.883 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.22 -74.07 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 24.33 112.453 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -71.2 -9.76 58.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 73.12 110.926 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.04 -39.99 5.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 65.4 112.47 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.02 -21.96 66.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 72.02 110.892 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -93.82 -46.88 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 72.51 110.949 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -68.09 -35.49 78.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 72.22 111.037 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 18.9 t -76.04 -33.24 59.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 73.33 110.827 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 9.6 pt-20 -87.45 -26.89 23.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 71.35 110.906 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 -17.53 54.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 63.31 111.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -100.24 -13.87 18.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 62.42 110.886 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' N ' HD12 ' A' ' 17' ' ' LEU . 33.1 mmtt -41.89 154.92 0.24 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 73.43 110.86 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -6.73 19.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 63.54 112.295 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 1.5 m-20 -136.76 53.73 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.03 110.818 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 5.5 m -98.98 -18.28 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 61.45 110.878 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.763 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 50.5 mt-30 -106.38 -13.93 15.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.925 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.584 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -101.17 -73.78 0.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.901 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.5 t -44.75 -28.71 0.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 63.24 110.818 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.3 m-85 -89.47 -56.81 3.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 64.54 110.937 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 22' ' ' GLN . . . -72.01 -49.78 34.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 41.23 111.121 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.584 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -50.3 -56.92 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 65.2 110.903 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -47.79 -35.74 10.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 71.11 110.923 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.68 -44.21 26.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.501 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.983 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -66.99 -51.31 56.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.807 0.337 . . . . 71.35 110.868 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.7 pt-20 -45.67 -28.31 0.98 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 75.22 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.69 -36.02 60.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 73.01 110.92 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -93.02 -59.14 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 74.32 111.095 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.983 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.2 t -37.02 -46.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.92 -55.94 18.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 64.0 110.857 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.793 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -60.24 -46.76 88.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 72.53 110.904 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -56.75 -49.3 75.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 74.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -49.78 -22.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.0 110.851 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -95.33 -39.7 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 64.25 110.927 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.3 m -62.08 -5.51 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.12 111.15 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.82 -10.51 24.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 63.55 111.124 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.01 -7.76 59.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.68 -0.771 . . . . 74.12 112.456 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.38 2.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.753 0.311 . . . . 73.44 110.874 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -33.08 -48.31 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 74.01 111.17 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.2 mt-30 -60.29 111.89 4.67 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.519 0.676 . . . . 74.44 110.901 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 54.1 Cg_endo -69.73 -16.64 37.78 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.648 2.232 . . . . 71.52 112.394 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.1 0.61 57.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 70.43 110.883 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.2 p-10 -75.01 -4.49 38.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 54.11 110.883 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.5 t-20 -56.5 -27.17 56.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 50.13 110.842 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.18 -42.63 8.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.915 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.81 -24.19 12.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.769 -0.729 . . . . 74.22 112.477 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 53' ' ' PHE . 30.0 m -74.18 -38.9 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 54.05 111.083 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HA ' HG22 ' A' ' 56' ' ' VAL . 87.0 m-85 -89.99 -4.54 57.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.157 -0.474 . . . . 74.32 110.888 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -57.81 -25.78 61.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 51.34 110.906 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.11 -51.24 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.46 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.659 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.5 m -62.64 -35.14 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.353 . . . . 74.52 111.14 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -50.75 -51.47 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 34.23 110.91 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -17.54 62.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 74.35 110.843 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.6 t -83.45 -28.57 28.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 62.43 110.837 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.19 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 55.11 111.116 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 -52.1 -29.36 21.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 74.2 110.881 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -82.79 -35.08 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.482 . . . . 74.15 110.892 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.66 18.13 58.05 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.727 -0.749 . . . . 62.45 112.473 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.9 24.44 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 72.2 110.867 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -109.97 13.67 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.841 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.97 -25.66 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 73.42 110.991 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.67 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 63.55 111.038 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -61.83 145.96 51.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.246 -0.433 . . . . 74.33 110.921 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.3 -47.22 3.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 72.21 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -52.03 149.35 5.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.746 0.308 . . . . 72.54 110.972 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.88 -64.83 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 45.24 112.447 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' SER . 5.5 pt-20 -100.55 -33.54 10.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.863 0.364 . . . . 72.54 110.921 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 163.38 140.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 75.11 110.83 -179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.564 ' H ' HD22 ' A' ' 74' ' ' LEU . 1.7 mm? -72.04 -9.32 58.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.922 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.12 -32.96 24.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 52.43 111.08 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -57.09 -40.99 78.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 72.41 110.879 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.59 ' O ' ' N ' ' A' ' 81' ' ' TYR . 11.5 mm-40 -81.83 -41.44 21.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.24 -34.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 53.41 111.166 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -75.26 -61.71 1.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 71.54 110.914 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.76 -53.15 9.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 70.1 110.858 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.59 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.3 -65.1 0.5 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 71.25 110.923 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.5 ptm -46.31 -36.61 6.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 72.34 110.876 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.49 5.16 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.741 -0.742 . . . . 53.32 112.457 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.68 -19.16 9.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.783 0.325 . . . . 74.35 111.08 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.34 -74.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 50.33 111.115 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -46.08 -34.6 4.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 71.02 110.922 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.4 OUTLIER -78.38 -68.81 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.444 . . . . 71.12 110.864 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -61.05 -61.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.25 110.877 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 HD13 ' C ' ' A' ' 89' ' ' LEU . 2.3 tm? -43.07 -55.12 3.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 65.41 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.678 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.4 t30 -67.72 -63.36 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.842 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.6 m-20 -54.45 -18.06 3.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 64.14 110.882 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.86 -30.62 11.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.114 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.39 -46.24 7.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 72.4 111.101 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -72.65 -37.84 67.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.83 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.69 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.4 t80 -83.47 -42.79 16.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 64.51 110.898 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.7 t -84.75 -65.94 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 75.3 111.156 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -62.1 -19.38 62.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 75.54 110.861 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.83 -19.92 49.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.738 -0.744 . . . . 74.41 112.542 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.15 -47.88 9.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 73.14 110.86 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.94 -33.92 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.434 . . . . 73.41 111.17 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -55.07 -30.32 59.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 54.34 110.855 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -112.88 -125.34 4.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.745 -0.741 . . . . 62.41 112.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -97.78 129.31 44.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.846 0.355 . . . . 71.44 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -99.93 10.11 41.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.946 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.0 144.8 86.01 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.622 0.725 . . . . 72.13 110.842 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 100.93 0.84 Allowed 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.719 2.279 . . . . 70.33 112.356 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.69 20.0 12.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 72.42 111.16 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -110.7 173.73 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.923 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 73.3 110.84 179.882 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mmt . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.803 0.335 . . . . 72.53 110.865 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 p -174.3 119.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.889 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -109.08 -30.62 7.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 62.33 110.889 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.3 -23.71 57.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 73.13 111.149 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.99 108.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 64.13 112.472 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -84.8 -44.24 13.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.952 0.406 . . . . 72.04 110.925 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -17.48 36.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 43.01 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 102.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 75.42 112.483 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -89.48 -26.9 20.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.928 0.394 . . . . 72.21 110.882 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.0 -16.18 45.62 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.78 -0.724 . . . . 70.43 112.525 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -86.08 -28.19 24.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.398 . . . . 74.23 110.877 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.21 -38.48 11.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 52.24 110.847 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -73.02 -20.43 61.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 52.11 111.076 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 34.4 t -96.99 -25.39 15.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.43 110.884 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 11.6 pt-20 -99.74 -24.8 14.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 65.44 110.903 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -94.4 -17.21 22.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 74.35 111.096 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.8 mt -113.31 -11.54 13.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.972 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.58 107.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.645 0.736 . . . . 44.42 110.909 179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.2 Cg_endo -69.76 67.48 1.74 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.683 2.255 . . . . 63.5 112.251 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.6 t0 52.67 29.15 6.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.434 . . . . 51.23 110.848 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 49.2 m -102.41 -11.67 18.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 71.11 110.788 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.3 mp0 -116.72 -63.08 1.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 71.4 110.901 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -39.04 -74.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 72.01 110.89 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -37.44 -31.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 65.14 110.913 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.57 -57.1 3.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 75.43 110.968 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.2 51.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 54.53 111.08 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.41 -56.9 6.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.882 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -48.47 -35.88 13.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.927 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.57 -43.94 28.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.763 . . . . 44.44 112.535 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.997 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -67.22 -51.23 55.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.799 0.333 . . . . 73.43 110.941 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 10.2 pt-20 -45.79 -27.93 0.95 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.927 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -76.01 -36.07 59.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.909 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.9 -59.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 50.13 111.08 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.997 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t -36.7 -46.93 0.63 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.173 -0.467 . . . . 73.31 111.165 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -63.69 -56.05 18.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.54 110.863 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.777 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -59.86 -45.92 90.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 75.33 110.854 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -58.37 -48.65 79.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 53.42 111.044 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -49.68 -22.73 1.44 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.849 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.25 -39.87 9.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 74.24 110.917 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.4 m -61.7 -6.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.272 -0.422 . . . . 63.34 111.152 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.0 -13.51 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 70.32 111.121 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.59 -12.17 59.85 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 61.24 112.487 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.632 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.24 -37.22 2.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 61.44 110.907 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.632 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -11.97 107.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 71.23 111.189 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.08 108.07 0.93 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.653 0.74 . . . . 74.4 110.933 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.07 32.55 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.628 2.219 . . . . 73.54 112.353 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -91.08 -3.38 57.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 64.42 110.922 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.437 ' O ' HG13 ' A' ' 52' ' ' VAL . 27.5 t70 -81.27 1.5 32.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 74.42 110.919 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -69.41 -23.52 63.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 60.21 110.912 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.29 -18.01 20.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 72.34 110.891 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.19 -13.01 82.58 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.73 -0.748 . . . . 50.5 112.436 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 48' ' ' ASP . 32.9 m -85.45 -38.17 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.373 . . . . 73.22 111.199 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -90.42 -7.68 52.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.856 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.72 -37.9 44.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.24 110.827 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.11 -11.17 60.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.742 -0.742 . . . . 64.33 112.563 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 t -90.19 -32.4 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.863 0.363 . . . . 64.22 111.171 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -50.87 -30.07 13.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.52 110.841 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -55.17 -30.13 59.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 74.54 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.1 p -64.52 -21.94 66.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 72.34 110.899 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.09 10.64 23.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.5 . . . . 64.33 111.094 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -51.43 -29.01 14.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.868 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -74.13 -50.05 21.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 45.13 110.913 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -91.74 20.14 43.85 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 74.05 112.459 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -15.73 59.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.74 0.305 . . . . 74.14 110.898 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -73.39 -13.46 61.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.25 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.589 ' N ' ' ND2' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -96.22 0.74 51.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.854 -179.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -25.29 51.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 75.53 111.079 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -52.2 145.81 10.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.86 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.27 -50.35 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 72.14 112.495 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.76 120.02 7.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.877 0.37 . . . . 74.21 110.818 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 170.55 -44.3 0.2 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.713 -0.756 . . . . 60.41 112.468 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -102.92 -4.47 24.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.361 . . . . 75.02 110.913 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.3 OUTLIER 80.01 -41.04 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.812 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 23.3 mt -91.34 -13.61 32.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.971 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.2 -32.46 24.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 60.12 111.086 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.2 t0 -61.79 -34.96 76.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 74.32 110.853 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.656 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.2 mm100 -88.3 -39.42 14.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 75.23 110.912 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.33 -34.58 3.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 73.23 111.082 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 1.6 ptm180 -76.51 -45.06 32.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 62.33 110.931 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -89.92 -58.02 2.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.816 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.5 t80 -38.59 -59.64 0.9 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.24 110.951 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.3 mmt -59.91 -55.51 33.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.876 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.79 -22.82 6.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 63.1 112.444 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.22 -41.67 9.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 74.25 111.071 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.52 -77.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.28 -0.418 . . . . 74.24 111.089 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 5.0 tmtm? -42.72 -34.31 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.927 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.4 -70.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.827 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 2.0 tmtt? -60.73 -60.97 2.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 63.14 110.937 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -43.08 -53.21 5.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.96 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.0 t-20 -70.36 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 74.0 110.883 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 68.0 m-20 -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 64.54 110.856 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.599 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.39 -31.52 11.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 32.45 111.124 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -106.72 -46.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 70.12 111.085 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -72.08 -38.31 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 72.45 110.846 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 27.1 t80 -83.14 -42.82 16.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.98 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.57 -65.89 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 74.42 111.138 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.52 -18.44 59.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.868 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.84 -19.32 48.11 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.74 -0.743 . . . . 50.32 112.498 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.23 -37.63 15.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.856 0.36 . . . . 63.05 110.914 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.99 -45.67 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.448 . . . . 54.13 111.108 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -103.88 29.41 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.842 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.09 -28.49 41.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.787 -0.721 . . . . 65.43 112.463 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.03 116.66 1.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.84 0.352 . . . . 75.52 110.891 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -90.13 10.62 23.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 64.33 110.878 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -85.98 159.08 55.1 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.592 0.711 . . . . 74.35 110.887 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 79.59 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.64 2.227 . . . . 65.11 112.389 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -22.82 8.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 70.14 111.165 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -78.5 128.84 34.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 55.21 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.29 -0.413 . . . . 72.33 110.879 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.857 0.36 . . . . 73.44 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 t -72.93 -57.74 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 73.55 110.838 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.17 127.47 1.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.34 110.876 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.62 -22.98 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 64.2 111.11 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.61 97.69 1.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.703 -0.76 . . . . 72.45 112.477 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.42 10.14 21.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.908 0.385 . . . . 53.24 110.876 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -18.09 57.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 73.33 110.878 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.65 -16.84 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.741 . . . . 73.4 112.53 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -90.16 -6.15 55.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 75.32 110.923 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.11 -29.3 17.97 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.675 -0.774 . . . . 63.41 112.463 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -58.55 -24.77 61.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.924 0.393 . . . . 74.33 110.898 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -96.61 -52.54 3.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 73.04 110.932 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -60.73 -41.36 95.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.146 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.7 m -70.99 -41.06 71.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.829 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 12.1 pt-20 -77.84 -24.87 48.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 74.41 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.47 -25.92 38.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.098 -0.501 . . . . 70.24 111.111 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -105.94 -11.57 16.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 75.33 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.69 157.22 0.27 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.549 0.69 . . . . 75.22 110.923 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -8.51 23.79 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.667 2.244 . . . . 60.52 112.341 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.9 t70 -58.66 -18.46 30.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.883 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 1.1 t -92.73 -5.56 51.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 55.3 110.924 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.12 -37.82 5.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 70.1 110.872 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -69.8 -71.42 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.25 110.9 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.81 -29.04 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 73.23 110.843 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.9 m-85 -86.61 -56.64 3.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 71.11 110.901 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.48 37.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 111.17 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.93 -56.72 7.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 75.12 110.912 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -47.81 -38.44 15.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.115 -0.493 . . . . 71.14 110.899 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -46.58 37.82 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.829 -0.701 . . . . 65.45 112.47 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.965 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -64.26 -47.65 78.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 74.23 110.929 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mt-10 -44.0 -34.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 44.34 110.858 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.59 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.52 -39.53 45.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 71.43 110.937 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.71 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -79.09 -60.89 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.15 111.158 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.965 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -30.35 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 72.22 111.125 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.18 -66.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.839 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.764 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -66.83 -44.87 79.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.867 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.71 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.41 -53.64 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.097 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -49.18 -25.88 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.33 110.863 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 17.9 ttpt -95.46 -40.28 9.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.91 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.96 -5.94 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 61.31 111.156 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.36 -16.46 24.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.478 . . . . 70.34 111.063 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.48 69.94 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.773 -0.727 . . . . 72.32 112.469 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -36.39 2.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 73.1 110.92 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.21 -45.38 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 52.51 111.156 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 17.4 mt-30 -56.94 110.79 2.66 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.541 0.686 . . . . 63.24 110.957 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.9 Cg_endo -69.82 -17.93 37.01 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.636 2.224 . . . . 73.42 112.381 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -90.22 0.63 57.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 73.34 110.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -83.67 4.37 28.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 63.12 110.832 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -53.72 -27.73 29.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 62.42 110.877 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.88 -21.99 11.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 63.45 110.92 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.84 -31.13 30.84 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.716 -0.754 . . . . 44.24 112.519 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 53' ' ' PHE . 18.3 m -62.62 -38.61 81.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.891 0.377 . . . . 64.04 111.133 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 52' ' ' VAL . 50.6 m-85 -90.52 -10.67 42.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 72.45 110.96 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -65.78 -43.13 89.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 73.24 110.918 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.26 57.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 13.02 112.549 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.02 -53.74 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.864 0.364 . . . . 74.43 111.141 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.408 ' N ' HG12 ' A' ' 56' ' ' VAL . 16.8 t60 -52.36 -48.42 65.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 50.43 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.7 -23.82 63.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 75.31 110.819 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -81.33 -24.15 37.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 72.2 110.877 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.17 8.32 27.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.125 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -52.2 -29.72 23.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.87 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -82.44 -37.91 24.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.476 . . . . 63.44 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -89.56 11.79 68.98 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 70.14 112.523 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -96.05 28.84 2.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 73.14 110.87 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -110.04 13.7 23.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 74.05 110.882 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.01 -25.79 1.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 62.14 110.863 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.76 16.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 64.22 111.083 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 tp10 -52.15 155.03 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 72.45 110.978 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.33 -145.26 17.67 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.705 -0.76 . . . . 72.03 112.495 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -57.21 120.09 7.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.893 0.378 . . . . 72.35 110.917 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.76 -64.05 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.746 -0.74 . . . . 72.55 112.495 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.3 mp0 -100.82 -36.34 9.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 63.55 110.895 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.59 136.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 75.43 110.833 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.1 mt -69.98 -12.6 61.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 75.32 110.921 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.49 -32.7 28.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 30.2 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.85 -40.68 85.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.882 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 12.9 mm-40 -82.11 -41.6 20.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 75.23 110.909 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -40.95 -35.91 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 73.32 111.158 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -73.57 -59.77 2.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.25 110.857 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.35 -55.42 5.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 45.41 110.826 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -39.65 -67.52 0.22 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 74.15 110.929 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 17.3 mmm -53.24 -55.55 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.1 110.849 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.25 -23.09 5.58 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.777 -0.725 . . . . 42.22 112.544 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.19 -41.67 9.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 71.43 111.107 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.68 -77.2 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 63.44 111.121 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.6 tmtm? -42.92 -34.05 0.9 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 73.3 110.868 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -79.84 -70.65 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 71.3 110.786 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.29 -62.01 2.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 61.31 110.93 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.6 tt -42.36 -53.22 4.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 73.24 110.864 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.1 t30 -69.84 -63.31 1.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 74.53 110.864 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.707 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 67.6 m-20 -55.64 -16.2 3.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 72.3 110.932 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.588 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.35 -30.07 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 63.5 111.084 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -106.93 -46.96 8.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 71.52 111.165 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.628 ' N ' ' O ' ' A' ' 90' ' ' ASN . 3.8 mt-10 -73.04 -38.76 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 73.24 110.89 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.8 t80 -81.96 -43.89 17.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 75.11 110.879 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.4 t -84.23 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 70.11 111.142 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -60.74 -19.31 58.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 65.04 110.824 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.46 -21.11 42.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 61.35 112.503 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -83.27 -48.32 10.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 63.23 110.928 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.33 -33.85 65.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.03 111.076 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -54.69 -28.62 48.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.831 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.05 -21.08 44.67 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.442 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -78.16 175.44 10.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 72.41 110.866 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -98.16 -20.99 16.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.889 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.666 ' OD1' HG23 ' A' ' 107' ' ' THR . 0.2 OUTLIER -56.29 144.85 59.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.623 0.725 . . . . 35.51 110.92 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 100.28 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.692 2.261 . . . . 65.05 112.407 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.666 HG23 ' OD1' ' A' ' 105' ' ' ASP . 5.4 p -119.77 20.03 12.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 74.42 111.129 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -112.03 153.63 26.57 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.188 -0.46 . . . . 63.32 110.911 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.8 tmtp? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.875 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ttt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.812 0.339 . . . . 72.52 110.877 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.89 178.02 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.46 . . . . 74.12 110.834 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.8 141.08 38.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.872 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.5 9.0 25.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 61.01 111.079 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.48 77.57 0.89 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 42.54 112.511 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -109.94 10.12 24.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.849 0.357 . . . . 73.22 110.881 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -12.51 59.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 73.32 110.848 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.27 110.2 0.25 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.674 -0.774 . . . . 72.44 112.455 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.61 -7.73 53.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 74.43 110.896 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.12 -32.5 8.33 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.716 -0.754 . . . . 72.21 112.489 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 41.6 mm-40 -57.1 -20.99 28.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 71.31 110.853 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -104.55 -46.46 4.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.926 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -68.26 -19.45 64.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 43.24 111.109 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 26.0 t -94.67 -32.56 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 73.34 110.806 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 12.6 mm-40 -93.57 -23.0 18.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.846 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -90.96 -26.57 19.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 52.14 111.169 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.7 mt -105.11 -3.68 22.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 53.13 110.958 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.88 151.09 0.2 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.569 0.7 . . . . 75.03 110.866 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.82 -29.29 23.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.644 2.229 . . . . 75.23 112.295 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 23.7 m-20 -59.25 -17.66 30.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.871 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.529 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 51.1 m -93.03 -5.74 49.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 64.33 110.88 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -111.02 -38.54 5.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.44 110.911 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 27' ' ' GLU . 2.5 ptpt -69.48 -71.27 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 72.54 110.955 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.424 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -42.71 -29.12 0.28 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.23 -0.441 . . . . 52.15 110.852 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.8 m-85 -86.62 -56.69 3.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.31 110.972 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.69 -49.66 37.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 70.33 111.15 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -48.8 -56.83 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.24 110.916 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -47.58 -38.44 14.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 63.23 110.91 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.88 -45.92 48.57 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.732 -0.747 . . . . 64.43 112.523 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.888 ' O ' HG22 ' A' ' 34' ' ' THR . 2.0 mtpp -65.87 -46.54 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 75.1 110.958 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.7 mm-40 -44.72 -32.12 1.41 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 74.14 110.861 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.579 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.8 t80 -79.12 -38.0 37.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.925 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.579 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.9 mp -81.53 -58.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 75.41 111.084 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.9 t -36.28 -47.6 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 44.41 111.104 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 34' ' ' THR . 0.1 OUTLIER -54.23 -67.69 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 72.51 110.839 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.6 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -71.0 -12.9 61.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 74.22 110.86 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -69.74 -42.0 74.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 52.34 111.118 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -67.12 -19.79 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 74.31 110.886 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.73 -46.79 6.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 54.05 110.925 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG22 ' HA ' ' A' ' 37' ' ' ALA . 21.9 m -59.4 -8.24 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 73.53 111.125 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.81 -16.43 30.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 72.15 111.096 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.32 -2.9 65.48 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.747 -0.739 . . . . 42.45 112.533 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.39 -37.58 2.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.333 . . . . 72.51 110.9 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -36.26 -49.1 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.3 111.137 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -61.37 112.38 5.84 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.532 0.682 . . . . 73.32 110.898 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -18.94 36.52 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.739 2.293 . . . . 51.42 112.301 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -89.28 0.24 56.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 65.15 110.851 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.21 -14.15 53.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 74.53 110.889 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -59.04 -22.84 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 60.55 110.926 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.74 -19.16 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.948 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.45 -28.12 13.77 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.706 -0.759 . . . . 64.33 112.489 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.9 m -63.1 -34.11 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 72.4 111.152 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -90.48 -2.96 57.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.861 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -55.79 -24.77 37.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 70.11 110.939 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -49.58 2.88 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.782 -0.723 . . . . 73.03 112.464 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -63.39 -35.73 73.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.349 . . . . 71.25 111.087 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -50.76 -52.91 36.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.938 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.18 -14.16 62.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 54.35 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.2 t -87.81 -23.98 23.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 63.44 110.883 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.84 25.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 53.23 111.082 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -53.43 -40.95 65.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.922 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt -66.16 -46.22 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 73.01 110.943 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.4 -1.35 81.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 40.41 112.541 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -119.3 29.79 7.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 64.3 110.904 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -99.65 13.73 32.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 72.34 110.887 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -51.6 -21.25 2.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 70.22 110.845 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' N ' HD22 ' A' ' 66' ' ' ASN . . . -60.44 -18.33 50.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.124 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -52.02 169.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.96 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.18 -30.18 16.89 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.774 -0.727 . . . . 64.15 112.472 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.505 ' CD ' HD21 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -54.29 120.06 6.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 71.03 110.956 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.59 -65.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.741 -0.742 . . . . 55.22 112.52 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.452 ' O ' ' CB ' ' A' ' 73' ' ' SER . 25.7 mm-40 -100.77 -35.59 9.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 73.34 110.922 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.52 137.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 62.43 110.835 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.505 HD21 ' CD ' ' A' ' 70' ' ' GLN . 25.4 mt -70.46 -12.7 61.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.921 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.25 -33.12 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 61.22 111.113 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -58.1 -40.61 81.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 72.45 110.866 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.4 mt-30 -82.79 -41.36 19.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.894 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.82 -32.62 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 41.4 111.166 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 39.2 mtp180 -77.09 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 61.52 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -74.02 -51.86 14.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.836 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.53 -60.42 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 74.03 110.942 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.01 -33.78 39.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 65.31 110.873 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -68.45 -22.75 75.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.748 -0.739 . . . . 72.55 112.481 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.95 -37.35 10.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 72.4 111.005 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -94.37 -78.01 0.45 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 74.55 111.101 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 7.9 tmtt? -44.23 -32.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.41 110.909 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -80.58 -71.48 0.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 71.11 110.906 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 1.3 tptt -61.11 -61.5 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.505 . . . . 74.41 110.86 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.9 tt -42.92 -52.84 4.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.934 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.3 t30 -70.64 -63.73 1.04 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.887 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.708 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.6 m-20 -53.77 -17.99 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 75.44 110.84 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -98.82 -32.67 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 64.21 111.118 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.553 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.83 -46.59 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 53.32 111.119 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.664 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -70.63 -38.99 73.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 65.32 110.914 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.708 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 23.0 t80 -81.97 -44.11 17.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 74.32 110.85 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.9 t -84.29 -66.42 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 72.02 111.145 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -58.66 -19.0 35.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.837 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.84 -26.77 25.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.718 -0.753 . . . . 64.35 112.523 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -85.04 -25.17 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 64.31 110.794 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -82.25 -33.43 11.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 71.43 111.116 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -113.01 26.95 10.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.863 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -102.96 67.36 0.34 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 54.33 112.52 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -84.45 123.63 30.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 75.45 110.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -95.78 10.13 38.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 73.12 110.899 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.1 160.53 1.18 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.489 0.661 . . . . 60.44 110.934 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 98.51 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.673 2.248 . . . . 70.53 112.39 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -63.38 -25.86 68.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.436 . . . . 51.2 111.131 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 171.15 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.883 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 71.33 110.903 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mpp? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.754 0.311 . . . . 53.31 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.9 p -137.55 137.67 38.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 72.11 110.923 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -137.12 53.89 1.87 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 73.14 110.891 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.01 20.06 18.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 53.12 111.104 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.84 102.48 2.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.656 -0.783 . . . . 62.53 112.518 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -107.0 10.1 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.969 0.414 . . . . 73.42 110.959 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -16.28 62.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.919 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.37 -17.41 59.36 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.686 -0.769 . . . . 70.32 112.481 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -6.52 49.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.918 0.389 . . . . 72.21 110.917 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.08 -37.55 6.27 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.693 -0.765 . . . . 32.14 112.426 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -49.03 -27.64 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.392 . . . . 65.24 110.811 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.83 -59.97 1.69 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.889 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 17' ' ' LEU . . . -58.69 -50.37 74.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 43.43 111.079 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 t -59.77 -40.61 88.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.88 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -80.72 -22.78 39.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 61.13 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -84.51 -21.58 30.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 70.33 111.148 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 13' ' ' ALA . 3.2 mt -103.41 -18.06 14.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.843 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -41.83 108.98 0.64 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.561 0.696 . . . . 70.12 110.862 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -17.57 37.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 54.43 112.319 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.9 t0 58.43 19.83 6.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.246 -0.434 . . . . 72.35 110.951 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.45 -12.23 18.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 64.01 110.823 -179.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 mp0 -116.46 -62.77 1.54 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 65.5 110.926 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 1.6 ptmt -39.03 -74.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 73.33 110.876 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.54 -31.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.889 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.8 m-85 -83.47 -57.22 3.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.895 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.8 -49.03 50.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 61.34 111.138 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.46 -57.0 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 75.01 110.931 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -46.71 -40.24 12.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.879 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -52.71 18.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 53.02 112.546 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -58.39 -46.67 85.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.697 0.284 . . . . 71.14 110.882 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 1.4 mm-40 -44.17 -32.63 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 71.0 110.923 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.0 t80 -78.96 -34.26 44.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 74.33 110.874 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.4 mp -86.99 -59.81 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 63.15 111.089 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -31.94 -47.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 71.42 111.118 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.52 -57.06 4.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.882 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.6 tptt -60.26 -55.54 32.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.439 . . . . 72.1 110.836 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.47 -52.86 12.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 62.21 111.121 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -48.24 -25.45 1.53 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 65.13 110.866 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -40.3 9.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 72.33 110.948 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.83 -5.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 72.22 111.106 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.31 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.23 111.104 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.62 -12.17 59.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 72.31 112.499 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.638 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.12 -37.45 2.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.761 0.315 . . . . 63.31 110.826 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.638 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.1 107.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.422 . . . . 72.11 111.081 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.03 108.02 0.92 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.533 0.683 . . . . 71.42 110.917 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -21.05 33.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.66 2.24 . . . . 65.31 112.295 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.61 -11.31 40.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 73.13 110.925 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -97.26 13.09 30.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 75.45 110.905 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.3 m120 -106.61 -21.64 13.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.04 110.835 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 -19.2 23.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 75.34 110.973 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.83 -29.49 59.14 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.475 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 49' ' ' ASN . 27.6 m -64.63 -38.01 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 53.44 111.126 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.642 ' HA ' HG22 ' A' ' 56' ' ' VAL . 1.5 m-85 -88.77 -3.06 58.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 50.2 110.917 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -25.01 41.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.5 . . . . 71.33 110.927 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -50.18 2.76 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.444 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.1 m -62.87 -35.68 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 61.14 111.098 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -49.57 -55.34 13.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 62.54 110.92 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.65 -18.76 65.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 44.22 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 30.9 t -80.67 -31.92 36.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 62.3 110.883 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.48 10.26 23.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 70.02 111.125 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -51.68 -30.45 21.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 72.44 110.862 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -72.51 -47.43 48.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 74.12 110.863 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.91 11.38 67.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.792 -0.718 . . . . 55.01 112.464 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -119.25 29.7 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 74.22 110.905 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -107.24 13.46 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.871 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.43 -25.18 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.35 110.905 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.22 -28.38 18.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 71.44 111.111 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -52.73 157.79 1.51 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.868 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.33 -141.94 29.65 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 65.14 112.547 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 178.05 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.831 0.348 . . . . 72.44 110.936 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.39 -64.57 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 53.44 112.43 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 31.7 mt-10 -100.53 -33.48 10.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.352 . . . . 64.35 110.888 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.58 140.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 72.13 110.812 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.1 mm? -72.38 -9.91 59.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 71.44 110.889 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.43 -32.91 22.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 54.42 111.12 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -55.66 -42.88 75.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 62.51 110.794 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.6 ' O ' ' N ' ' A' ' 81' ' ' TYR . 8.0 pt20 -80.76 -39.14 27.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.35 110.954 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.5 -34.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 62.11 111.053 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -75.89 -57.29 3.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 63.33 110.858 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.15 -55.13 5.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 55.33 110.836 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -38.82 -67.07 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 75.23 110.883 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.2 mmt -45.36 -61.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.23 110.865 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.51 -62.01 5.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.692 -0.766 . . . . 51.11 112.54 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -50.98 -32.55 21.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 34.04 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.54 -74.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 55.1 111.116 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 10.6 tmtt? -55.05 -32.01 61.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 74.22 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.1 t -74.1 -51.94 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.44 . . . . 60.43 110.852 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 1.066 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -79.19 -16.37 56.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 75.23 110.913 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.61 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 8.9 tp -95.28 -23.59 17.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 44.41 110.918 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.7 t30 -107.69 -29.57 9.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 64.04 110.89 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.695 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.9 t70 -97.3 -20.38 17.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 72.34 110.872 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 1.066 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -107.26 -19.41 13.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 70.13 111.11 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -109.68 -41.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 73.51 111.056 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -88.71 -35.43 16.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.892 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.695 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 18.8 t80 -86.51 -39.87 15.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 75.1 110.927 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.628 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 2.2 t -87.15 -63.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.122 -0.49 . . . . 62.45 111.109 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.545 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.0 OUTLIER -66.69 -40.28 88.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 75.51 110.873 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.9 -27.71 71.64 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.661 -0.781 . . . . 64.25 112.566 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -56.07 5.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.904 0.383 . . . . 70.13 110.895 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.9 t -65.34 -23.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 74.15 111.156 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -51.69 -31.78 27.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 63.01 110.857 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 113.19 3.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.749 . . . . 63.44 112.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -99.39 133.46 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.792 0.329 . . . . 72.55 110.933 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -99.95 10.21 41.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 71.12 110.881 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.44 160.57 75.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.618 0.723 . . . . 63.11 110.861 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.625 2.217 . . . . 63.12 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.9 m -56.61 -23.92 44.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.19 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 120.97 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.441 . . . . 73.52 110.871 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 74.24 110.936 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.749 0.309 . . . . 73.03 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -133.8 166.8 21.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 73.25 110.879 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.84 127.5 6.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.485 . . . . 62.0 110.872 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.58 -23.15 49.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 73.3 111.055 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.35 121.34 0.9 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 70.14 112.48 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.6 mtt85 -93.67 10.14 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.944 0.402 . . . . 72.53 110.901 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -4.88 59.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 74.51 110.892 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.57 -17.32 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 72.43 112.465 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.9 -13.77 35.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.863 0.363 . . . . 73.35 110.825 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.62 -40.74 4.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.709 -0.757 . . . . 74.22 112.476 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -60.75 -22.75 64.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 72.41 110.875 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.08 -52.32 4.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 63.03 110.92 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.72 -41.99 99.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 63.54 111.074 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 m -69.38 -36.57 76.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 72.04 110.881 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.45 -24.25 31.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 64.01 110.901 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -90.13 -13.7 35.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 63.23 111.108 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -110.84 -18.31 13.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 63.42 110.964 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 136.41 5.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.586 0.708 . . . . 72.41 110.891 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 61.18 1.77 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.727 2.285 . . . . 71.14 112.323 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.19 -13.81 5.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 53.22 110.802 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.98 -12.24 59.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.8 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 6.7 mm100 -115.33 -64.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.943 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -41.32 -73.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 53.32 110.927 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.07 -31.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 71.15 110.836 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.39 -56.28 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 65.54 110.885 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -49.28 49.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 73.34 111.121 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.87 -57.3 6.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.27 -0.423 . . . . 65.21 110.891 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.95 -38.21 10.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.12 -0.491 . . . . 73.21 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.25 -44.85 51.75 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 61.11 112.492 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.969 ' O ' HG22 ' A' ' 34' ' ' THR . 0.6 OUTLIER -66.83 -50.39 62.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 55.31 110.918 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.3 mt-10 -44.68 -29.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.927 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -74.98 -37.7 61.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 73.51 110.923 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -91.7 -58.71 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 62.32 111.073 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.969 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.4 t -41.32 -43.07 2.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 72.24 111.15 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.58 -52.16 66.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.841 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.8 -20.3 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.923 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -73.44 -40.47 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 72.25 111.099 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.62 -19.6 64.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.821 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.2 7.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 54.31 110.913 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 19.7 m -60.12 -8.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.237 -0.438 . . . . 44.3 111.079 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -94.25 -9.86 34.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.254 -0.43 . . . . 54.54 111.078 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.16 -8.61 58.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.806 -0.711 . . . . 61.2 112.529 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.4 -35.46 2.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 70.34 110.885 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.72 -49.1 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.43 . . . . 64.02 111.113 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 23.6 mt-30 -63.64 112.72 7.8 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.564 0.697 . . . . 74.12 110.921 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.5 Cg_endo -69.82 -14.28 35.69 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.628 2.219 . . . . 75.55 112.331 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -90.88 -4.19 56.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.86 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.98 0.78 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.931 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -58.28 -23.02 54.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.917 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -104.91 -19.71 13.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.781 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.51 -31.35 79.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 60.45 112.482 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.7 m -62.51 -39.23 83.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 64.14 111.081 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.0 m-85 -90.52 -10.45 43.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 75.44 110.883 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -65.97 -43.14 88.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 75.1 110.846 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.73 -14.37 56.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.715 -0.755 . . . . 41.21 112.487 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -89.97 -53.66 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 71.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' HG12 ' A' ' 56' ' ' VAL . 1.2 t-80 -53.76 -27.54 29.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.61 -25.68 40.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.223 -0.444 . . . . 75.51 110.85 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -59.7 -48.84 80.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 52.22 110.881 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.95 10.22 24.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 72.43 111.079 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -51.67 -32.91 31.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.272 -0.422 . . . . 71.23 110.821 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -79.23 -30.57 43.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 62.43 110.909 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.7 13.6 62.38 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.734 -0.746 . . . . 45.2 112.516 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -112.0 -28.72 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.804 0.335 . . . . 63.41 110.954 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.09 11.48 21.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.905 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.44 -38.22 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 62.24 110.868 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.98 -48.82 10.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 65.13 111.113 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -57.22 166.94 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.889 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.16 -86.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.683 -0.77 . . . . 73.41 112.583 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -66.69 120.46 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.782 0.325 . . . . 63.14 110.914 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.71 -57.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.771 . . . . 45.13 112.525 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.645 ' O ' ' N ' ' A' ' 76' ' ' ASP . 4.1 mm-40 -100.3 10.43 41.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 65.5 110.886 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.47 ' HB2' HD22 ' A' ' 74' ' ' LEU . 68.2 m -35.92 -53.15 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.863 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.1 mm? -95.11 -24.13 17.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 71.4 110.875 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . . . -79.57 -50.39 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 74.24 111.122 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 72' ' ' GLU . 3.1 t70 -44.2 -41.32 5.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.266 -0.425 . . . . 72.12 110.799 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.58 ' O ' ' N ' ' A' ' 81' ' ' TYR . 10.2 mm-40 -80.42 -43.15 21.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 75.02 110.845 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -39.9 -34.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 74.43 111.092 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 49.3 mtp85 -74.51 -62.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 74.14 110.885 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -74.33 -52.95 10.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 70.11 110.854 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.58 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -42.19 -65.57 0.45 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.258 -0.428 . . . . 64.34 110.876 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptt? -45.97 -36.2 5.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 73.11 110.876 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.5 -59.43 4.5 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.768 -0.73 . . . . 33.3 112.467 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.71 -19.86 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.807 0.337 . . . . 73.45 111.149 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.82 -74.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.02 111.131 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 9.9 tmtt? -45.22 -31.67 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 74.14 110.937 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -82.09 -67.05 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.866 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -65.0 -60.47 3.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 70.31 110.901 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.8 tt -44.65 -52.15 8.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 64.42 110.935 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.67 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.7 t-20 -71.23 -61.76 1.65 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 63.24 110.825 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.8 t70 -55.68 -17.78 6.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.445 . . . . 75.54 110.875 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.23 -31.5 11.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.169 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.549 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.4 OUTLIER -106.79 -46.11 8.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 73.44 111.202 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -71.97 -38.43 69.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.191 -0.459 . . . . 75.22 110.895 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.702 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 24.3 t80 -82.92 -42.91 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.944 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.5 t -85.45 -66.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.493 . . . . 50.22 111.144 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -61.46 -18.91 61.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 52.15 110.814 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.96 -19.77 49.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 63.51 112.475 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.43 -46.86 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.31 110.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.2 t -69.36 -24.21 27.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 73.43 111.13 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -52.82 -33.95 51.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 72.32 110.898 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -100.87 -76.27 1.2 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 73.12 112.551 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -97.66 110.41 22.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 52.21 110.841 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -95.73 10.15 37.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 73.11 110.894 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.35 155.67 35.02 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 72.11 110.918 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 100.87 0.85 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.719 2.279 . . . . 50.45 112.391 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -95.64 20.04 10.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 74.33 111.13 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 -45.27 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 63.25 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 tttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 62.41 110.943 179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.677 0.275 . . . . 74.23 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -142.38 134.21 27.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 61.43 110.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -53.29 127.75 25.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.52 110.841 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.02 -24.79 14.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 70.5 111.161 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -154.51 173.83 32.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.751 -0.738 . . . . 60.42 112.484 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 52.8 mtp85 -108.9 10.11 26.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.903 0.382 . . . . 72.35 110.819 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -17.25 63.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 61.24 110.865 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.37 119.3 1.8 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.746 -0.74 . . . . 70.03 112.501 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -63.23 -16.06 59.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 74.31 110.856 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.5 -42.94 4.09 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 74.22 112.488 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -65.34 -20.4 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.869 0.366 . . . . 74.2 110.834 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -47.19 6.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 72.31 110.823 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.55 -34.99 76.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 45.11 111.129 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 44.3 m -76.39 -32.98 58.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 64.1 110.878 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 10.7 pt-20 -87.77 -26.92 22.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 75.52 110.878 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.04 -17.74 54.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.487 . . . . 71.55 111.069 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.666 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -99.76 -14.65 18.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 74.34 110.841 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.52 ' N ' HD12 ' A' ' 17' ' ' LEU . 26.0 mmtt -41.3 153.42 0.25 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.59 0.709 . . . . 63.13 110.871 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.674 2.249 . . . . 75.32 112.334 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 42.24 40.61 1.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 74.4 110.833 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.412 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 29.4 m -100.29 -18.98 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 60.22 110.862 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -115.48 -63.15 1.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.929 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -40.65 -71.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.87 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.01 -30.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.875 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.492 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.1 m-85 -87.23 -49.78 7.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 74.35 110.912 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.91 -49.72 23.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.061 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -54.44 -56.35 19.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 73.41 110.905 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 13.2 pt20 -46.98 -34.86 5.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 71.2 110.85 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.02 -46.9 20.64 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.792 -0.718 . . . . 63.22 112.504 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.979 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -65.55 -47.29 76.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 62.25 110.868 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 5.1 mm-40 -44.55 -34.16 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 73.44 110.849 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.8 t80 -77.18 -39.04 50.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.179 -0.464 . . . . 75.32 110.898 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.696 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -80.05 -61.21 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 53.24 111.141 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.979 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t -30.01 -49.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 70.31 111.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.64 -66.12 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.12 110.81 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.77 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -67.26 -44.61 78.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 72.14 110.905 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.696 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.52 -53.78 8.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 73.42 111.065 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -49.69 -25.25 2.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 72.34 110.886 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -95.59 -41.74 8.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 65.24 110.806 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -59.29 -7.09 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 73.44 111.14 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.23 -31.95 16.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 31.12 111.083 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.71 -3.28 66.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.683 -0.77 . . . . 60.33 112.42 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.93 -50.42 2.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 51.22 110.899 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER 33.83 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 74.34 111.156 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -49.91 108.66 1.05 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 74.55 110.916 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 -16.62 37.52 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.748 2.299 . . . . 61.33 112.281 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -90.28 0.28 57.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.887 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -73.31 -6.29 45.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.848 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.608 ' O ' HG22 ' A' ' 52' ' ' VAL . 35.0 t30 -56.63 -32.67 65.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 73.32 110.928 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -70.91 -23.35 62.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.931 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.2 61.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.796 -0.716 . . . . 71.25 112.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 49' ' ' ASN . 8.9 m -63.3 -37.2 78.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.864 0.364 . . . . 44.44 111.116 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.671 ' HA ' HG22 ' A' ' 56' ' ' VAL . 27.7 m-85 -85.04 -5.14 59.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 64.44 110.888 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -60.25 -24.32 64.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 72.21 110.865 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.14 -46.93 3.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.76 . . . . 54.11 112.475 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.671 HG22 ' HA ' ' A' ' 53' ' ' PHE . 34.0 m -68.15 -37.26 77.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 74.32 111.121 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -49.99 -56.52 10.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 61.34 110.837 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.05 -16.39 64.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 73.43 110.871 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.7 -31.0 28.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.836 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.37 10.9 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 34.32 111.127 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -54.77 -38.05 66.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 71.11 110.929 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -69.3 -45.98 68.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 64.22 110.873 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.77 -0.96 86.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 62.25 112.443 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -117.41 29.92 7.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.814 0.34 . . . . 51.23 110.895 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 13.4 30.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.889 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.1 -25.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 73.14 110.81 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -50.83 -29.43 11.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 72.11 111.041 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.24 171.89 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.1 110.92 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.5 -59.58 7.67 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.726 -0.749 . . . . 43.4 112.475 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -55.46 121.58 9.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.845 0.355 . . . . 73.33 110.87 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -177.08 -65.88 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 44.44 112.516 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 73' ' ' SER . 22.4 mt-10 -100.53 -35.49 9.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 75.24 110.879 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.5 p 164.79 138.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 54.5 110.858 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.563 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.0 mm? -71.12 -9.52 58.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 64.35 110.904 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -35.05 24.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.215 -0.448 . . . . 71.41 111.179 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -53.84 -43.54 69.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.915 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -76.43 -42.05 45.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 71.33 110.919 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.62 -34.13 0.55 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.079 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -71.69 -59.33 2.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 72.12 110.874 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -80.04 -53.92 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 64.24 110.854 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -39.44 -66.22 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.41 110.948 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.7 mmm -51.35 -59.76 3.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 53.31 110.908 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -50.84 -23.75 7.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.706 -0.759 . . . . 61.13 112.481 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.58 -29.69 17.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 73.4 111.082 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -94.36 -75.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 63.54 111.054 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -42.71 -34.14 0.85 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.852 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -81.87 -69.48 0.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.15 110.831 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 1.6 ttmt -62.31 -57.86 9.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.877 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.7 tt -47.5 -54.34 11.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.13 110.856 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.2 t-20 -69.05 -50.29 49.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 72.25 110.92 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.683 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 31.3 t70 -67.58 -13.74 62.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.86 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.56 -25.37 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 73.55 111.118 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -106.2 -36.43 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.14 111.187 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -91.55 -34.07 14.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 62.53 110.849 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.683 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 21.6 t80 -91.91 -39.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 74.11 110.908 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.586 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.4 t -90.61 -59.47 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.118 -0.492 . . . . 61.5 111.145 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.584 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.95 -17.59 60.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 71.42 110.829 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.96 -19.74 52.44 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.781 -0.723 . . . . 75.34 112.418 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -87.61 -56.13 3.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 74.52 110.868 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.5 t -59.26 -27.61 37.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 73.53 111.129 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -32.88 69.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 61.23 110.89 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.11 95.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.804 -0.713 . . . . 52.1 112.437 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -81.13 133.67 35.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 42.41 110.908 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -98.6 10.23 41.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 70.12 110.905 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.01 160.48 76.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.556 0.693 . . . . 73.42 110.9 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.7 90.78 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.694 2.263 . . . . 52.13 112.357 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.9 p -109.38 20.12 18.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 64.35 111.102 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -69.6 150.78 46.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 75.12 110.902 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 71.15 110.921 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mmt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.736 0.303 . . . . 73.23 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.33 106.66 2.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 63.52 110.836 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -67.67 -25.67 65.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 75.22 110.894 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.09 20.3 8.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.161 -0.472 . . . . 75.5 111.061 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.31 111.01 3.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.812 -0.708 . . . . 72.04 112.459 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -91.16 10.18 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.92 0.39 . . . . 72.31 110.899 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -89.36 -1.15 57.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 52.13 110.911 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.92 -17.32 1.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.695 -0.764 . . . . 75.31 112.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -73.12 -9.97 59.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 73.4 110.843 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.97 -9.82 58.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.759 -0.734 . . . . 60.12 112.484 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.22 -28.29 25.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.938 0.399 . . . . 73.12 110.893 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -95.21 -38.24 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.932 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -71.44 -36.09 71.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 70.24 111.103 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 t -79.13 -29.25 43.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 63.4 110.867 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 13.3 pt-20 -89.42 -22.73 22.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.908 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 12' ' ' LYS . . . -86.63 -21.69 26.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 61.54 111.059 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.627 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.7 pp -110.86 -7.72 14.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.953 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -40.92 153.53 0.23 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.544 0.688 . . . . 72.12 110.889 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 9.75 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.652 2.234 . . . . 72.21 112.303 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -128.89 8.95 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 72.54 110.86 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -102.84 -9.19 20.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 73.4 110.831 -179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -109.66 -37.44 5.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 63.34 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.565 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -70.64 -71.34 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 54.14 110.958 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' H ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -43.43 -28.61 0.37 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.14 110.836 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.556 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.76 -56.28 3.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.936 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.3 -49.19 36.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.075 -0.511 . . . . 54.32 111.162 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -48.75 -57.43 6.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 54.01 110.869 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -43.0 16.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 64.24 110.943 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.67 -33.09 58.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.741 -0.742 . . . . 71.31 112.458 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.021 ' O ' HG22 ' A' ' 34' ' ' THR . 2.9 tttp -71.56 -48.61 47.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.744 0.307 . . . . 64.42 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.594 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 mm-40 -47.57 -27.17 1.71 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 53.55 110.941 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -76.77 -36.46 57.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 54.53 110.9 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.47 -58.42 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 45.12 111.1 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.021 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.0 t -36.27 -46.82 0.55 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 70.4 111.166 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -63.65 -56.12 18.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 70.2 110.834 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' O ' HG13 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -60.08 -46.68 88.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 71.04 110.944 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -57.16 -49.32 76.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 64.41 111.081 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -49.58 -22.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.856 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -95.36 -39.85 9.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.877 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.3 m -61.95 -5.68 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 75.34 111.076 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -97.83 -10.74 24.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.43 111.111 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 -7.8 59.98 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.818 -0.706 . . . . 43.43 112.532 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.32 -35.32 2.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.806 0.336 . . . . 54.51 110.929 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -32.74 -48.59 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.187 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.96 111.27 3.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.571 0.701 . . . . 75.21 110.891 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -15.05 36.79 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 73.42 112.377 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -90.25 0.87 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 75.11 110.881 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -79.12 -1.72 37.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 74.43 110.855 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.514 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 p30 -58.18 -21.78 48.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.938 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -89.01 -22.68 22.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.52 -30.9 78.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 65.23 112.514 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 49' ' ' ASN . 19.1 m -61.95 -37.4 78.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 73.51 111.075 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' HA ' HG22 ' A' ' 56' ' ' VAL . 55.8 m-85 -83.83 -7.44 59.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 72.25 110.823 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.98 -26.94 60.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.183 -0.462 . . . . 71.51 110.937 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.74 -48.8 3.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.775 -0.726 . . . . 72.43 112.545 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' HA ' ' A' ' 53' ' ' PHE . 3.2 m -66.24 -28.9 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.867 0.365 . . . . 73.34 111.135 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -48.96 -38.57 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 73.03 110.921 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -53.62 -26.77 23.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 75.31 110.852 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 t -58.18 -48.19 81.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.896 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.49 9.99 27.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.03 111.081 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -51.68 -35.89 44.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 62.31 110.937 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.37 -49.3 67.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 73.13 110.973 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.2 2.16 82.48 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 52.4 112.491 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -120.2 27.93 8.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 74.15 110.909 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -101.0 14.15 32.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 73.33 110.924 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -53.02 -21.13 4.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.868 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' N ' HD22 ' A' ' 66' ' ' ASN . . . -67.34 -29.35 68.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 61.11 111.073 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.81 170.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 65.43 110.875 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.1 116.2 0.71 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.783 -0.722 . . . . 74.32 112.519 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -51.61 137.42 24.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 61.43 110.863 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.99 -63.5 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 54.43 112.499 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 73' ' ' SER . 1.0 OUTLIER -102.02 -2.41 29.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.886 0.375 . . . . 54.53 110.873 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.0 OUTLIER 85.14 144.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.31 110.805 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.5 -14.82 14.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 64.12 110.874 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.51 -25.96 35.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 64.53 111.124 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 72' ' ' GLU . 8.2 t70 -57.89 -42.08 83.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 71.41 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 pt20 -81.77 -38.48 25.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.35 110.905 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.13 -33.57 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 70.32 111.134 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -77.77 -60.1 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.885 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.04 -53.32 9.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 70.41 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.93 -64.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.983 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -46.72 -35.39 6.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 73.11 110.868 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.63 -59.05 4.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.789 -0.719 . . . . 73.12 112.466 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.78 -19.22 5.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.761 0.315 . . . . 74.25 111.088 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.02 -75.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 74.4 111.085 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 4.5 tmtm? -45.63 -34.95 3.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 72.04 110.92 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 0.5 OUTLIER -77.22 -67.92 0.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 52.32 110.901 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.593 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.74 -61.46 2.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.959 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 85' ' ' ALA . 7.5 tt -42.22 -52.68 4.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 74.12 110.899 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.629 ' O ' ' N ' ' A' ' 94' ' ' GLU . 2.6 t-20 -70.46 -62.16 1.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.51 110.868 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.721 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 1.3 m-20 -57.02 -15.67 5.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.869 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.598 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -100.65 -29.52 12.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 74.51 111.055 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -107.29 -46.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.111 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.629 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.9 mt-10 -73.44 -38.27 65.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 74.03 110.886 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.721 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.9 t80 -82.47 -43.4 17.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.874 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 3.8 t -84.21 -66.66 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 62.55 111.166 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -60.98 -19.33 60.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 55.22 110.862 -179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.38 -22.65 39.89 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.684 -0.769 . . . . 73.44 112.444 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.08 -38.29 17.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.845 0.355 . . . . 70.31 110.837 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.16 -33.38 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 64.04 111.143 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -52.79 -31.58 39.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 73.3 110.852 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -94.85 59.04 1.78 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.75 -0.738 . . . . 44.22 112.441 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -52.09 121.61 7.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.867 0.365 . . . . 73.32 110.911 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.63 10.07 27.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 61.45 110.916 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -51.57 158.48 1.5 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.567 0.699 . . . . 65.04 110.865 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 88.74 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.622 2.215 . . . . 75.13 112.386 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.2 p -78.01 -24.88 47.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 74.52 111.115 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -135.32 82.45 1.95 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 71.22 110.903 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 71.44 110.88 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.724 0.297 . . . . 64.41 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.11 -170.21 2.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.814 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -110.59 150.23 29.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 75.53 110.876 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.17 -14.18 53.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 71.31 111.095 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.0 173.64 16.75 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.767 . . . . 63.13 112.475 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -109.28 10.2 25.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 74.13 110.911 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -18.21 65.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.878 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 126.86 -23.25 5.63 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 54.11 112.577 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -75.18 -6.6 50.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.932 0.396 . . . . 74.41 110.88 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.89 -27.95 17.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.1 112.53 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -60.09 -24.45 64.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.942 0.401 . . . . 75.32 110.868 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -96.53 -50.58 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 70.43 110.934 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.58 -40.44 96.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 61.22 111.067 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 4.8 t -71.59 -35.88 70.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.296 -0.411 . . . . 54.43 110.875 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 8.7 pt-20 -84.05 -25.69 29.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 70.42 110.922 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.07 -15.48 50.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.107 -0.497 . . . . 54.03 111.05 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.7 pp -102.56 -11.31 18.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 64.41 110.933 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 14' ' ' SER . 56.5 mmtt -41.97 153.86 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.499 0.666 . . . . 65.41 110.87 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -8.71 24.31 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.681 2.254 . . . . 72.12 112.356 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.16 53.62 1.81 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 73.24 110.878 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.549 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 24.9 t -91.47 -15.31 29.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 70.34 110.822 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -110.08 -42.02 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 71.11 110.895 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.64 -71.46 0.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 71.12 110.879 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.91 -30.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.433 . . . . 74.11 110.892 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -85.99 -56.98 3.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 74.55 110.917 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.05 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.486 . . . . 72.53 111.129 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -48.78 -57.08 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 70.41 110.916 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -45.27 -40.31 7.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 75.53 110.952 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.71 -32.35 46.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.779 -0.724 . . . . 42.31 112.452 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.047 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -72.48 -44.31 62.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.705 0.288 . . . . 74.11 110.903 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 23.4 mt-10 -50.99 -26.55 6.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.35 110.91 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -77.41 -36.03 53.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.898 -179.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -90.32 -58.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.08 -0.509 . . . . 75.53 111.156 179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.047 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.7 t -39.09 -44.27 1.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 73.12 111.121 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -60.08 -52.57 64.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.291 -0.413 . . . . 72.41 110.844 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -75.14 -20.52 59.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.838 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -74.53 -40.32 61.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 70.45 111.116 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -68.62 -19.41 64.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.899 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 -45.37 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 45.4 110.888 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.633 HG22 ' HA ' ' A' ' 37' ' ' ALA . 19.2 m -60.11 -8.3 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 64.32 111.084 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -93.86 -9.52 37.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 64.23 111.163 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -95.23 -8.83 58.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 73.4 112.497 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.38 -35.47 2.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.786 0.326 . . . . 74.45 110.869 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 p -31.82 -48.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.298 -0.41 . . . . 72.31 111.123 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -58.93 111.24 3.41 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 74.22 110.891 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -16.55 37.61 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 71.52 112.372 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.4 -0.12 57.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 70.54 110.852 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -82.51 2.79 31.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 51.22 110.84 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -62.9 -21.66 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 73.45 110.888 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -93.4 -20.86 19.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 75.03 110.902 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.05 -31.05 78.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.737 -0.744 . . . . 44.15 112.523 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 ' CD2' ' A' ' 53' ' ' PHE . 17.5 m -62.94 -38.59 82.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 71.43 111.133 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' HG23 ' A' ' 52' ' ' VAL . 62.7 m-85 -90.53 -11.01 41.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.844 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -65.27 -43.09 92.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 73.2 110.943 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.55 -14.07 57.44 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 64.14 112.459 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.0 -52.46 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 72.5 111.163 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -53.58 -32.27 50.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 55.33 110.824 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.44 -29.79 62.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.854 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.7 m -79.17 -30.23 43.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.862 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.61 10.28 23.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.057 -0.519 . . . . 70.25 111.125 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -51.9 -29.82 21.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 74.04 110.91 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.9 ptmt -77.72 -39.48 44.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 72.25 110.949 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.29 13.96 66.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 64.14 112.481 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -114.9 27.2 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 73.34 110.932 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -110.46 12.68 22.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.863 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.562 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.59 -32.77 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 64.45 110.921 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -46.97 -41.27 15.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 43.32 111.059 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -51.71 169.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 74.52 110.911 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.59 -117.08 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.653 -0.784 . . . . 62.03 112.461 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -52.15 121.58 7.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.809 0.338 . . . . 63.34 110.861 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.59 -63.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 73.35 112.549 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.505 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 1.31 40.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.957 0.408 . . . . 61.24 110.95 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.08 146.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 62.41 110.895 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.1 -14.44 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 62.3 110.923 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.03 -23.63 38.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 61.33 111.096 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 8.0 t70 -61.51 -37.09 82.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 52.13 110.838 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.653 ' O ' ' N ' ' A' ' 81' ' ' TYR . 7.6 pt20 -87.27 -36.38 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 64.33 110.877 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.1 -33.14 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 74.24 111.099 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 16.0 ptp180 -79.16 -45.93 18.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.15 110.812 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 14.4 t70 -88.13 -56.34 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 61.24 110.815 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.653 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.8 t80 -40.56 -58.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 44.22 110.902 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -60.36 -38.89 85.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 52.41 110.901 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.35 -20.99 70.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 54.44 112.517 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.09 -40.48 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.738 0.304 . . . . 73.15 111.064 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -93.56 -75.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 64.12 111.043 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 10.6 tmtt? -45.26 -28.73 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.857 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -86.18 -70.71 0.58 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 65.14 110.892 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.7 OUTLIER -60.09 -57.0 14.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.127 -0.488 . . . . 74.14 110.908 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 93' ' ' VAL . 7.9 tt -49.69 -58.55 5.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 62.22 110.878 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 19.2 t30 -64.29 -66.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 75.22 110.832 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 33.5 t0 -44.48 -31.24 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 65.43 110.802 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.7 ' O ' ' N ' ' A' ' 96' ' ' VAL . . . -90.61 -73.65 0.52 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.034 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 ' N ' ' O ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -42.87 -31.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 72.25 111.103 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -80.02 -50.8 9.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 64.34 110.8 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.529 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 32.7 t80 -88.7 -49.59 6.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 63.11 110.925 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.7 ' N ' ' O ' ' A' ' 92' ' ' ALA . 54.0 t -58.79 -60.24 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.073 -0.512 . . . . 64.21 111.111 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -40.28 78.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.43 110.863 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -19.98 63.17 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.716 -0.754 . . . . 24.44 112.474 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.01 -52.41 5.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.916 0.389 . . . . 75.33 110.896 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.24 -27.29 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.152 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.52 -27.3 62.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 63.44 110.866 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.46 101.12 0.54 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.73 -0.748 . . . . 63.34 112.515 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -99.75 123.33 43.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.852 0.358 . . . . 75.13 110.903 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -94.44 10.11 35.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 52.21 110.913 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.1 155.6 38.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 65.11 110.853 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 99.01 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.745 2.297 . . . . 55.45 112.297 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 m -52.43 -29.59 25.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.212 -0.449 . . . . 62.53 111.093 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 153.3 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.922 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 72.42 110.918 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.336 . . . . 71.0 110.866 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 t 62.71 89.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 52.53 110.856 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -122.99 130.54 52.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 61.11 110.882 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.74 20.08 18.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 64.11 111.081 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.27 111.78 3.89 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.769 -0.729 . . . . 71.14 112.5 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -109.64 10.26 24.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.913 0.387 . . . . 75.2 110.906 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -15.43 61.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 63.52 110.857 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.62 -17.36 0.98 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.713 -0.756 . . . . 53.01 112.457 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -81.21 -11.38 59.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.948 0.404 . . . . 75.44 110.909 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.0 -40.38 4.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 52.43 112.508 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.65 -22.66 66.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 63.3 110.87 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.42 -43.2 8.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.1 110.865 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 55.42 111.139 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 41.2 t -95.35 -27.88 15.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.819 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 12.1 pt-20 -97.35 -26.1 15.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 73.34 110.872 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -92.1 -20.98 20.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 51.15 111.103 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 13' ' ' ALA . 4.4 mt -114.06 -1.58 13.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 65.25 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' SER . 1.9 pttm -37.34 109.92 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.517 0.675 . . . . 75.12 110.862 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 62.5 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.692 2.261 . . . . 75.12 112.327 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.73 -14.09 5.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 65.05 110.848 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.7 -13.02 60.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 74.11 110.855 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 19.8 mm-40 -115.45 -64.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 55.13 110.865 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -41.46 -72.98 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.285 -0.416 . . . . 72.04 110.912 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.03 -31.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 70.43 110.828 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.4 m-85 -84.24 -56.42 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 44.41 110.944 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.42 -49.18 51.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 63.33 111.087 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -49.03 -57.2 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 73.24 110.859 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -48.08 -35.65 11.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.899 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.5 -42.57 33.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 41.25 112.458 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.981 ' O ' HG22 ' A' ' 34' ' ' THR . 0.2 OUTLIER -68.99 -50.17 51.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.76 0.314 . . . . 74.21 110.848 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 0.6 OUTLIER -45.46 -28.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 63.34 110.938 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -75.56 -36.42 60.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 74.2 110.919 -179.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG12 ' N ' ' A' ' 34' ' ' THR . 0.2 OUTLIER -92.59 -59.22 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 61.21 111.128 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.981 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.4 t -36.7 -46.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 43.02 111.157 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.37 -55.96 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.52 110.868 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.787 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -59.9 -46.99 87.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 64.21 110.915 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.582 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -56.78 -49.24 75.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 51.54 111.11 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -49.41 -23.27 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.82 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -95.06 -39.45 10.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 75.35 110.945 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.787 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.2 m -63.05 -5.81 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 71.44 111.141 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.79 -16.52 25.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 53.4 111.113 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.83 0.26 69.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.682 -0.77 . . . . 52.34 112.519 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.08 -36.32 2.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 72.24 110.955 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -40.28 -45.36 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 52.01 111.114 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -59.07 111.56 3.87 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.51 0.672 . . . . 74.15 110.896 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.9 -14.34 35.5 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.64 2.227 . . . . 74.35 112.273 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -91.14 -0.27 57.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 74.43 110.849 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.689 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -88.85 11.55 17.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 70.5 110.91 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -55.82 -24.96 39.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 63.11 110.877 -179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -94.24 -47.06 6.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 64.34 110.905 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.41 -23.24 2.94 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.745 -0.741 . . . . 73.05 112.491 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 48' ' ' ASP . 12.9 m -67.45 -42.07 86.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.937 0.399 . . . . 51.52 111.099 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' N ' HG23 ' A' ' 52' ' ' VAL . 1.6 p90 -90.87 -14.04 32.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 73.35 110.987 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -62.39 -43.98 97.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.045 -0.525 . . . . 74.31 110.942 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.56 -18.59 44.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 42.44 112.49 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.1 t -84.96 -55.88 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 71.3 111.158 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.416 ' N ' HG12 ' A' ' 56' ' ' VAL . 55.5 t-80 -52.02 -50.19 61.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 70.33 110.878 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -58.97 -24.72 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 71.55 110.955 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.6 m -85.8 -23.81 27.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 71.34 110.827 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.19 4.99 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.23 111.105 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.94 -69.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.05 110.916 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.95 10.11 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 71.42 110.884 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.24 0.12 25.23 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.733 -0.746 . . . . 71.52 112.492 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -103.95 29.66 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.34 110.884 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -110.34 13.74 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.4 110.917 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.02 -25.77 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.889 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.38 -29.67 16.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.17 -0.468 . . . . 75.13 111.083 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -67.37 147.65 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.92 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -102.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.739 . . . . 52.52 112.492 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -63.22 161.94 12.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 62.11 110.866 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.85 -64.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.757 . . . . 64.02 112.493 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.6 -33.48 10.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.836 0.35 . . . . 74.11 110.883 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.47 139.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.844 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' N ' HD22 ' A' ' 74' ' ' LEU . 3.2 mm? -72.07 -9.81 58.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 73.51 110.93 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.19 -32.98 22.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 75.14 111.113 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -55.51 -42.81 75.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 74.33 110.88 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.5 pt20 -80.87 -39.2 26.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.943 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.25 -33.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.1 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -76.54 -61.58 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.863 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.88 -53.09 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.878 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.17 -62.24 0.99 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 71.21 110.892 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.2 ptm -52.4 -37.02 55.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 74.24 110.838 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.42 ' O ' ' CB ' ' A' ' 87' ' ' SER . . . -66.82 -22.53 72.03 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.816 -0.707 . . . . 73.42 112.449 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.25 -40.54 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.825 0.345 . . . . 75.52 111.119 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -90.8 -78.46 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.122 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 6.8 tmtm? -42.93 -38.8 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.909 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER -73.15 -71.43 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 72.42 110.877 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.644 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -57.92 -56.36 22.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 75.41 110.91 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 85' ' ' ALA . 5.6 tt -46.55 -55.34 7.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.867 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 94' ' ' GLU . 5.5 t30 -69.48 -47.53 63.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 75.13 110.871 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.686 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 85.8 m-20 -69.48 -13.93 62.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 54.53 110.832 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.644 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -107.02 -25.06 11.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 41.2 111.137 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.7 OUTLIER -105.98 -36.3 3.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.121 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.05 -34.27 14.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.925 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.686 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 17.0 t80 -91.51 -39.66 11.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 63.35 110.928 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -90.86 -59.69 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.071 -0.513 . . . . 73.45 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.582 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.77 -17.77 60.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 53.54 110.87 -179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.39 -19.36 52.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 74.24 112.495 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.6 -57.19 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.877 0.37 . . . . 72.22 110.897 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.01 -26.56 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 73.54 111.13 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -95.94 26.84 3.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.874 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.28 -77.33 0.16 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.747 -0.739 . . . . 71.4 112.448 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.69 125.64 34.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.776 0.322 . . . . 74.41 110.887 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -97.62 10.17 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.91 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.4 144.79 70.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.631 0.729 . . . . 64.52 110.818 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.72 101.06 0.86 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 72.02 112.311 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -26.18 64.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 74.21 111.143 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -80.44 -74.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 72.21 110.893 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.433 . . . . 61.1 110.926 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.751 0.31 . . . . 63.23 110.86 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.8 t -173.82 168.91 4.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 65.42 110.902 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -137.72 127.25 25.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 73.44 110.892 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.62 -24.45 18.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.186 -0.461 . . . . 44.24 111.066 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.13 157.8 27.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.74 -0.743 . . . . 44.22 112.479 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.72 -49.56 5.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 75.44 110.932 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 -19.57 24.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.873 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.21 100.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.721 -0.752 . . . . 72.34 112.493 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -85.12 -9.59 57.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.936 0.398 . . . . 73.31 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -92.07 -37.39 6.0 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.679 -0.772 . . . . 43.34 112.491 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mt-10 -48.09 -26.6 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.881 0.372 . . . . 61.12 110.87 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -102.68 -60.72 1.5 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.9 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -61.0 -46.24 91.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 44.23 111.107 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -66.35 -36.87 83.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 54.24 110.779 -179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 18.2 mm-40 -82.18 -23.13 35.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.977 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -94.1 -10.71 32.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 74.11 111.07 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.4 pp -112.72 -22.43 10.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 72.15 110.922 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -42.81 106.3 0.47 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.598 0.713 . . . . 74.21 110.84 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 65.17 1.87 Allowed 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.71 2.273 . . . . 70.14 112.313 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 38.8 t70 51.34 42.97 29.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.889 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.521 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 87.9 p -104.93 -17.2 14.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 63.45 110.808 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -110.47 -39.48 4.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 65.24 110.962 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.07 -73.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 62.25 110.894 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.01 -30.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 64.54 110.867 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 3.4 m-85 -84.9 -57.29 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.917 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.2 -49.33 44.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 62.43 111.145 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.1 tp10 -48.49 -56.74 7.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 65.21 110.882 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.01 -35.78 16.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.901 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.638 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.17 -33.64 48.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.717 -0.754 . . . . 75.12 112.507 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -76.48 -49.22 17.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.713 0.292 . . . . 74.54 110.863 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 16.5 pt-20 -46.18 -31.27 2.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.26 -0.427 . . . . 75.15 110.856 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.664 ' HD1' HD12 ' A' ' 33' ' ' ILE . 3.9 t80 -79.27 -37.74 37.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.145 -0.479 . . . . 73.45 110.918 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.664 HD12 ' HD1' ' A' ' 32' ' ' TYR . 1.8 mp -81.85 -58.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 62.31 111.177 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 30' ' ' LYS . 3.3 t -35.48 -48.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.145 -0.479 . . . . 73.34 111.152 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.464 ' N ' HG23 ' A' ' 34' ' ' THR . 0.4 OUTLIER -58.77 -61.5 2.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 64.2 110.811 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.635 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -69.27 -16.49 63.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.916 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 40' ' ' VAL . . . -68.75 -41.59 78.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 20.54 111.069 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.5 -20.04 65.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 63.25 110.872 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -95.69 -48.26 5.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 75.32 110.896 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 37' ' ' ALA . 29.9 m -56.65 -9.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.34 111.168 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.99 -32.32 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 70.44 111.137 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.54 0.92 71.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.791 -0.719 . . . . 64.44 112.508 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -121.71 -34.54 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.803 0.335 . . . . 72.3 110.905 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER -34.86 -48.2 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.092 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -58.71 111.53 3.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.587 0.708 . . . . 62.11 110.925 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -17.38 37.64 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.734 2.289 . . . . 61.33 112.305 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -89.09 0.7 56.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.33 110.898 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.69 8.33 22.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.09 -0.504 . . . . 72.42 110.794 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 38.4 t30 -60.6 -23.54 64.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 75.12 110.864 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.86 -32.35 16.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.155 -0.475 . . . . 65.35 110.939 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.96 -26.36 11.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.737 -0.744 . . . . 63.5 112.479 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.1 m -68.97 -39.05 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 70.43 111.07 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 56' ' ' VAL . 89.6 m-85 -88.54 -5.85 57.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 75.34 110.893 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -58.47 -25.04 61.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.23 110.965 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 -49.98 2.96 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 65.32 112.488 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.646 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -64.08 -36.13 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.91 0.386 . . . . 74.01 111.129 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.0 t60 -50.26 -51.97 40.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 71.05 110.845 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -70.24 -19.4 63.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 74.42 110.877 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.2 t -82.04 -26.94 33.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 73.12 110.814 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.77 9.78 25.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 44.34 111.122 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -51.71 -35.54 43.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.9 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.71 -47.01 67.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 75.35 110.837 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.57 78.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.512 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -117.18 27.81 8.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.77 0.319 . . . . 60.42 110.863 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.12 11.63 21.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 74.13 110.843 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.506 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.51 -37.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.854 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.58 -58.35 6.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.04 111.093 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -89.58 151.76 21.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.25 110.928 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.07 -60.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.829 -0.7 . . . . 72.01 112.529 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.5 mm100 -52.28 122.75 9.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.773 0.321 . . . . 64.41 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.7 -64.82 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.81 -0.71 . . . . 63.41 112.488 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -100.58 -33.67 10.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.916 0.389 . . . . 42.44 110.905 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.75 139.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 73.2 110.874 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -69.77 -8.17 45.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.09 -0.504 . . . . 63.44 110.975 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.41 -32.64 28.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 74.02 111.049 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -55.83 -41.35 74.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.0 110.783 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' N ' ' A' ' 81' ' ' TYR . 6.0 mm-40 -81.07 -41.23 22.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 65.43 110.925 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.47 -33.76 0.47 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 75.32 111.151 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -74.71 -61.86 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 64.04 110.898 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.44 -53.02 10.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 53.53 110.901 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.57 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -42.45 -65.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.912 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.3 ptm -45.96 -36.35 5.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -72.04 -58.86 4.96 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 25.13 112.453 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.4 -19.28 8.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 63.32 111.071 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.27 -74.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 61.22 111.131 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.54 -34.65 3.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 70.21 110.926 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -78.23 -67.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.886 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -62.94 -60.08 3.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.903 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.36 -54.77 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 70.32 110.938 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.604 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.6 t30 -69.06 -55.93 9.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.936 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.687 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 28.0 t70 -62.22 -13.51 28.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 72.13 110.936 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.606 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.14 -25.79 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 71.25 111.126 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.498 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.9 OUTLIER -106.79 -39.28 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.186 -0.461 . . . . 62.35 111.137 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.6 mt-10 -88.41 -33.72 17.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.158 -0.474 . . . . 64.11 110.871 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.687 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 29.1 t80 -91.59 -40.73 11.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.918 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 1.3 t -89.52 -59.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 75.31 111.114 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.591 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.25 -16.74 60.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 63.01 110.858 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.81 -19.83 46.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 72.02 112.512 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -86.21 -55.35 3.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 73.43 110.899 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.2 t -60.52 -22.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 73.24 111.115 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -52.04 -34.33 42.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 63.4 110.882 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -105.31 112.54 4.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 72.24 112.489 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -96.72 159.66 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 75.03 110.871 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -87.46 -22.29 25.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 73.41 110.908 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.6 158.43 1.53 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.56 0.695 . . . . 73.33 110.911 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 101.0 0.86 Allowed 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.697 2.265 . . . . 62.34 112.31 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.6 p -85.13 -25.52 27.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 72.1 111.162 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -101.77 -175.26 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.89 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 62.42 110.872 179.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 72.22 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 p -55.89 163.0 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 63.53 110.9 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -137.94 121.87 17.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 71.41 110.832 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.95 35.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 74.35 111.079 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.59 -122.59 30.29 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.764 -0.731 . . . . 63.54 112.43 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -111.14 8.88 21.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.915 0.388 . . . . 74.1 110.871 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -51.94 -31.33 28.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 75.52 110.889 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.82 -26.85 65.77 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 64.43 112.42 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.31 -6.92 50.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 74.25 110.843 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.5 -36.21 6.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.771 -0.728 . . . . 74.55 112.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 5.6 mm-40 -51.11 -24.38 3.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 72.14 110.898 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -103.07 -57.53 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 73.2 110.894 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.63 92.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 64.01 111.105 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.8 m -67.66 -42.22 82.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 73.44 110.841 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 67.4 mm-40 -76.85 -24.75 52.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 62.24 110.896 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -81.9 -24.44 35.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 54.14 111.115 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.5 pp -107.0 -10.99 15.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 75.53 110.913 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 3.8 mttm -43.0 106.72 0.5 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.6 0.714 . . . . 75.2 110.892 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.8 Cg_endo -69.8 69.8 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.706 2.271 . . . . 73.01 112.364 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HA ' ' CG ' ' A' ' 23' ' ' LYS . 1.3 m-20 -63.86 -8.28 10.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 64.33 110.845 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -79.32 -13.5 59.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 61.25 110.845 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -114.08 -64.23 1.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 73.04 110.923 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -43.02 -72.03 0.07 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 63.32 110.878 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.0 -31.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 70.43 110.88 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' LYS . 2.3 m-85 -84.79 -56.8 3.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.44 110.947 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.95 -49.66 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 73.04 111.078 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.7 -56.84 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.23 110.886 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -47.52 -37.85 12.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.905 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.19 -45.33 40.48 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.764 -0.731 . . . . 11.21 112.456 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.974 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -65.86 -47.51 74.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.695 0.283 . . . . 60.4 110.874 -179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 4.9 mt-10 -44.4 -34.13 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.11 110.933 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.594 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.47 -39.79 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.969 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -78.7 -60.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.063 -0.517 . . . . 73.23 111.147 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.974 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -29.92 -48.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 65.05 111.192 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.02 -64.85 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 73.54 110.849 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' O ' HG22 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -68.46 -42.89 78.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.283 -0.417 . . . . 55.11 110.844 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.702 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -44.78 -52.43 8.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.133 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -53.89 -25.97 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 75.51 110.859 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 41' ' ' ALA . 6.3 tttp -93.08 -59.67 1.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 74.43 110.884 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 36' ' ' LYS . 1.6 m -55.75 -5.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 64.25 111.174 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -98.4 -30.92 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 53.11 111.067 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.29 -22.59 24.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.689 -0.767 . . . . 43.41 112.49 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' CG ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -83.81 -46.41 12.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.846 0.355 . . . . 64.34 110.892 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -42.54 -39.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 74.35 111.091 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.402 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 14.2 mt-30 -40.87 102.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.578 0.704 . . . . 70.32 110.925 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.8 Cg_endo -69.72 -18.59 37.11 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.702 2.268 . . . . 75.42 112.344 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -91.11 -16.0 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.34 110.864 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.464 ' O ' HG13 ' A' ' 52' ' ' VAL . 5.1 t0 -105.01 20.15 19.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.891 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 52' ' ' VAL . 7.4 t30 -54.14 -27.48 33.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 71.5 110.845 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -44.98 7.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 73.42 110.896 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.77 -29.21 12.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 41.14 112.45 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 48' ' ' ASP . 35.8 m -68.26 -39.67 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 51.01 111.149 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' N ' HG23 ' A' ' 52' ' ' VAL . 49.6 m-85 -90.35 -9.86 46.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.898 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.51 -43.16 86.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.3 110.954 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.83 -14.48 56.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 44.23 112.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -89.93 -54.53 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 64.33 111.152 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.426 ' N ' HG12 ' A' ' 56' ' ' VAL . 11.2 t60 -55.49 -30.62 60.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.893 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.05 -23.07 36.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.21 110.871 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 t -84.99 -25.0 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 71.52 110.864 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.31 10.31 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 61.43 111.09 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -52.06 -29.61 22.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 65.23 110.886 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -83.65 -35.56 24.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 64.32 110.86 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.72 17.58 58.88 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 33.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -95.97 23.73 6.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.74 0.305 . . . . 74.22 110.858 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -110.08 13.68 23.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 73.14 110.861 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.12 -25.76 1.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 71.2 110.827 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.48 -29.39 16.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 53.13 111.121 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.94 141.73 28.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.871 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.86 -35.84 2.25 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 71.54 112.511 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -52.12 160.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.867 0.365 . . . . 65.24 110.933 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.92 -64.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.739 -0.743 . . . . 53.31 112.519 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 73' ' ' SER . 61.6 mm-40 -100.51 -33.28 10.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.855 0.36 . . . . 63.44 110.883 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 t 162.53 140.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.869 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.64 -25.85 59.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 73.14 110.999 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.19 -31.75 30.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 60.14 111.093 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.47 -40.85 79.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 72.32 110.867 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 81' ' ' TYR . 1.8 pt20 -82.2 -38.95 23.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 73.34 110.922 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.72 -33.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.08 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -76.79 -60.82 2.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 74.2 110.914 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -74.63 -53.34 9.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 75.1 110.783 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.8 t80 -42.81 -64.72 0.57 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 72.22 110.879 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.9 ptm -46.59 -35.72 6.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 61.11 110.872 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.24 -59.98 4.0 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.731 . . . . 34.41 112.483 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.44 -21.51 6.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 63.01 111.141 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.66 -75.34 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 65.03 111.117 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 8.7 tmtt? -43.69 -29.99 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.04 110.912 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -84.05 -64.5 1.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.808 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 3.6 tttm -74.09 -55.53 6.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 65.24 110.909 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 85' ' ' ALA . 4.2 tp -50.3 -30.0 10.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 73.23 110.983 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 3.2 t-20 -93.67 -57.97 2.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 73.14 110.851 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.653 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 64.7 m-20 -62.7 -20.01 64.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 55.44 110.908 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -94.38 -31.66 13.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 74.42 111.137 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.8 t -107.03 -63.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 73.12 111.133 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.95 -39.96 66.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 73.51 110.923 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.653 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.4 t80 -80.16 -49.74 11.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 71.44 110.931 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.3 t -80.73 -66.22 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.055 -0.521 . . . . 65.33 111.174 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -54.95 -24.78 25.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 64.53 110.8 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.65 53.38 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.788 -0.72 . . . . 75.45 112.53 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.08 -28.04 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.859 0.362 . . . . 75.53 110.899 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.65 -33.44 10.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 71.13 111.19 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -94.96 -39.28 10.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 64.22 110.848 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.83 38.68 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.762 -0.732 . . . . 70.42 112.474 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.47 118.68 21.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 64.21 110.882 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -93.23 10.11 33.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 72.23 110.866 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.47 160.56 32.79 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.629 0.728 . . . . 70.51 110.828 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 85.01 0.62 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.676 2.251 . . . . 74.43 112.36 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.96 -31.98 52.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 74.45 111.133 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.61 154.28 9.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 53.32 110.895 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 70.35 110.865 179.832 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.803 0.335 . . . . 74.25 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.45 178.95 9.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 34.13 110.86 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.28 130.12 12.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 64.22 110.859 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.688 ' HB3' ' CA ' ' A' ' 8' ' ' GLY . . . -64.32 -21.28 66.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 63.33 111.11 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.01 -118.56 5.54 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.642 -0.789 . . . . 73.5 112.52 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 -69.86 -44.15 70.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.924 0.392 . . . . 73.31 110.821 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.43 -1.57 37.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 65.12 110.895 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.688 ' CA ' ' HB3' ' A' ' 4' ' ' ALA . . . -94.38 69.08 1.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.712 -0.756 . . . . 63.31 112.539 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -90.34 -5.61 56.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 74.12 110.909 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.98 -30.76 19.53 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.754 -0.736 . . . . 73.31 112.491 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -58.62 -25.98 63.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.882 0.372 . . . . 73.43 110.865 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -96.93 -52.38 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 62.14 110.882 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -61.22 -43.99 97.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.23 111.118 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 t -68.39 -37.96 80.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 52.34 110.85 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 8.1 pt-20 -81.42 -23.97 37.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.114 -0.494 . . . . 72.15 110.9 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.25 -13.8 32.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 53.42 111.095 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.547 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.4 pp -111.48 -17.56 13.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.447 . . . . 53.55 110.889 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -44.5 107.08 0.58 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.524 0.678 . . . . 70.21 110.86 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 54.6 Cg_endo -69.75 65.33 1.79 Allowed 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.676 2.251 . . . . 74.21 112.366 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 23' ' ' LYS . 25.9 t70 51.45 39.08 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.1 110.89 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -98.62 -15.53 19.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 60.23 110.881 -179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 56.7 mm-40 -116.79 -61.95 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.9 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.7 ptpt -40.02 -74.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 63.12 110.89 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.47 -31.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 73.25 110.886 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' N ' ' O ' ' A' ' 23' ' ' LYS . 4.5 m-85 -83.33 -56.95 3.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 74.31 110.911 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.82 -49.46 46.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.14 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.02 -57.14 6.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.937 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -47.66 -38.25 14.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 74.43 110.9 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.49 -46.76 38.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 72.31 112.441 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.966 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -64.38 -47.69 78.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.664 0.268 . . . . 72.14 110.924 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 7.9 mm-40 -43.87 -34.22 1.57 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 64.54 110.884 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.586 ' HD1' HD12 ' A' ' 33' ' ' ILE . 2.7 t80 -77.34 -39.66 46.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 73.21 110.98 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.711 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -79.2 -60.88 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.488 . . . . 73.43 111.111 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.966 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -30.38 -48.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 63.34 111.085 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -66.7 0.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.432 . . . . 73.41 110.91 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -66.9 -44.78 79.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 75.41 110.821 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.711 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -45.23 -53.7 7.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 45.33 111.151 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -49.29 -25.86 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.912 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -95.43 -40.26 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 71.13 110.829 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.4 m -61.79 -6.37 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 64.24 111.075 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 -17.05 23.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 54.33 111.116 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.59 0.23 70.43 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.794 -0.717 . . . . 75.15 112.536 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -36.28 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.771 0.32 . . . . 71.33 110.824 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.29 -45.92 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.42 . . . . 71.42 111.122 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -57.09 110.26 2.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 75.24 110.949 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -16.8 37.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.624 2.216 . . . . 75.22 112.335 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -91.14 -1.16 57.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.11 110.882 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -92.5 9.29 35.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.89 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.36 2.4 31.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.906 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -110.29 -19.24 13.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.836 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.72 -30.56 78.26 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 53.11 112.525 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 53' ' ' PHE . 21.9 m -64.04 -39.52 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 74.11 111.136 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' N ' HG23 ' A' ' 52' ' ' VAL . 60.3 m-85 -90.12 -12.99 36.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 75.22 110.893 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -62.11 -42.59 99.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 65.24 110.931 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.5 -11.18 61.12 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 24.41 112.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 t -90.71 -49.25 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.912 0.387 . . . . 64.35 111.101 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -53.92 -29.26 41.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.816 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.75 -22.7 64.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.269 -0.423 . . . . 63.22 110.817 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 t -86.32 -24.03 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 74.24 110.856 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.96 9.43 27.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.42 111.11 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -51.32 -31.85 23.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 70.11 110.876 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -83.87 -35.33 24.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 75.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.33 18.12 56.97 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 65.31 112.52 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.84 28.69 2.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.857 0.36 . . . . 72.12 110.939 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -111.37 12.92 21.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 62.04 110.862 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.543 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -42.72 -32.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 63.1 110.855 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.91 25.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 75.4 111.124 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.18 169.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 54.21 110.888 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.62 -95.54 0.1 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.792 -0.718 . . . . 65.1 112.449 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.61 155.0 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 73.4 110.881 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.28 -64.39 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 71.23 112.438 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.8 mm-40 -100.64 -33.68 10.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.37 . . . . 75.11 110.928 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.4 t 162.55 139.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 71.13 110.844 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.77 HD22 ' C ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -70.14 -8.26 48.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 61.14 110.867 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 74' ' ' LEU . . . -82.44 -31.36 29.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 65.33 111.186 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 9.9 t70 -56.72 -41.25 77.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 64.53 110.79 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 26.4 mm-40 -81.66 -34.83 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.53 110.929 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.12 -31.34 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 23.11 111.1 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.459 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 8.3 ptm180 -77.61 -47.24 19.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 71.43 110.861 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.459 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 1.0 OUTLIER -86.34 -54.86 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 54.22 110.92 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.0 t80 -42.76 -59.02 2.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 75.11 110.956 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.5 ptt? -50.94 -40.23 56.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.063 -0.517 . . . . 70.42 110.865 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.86 -60.82 4.69 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.743 -0.741 . . . . 43.25 112.526 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.96 -23.48 5.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 74.13 111.088 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -76.6 -76.18 0.17 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 41.44 111.11 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 5.1 tmtt? -55.04 -39.19 68.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.916 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.9 t -63.55 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 72.54 110.87 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -62.3 -47.07 85.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 73.42 110.95 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 8.4 tp -56.81 -47.79 79.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 71.14 110.919 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 9.4 t-20 -75.31 -42.01 55.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.914 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.705 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 91.5 m-20 -72.84 -23.05 60.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 71.42 110.863 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.569 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.82 -27.55 15.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.14 111.112 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 97' ' ' SER . 57.4 t -107.2 -65.35 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 64.03 111.126 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.57 -39.49 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.96 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.705 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 37.4 t80 -79.86 -48.77 12.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.921 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.569 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.8 t -81.49 -66.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 75.22 111.208 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 93' ' ' VAL . 6.9 m -56.22 -22.13 27.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 65.44 110.826 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.94 -19.91 45.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.7 -0.762 . . . . 63.41 112.435 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -51.25 6.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.879 0.371 . . . . 62.44 110.81 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.0 t -64.36 -26.1 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 74.11 111.103 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -71.22 -29.98 65.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.856 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.82 179.19 0.43 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.732 -0.747 . . . . 44.52 112.519 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -75.89 121.77 23.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 73.44 110.908 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -91.47 10.09 29.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 75.33 110.874 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -51.65 158.56 1.51 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.709 . . . . 72.31 110.885 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 92.15 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.615 2.21 . . . . 62.43 112.322 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -99.24 20.07 14.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.33 111.166 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -153.91 -175.87 5.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 74.43 110.927 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 65.24 110.954 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 mmt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.768 0.318 . . . . 73.44 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.7 m -73.61 137.08 44.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 74.45 110.87 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -115.88 -26.47 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 72.44 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.69 20.14 9.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 71.4 111.11 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.18 73.43 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.81 -0.71 . . . . 71.44 112.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -109.76 10.11 24.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.877 0.37 . . . . 72.55 110.881 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -18.16 57.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 54.23 110.864 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.43 103.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.812 -0.709 . . . . 63.5 112.482 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -57.17 -23.75 49.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.957 0.408 . . . . 65.44 110.929 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.6 -45.17 3.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 75.11 112.491 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -61.9 -19.9 63.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.01 110.833 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -94.59 -52.91 4.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.443 . . . . 74.11 110.912 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.8 92.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.097 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.413 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 6.0 t -71.4 -35.75 71.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 75.02 110.895 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -85.26 -25.45 27.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.899 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -83.43 -14.36 52.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.14 111.058 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.653 ' C ' HD12 ' A' ' 17' ' ' LEU . 3.6 pp -102.05 -13.18 17.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 71.42 110.929 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' N ' HD12 ' A' ' 17' ' ' LEU . 15.7 mmtp -42.84 155.91 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.624 0.726 . . . . 63.31 110.835 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -7.89 22.21 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.721 2.281 . . . . 73.12 112.359 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.1 m-20 -135.25 52.8 2.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.31 110.869 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.545 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 75.2 p -89.38 -14.54 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.02 110.85 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -110.16 -41.47 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.894 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -67.94 -71.69 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.916 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -41.21 -30.21 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 45.44 110.877 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 2.6 m-85 -86.1 -56.99 3.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.833 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -49.93 38.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.111 -0.495 . . . . 73.13 111.138 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.56 -56.89 7.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 53.55 110.951 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -46.5 -40.01 11.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 63.02 110.945 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.11 -49.96 30.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.15 112.506 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.973 ' O ' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -60.78 -46.76 89.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.741 0.305 . . . . 75.54 110.956 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 2.4 mm-40 -44.21 -32.27 1.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.17 -34.51 43.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.906 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.754 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.3 mp -86.75 -59.68 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 64.11 111.141 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.973 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.4 t -32.15 -47.84 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.01 111.117 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.58 -56.95 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.814 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.763 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.5 tptt -60.11 -55.52 32.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.11 110.937 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.49 -52.96 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.11 111.128 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -48.42 -25.3 1.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.55 110.897 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.46 -40.17 9.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 71.11 110.93 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.88 -5.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 74.33 111.142 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.14 -14.0 24.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 73.54 111.092 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.33 -13.47 60.07 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.798 -0.715 . . . . 63.11 112.515 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.76 -39.72 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 71.31 110.91 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER 27.14 93.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 73.3 111.121 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -49.1 108.22 0.92 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.654 0.74 . . . . 74.13 110.911 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -20.39 35.18 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.732 2.288 . . . . 64.25 112.338 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.69 -1.49 57.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 72.05 110.907 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -88.8 13.22 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 62.2 110.871 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -63.37 -22.33 66.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.1 tptm -94.44 -20.6 19.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 60.51 110.978 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.35 -30.23 76.28 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.462 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 53' ' ' PHE . 21.8 m -62.08 -38.37 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 72.24 111.115 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' HA ' HG22 ' A' ' 56' ' ' VAL . 57.5 m-85 -82.93 -6.49 59.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 75.01 110.889 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -23.34 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 72.45 110.916 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.39 -46.64 3.73 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.709 -0.758 . . . . 73.1 112.528 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 53' ' ' PHE . 27.8 m -68.13 -37.33 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.52 111.097 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -49.69 -57.31 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 42.34 110.841 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.55 -15.53 63.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 73.2 110.867 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -85.36 -25.0 27.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 72.12 110.898 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.43 3.49 35.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 65.13 111.069 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -50.89 -34.18 27.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 62.52 110.938 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -71.5 -42.04 68.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 75.41 110.864 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.28 -1.37 90.39 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.801 -0.714 . . . . 62.22 112.502 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -113.59 24.42 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 74.04 110.9 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -110.04 13.53 23.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.851 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.06 -25.68 1.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.12 110.911 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.45 -29.73 17.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 73.02 111.074 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -53.91 153.8 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 62.15 110.894 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.44 -150.26 5.82 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 63.31 112.544 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -55.68 122.76 12.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.887 0.375 . . . . 62.42 110.854 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.53 -62.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.78 -0.724 . . . . 45.22 112.51 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -100.25 13.32 34.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 75.05 110.95 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.523 ' HB2' HD22 ' A' ' 74' ' ' LEU . 73.6 m -32.42 -64.01 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 64.02 110.911 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 74' ' ' LEU . 1.3 mm? -95.06 -21.85 18.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 75.22 110.821 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . . . -78.08 -22.54 48.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 42.0 111.099 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.615 ' N ' ' O ' ' A' ' 72' ' ' GLU . 5.0 t0 -67.69 -37.91 82.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.442 . . . . 64.21 110.852 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 9.0 mm-40 -85.79 -41.04 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 72.44 110.899 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.44 -34.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.42 111.091 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -75.92 -60.57 2.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 71.23 110.886 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.9 -53.99 8.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 64.5 110.862 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.14 -64.74 0.54 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 74.14 110.892 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -46.58 -36.92 7.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 73.2 110.827 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.72 -58.6 5.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.765 -0.731 . . . . 72.32 112.477 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.38 -19.49 9.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.762 0.315 . . . . 72.24 111.076 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.25 -74.41 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 44.21 111.126 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -44.92 -31.75 1.37 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.226 -0.443 . . . . 74.43 110.893 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.469 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -82.33 -66.07 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 72.43 110.927 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -66.8 -60.35 2.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.883 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.4 tt -44.95 -50.23 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 52.52 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 94' ' ' GLU . 4.3 t30 -72.57 -63.2 1.21 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.892 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.684 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 9.7 t70 -54.32 -21.44 9.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 75.4 110.822 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 88' ' ' LYS . . . -94.04 -33.51 13.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 63.12 111.078 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' SER . 76.5 t -105.12 -63.65 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 75.35 111.173 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -53.03 -41.06 64.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.892 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.684 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 43.1 t80 -78.29 -50.3 12.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.892 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 5.8 t -80.75 -66.76 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 72.3 111.093 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 93' ' ' VAL . 1.3 t -53.57 -26.27 20.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.86 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -84.34 -26.25 40.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 34.21 112.489 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -77.58 -45.27 25.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 74.15 110.859 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.8 t -69.33 -24.35 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 62.03 111.153 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -52.02 -32.36 33.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.809 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.16 -60.93 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 63.11 112.479 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.04 165.85 11.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 74.03 110.898 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -95.31 -20.38 19.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 43.44 110.9 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.81 144.79 18.26 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 73.45 110.852 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 101.37 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.606 2.204 . . . . 72.4 112.37 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.7 t -75.05 -25.06 58.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 62.22 111.147 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -115.07 -178.67 3.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 72.02 110.963 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 65.55 110.912 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 mmt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.83 0.348 . . . . 65.24 110.925 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.12 123.9 50.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.14 110.853 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.52 129.32 56.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 70.11 110.873 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.93 -24.83 10.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 53.3 111.115 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -144.99 -168.21 12.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 73.15 112.494 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -80.42 -44.35 19.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.853 0.359 . . . . 72.42 110.799 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.77 -18.15 26.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 72.12 110.879 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.56 103.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.722 . . . . 74.11 112.479 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -87.78 -13.02 43.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.918 0.389 . . . . 72.13 110.896 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.35 -45.03 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.659 -0.781 . . . . 71.31 112.523 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.51 -20.37 59.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.959 0.409 . . . . 74.45 110.967 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.17 -54.18 3.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 72.32 110.917 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.51 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.43 -41.38 98.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 64.41 111.062 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 t -69.22 -36.22 77.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 74.22 110.862 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -84.73 -22.79 29.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 74.23 110.886 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 12' ' ' LYS . . . -91.87 -11.3 36.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 55.13 111.133 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.7 pp -110.55 -25.19 10.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 70.24 110.949 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -47.27 154.06 0.85 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.571 0.7 . . . . 71.44 110.925 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -7.86 22.13 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.738 2.292 . . . . 73.25 112.35 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -126.23 43.72 3.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 75.14 110.878 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 6.3 p -80.24 -15.63 56.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 63.32 110.883 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -115.53 -61.79 1.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.5 . . . . 72.43 110.919 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.12 -71.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 73.23 110.929 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -38.18 -30.81 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 60.33 110.824 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.2 m-85 -84.4 -56.73 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 54.43 110.947 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.13 -49.2 46.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 34.35 111.105 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.81 -56.75 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 54.42 110.936 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -49.1 -34.89 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 71.22 110.933 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.84 -34.5 42.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 54.35 112.458 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.3 mtpp -76.01 -48.4 21.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.823 0.344 . . . . 72.13 110.904 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 11.2 pt-20 -46.37 -31.31 2.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.918 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.656 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.3 t80 -79.27 -36.32 40.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.89 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.733 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -83.72 -59.0 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.11 111.149 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t -32.24 -47.84 0.16 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 72.01 111.131 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 -56.02 5.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.42 110.944 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.737 ' O ' HG22 ' A' ' 40' ' ' VAL . 2.4 tptm -60.26 -54.78 41.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 74.43 110.863 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.733 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.11 -53.71 9.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.318 -0.401 . . . . 72.41 111.066 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -51.37 -24.22 4.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 73.41 110.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 41' ' ' ALA . 3.6 ttpm? -94.79 -58.87 2.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 75.21 110.841 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 36' ' ' LYS . 2.0 m -58.78 -5.78 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 73.15 111.134 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . -92.27 -16.55 25.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 51.13 111.115 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.13 -6.22 65.11 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 70.42 112.483 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.13 -37.12 2.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.792 0.329 . . . . 72.24 110.885 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.569 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -21.71 106.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.12 111.213 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.436 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.2 mt-30 -50.03 108.27 0.97 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.537 0.684 . . . . 74.23 110.939 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 53.6 Cg_endo -69.77 -19.21 36.37 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.745 2.297 . . . . 64.12 112.36 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -90.85 -4.07 56.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 74.3 110.914 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.63 8.83 20.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 60.04 110.891 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 52' ' ' VAL . 47.4 t30 -73.92 -16.65 61.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.34 110.874 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -14.39 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.243 -0.435 . . . . 74.21 110.837 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.37 -24.86 56.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.774 -0.727 . . . . 50.21 112.504 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.462 HG23 ' CD2' ' A' ' 53' ' ' PHE . 19.2 m -71.64 -38.06 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 75.23 111.066 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HA ' HG22 ' A' ' 56' ' ' VAL . 65.5 m-85 -86.37 -6.38 58.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.846 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -60.44 -24.03 64.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.499 . . . . 75.43 110.917 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.03 -46.85 3.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.699 -0.762 . . . . 71.13 112.49 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.661 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -68.51 -36.78 76.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.849 0.357 . . . . 74.1 111.102 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -50.97 -49.17 60.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.813 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -71.46 -20.49 62.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 73.24 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.53 -28.86 33.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.841 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.94 10.23 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 60.01 111.069 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -50.9 -32.63 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 64.32 110.912 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -41.98 68.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 70.23 110.907 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -90.33 9.18 78.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.716 -0.754 . . . . 72.34 112.473 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 28.75 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.734 0.302 . . . . 74.14 110.869 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -110.93 12.46 22.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.865 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -41.72 -34.2 0.59 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.42 110.93 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.96 -48.34 43.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 65.51 111.129 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -53.63 141.53 25.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 64.42 110.836 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.0 -18.78 30.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 72.43 112.422 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -54.75 169.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 73.5 110.845 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.49 -65.12 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 73.32 112.504 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 73' ' ' SER . 4.4 mm-40 -100.57 -34.15 10.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.947 0.403 . . . . 63.24 110.954 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.4 OUTLIER 162.76 139.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 62.32 110.847 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 27.3 mt -71.81 -12.71 61.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 64.05 110.926 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.01 28.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 51.15 111.133 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -58.1 -40.48 81.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.854 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.587 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -82.78 -41.13 19.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 75.44 110.891 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -33.27 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 65.44 111.128 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -77.18 -63.06 1.46 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 74.04 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.57 -52.17 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.44 110.892 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.7 t80 -43.62 -63.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.908 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.11 -33.01 4.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.5 . . . . 65.32 110.803 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -76.61 -57.84 3.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.829 -0.7 . . . . 75.24 112.455 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.42 -19.09 8.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 74.44 111.053 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -91.97 -74.42 0.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 43.21 111.096 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.43 -32.41 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.04 110.959 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.468 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -81.39 -66.75 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 41.34 110.86 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.572 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -64.84 -61.53 2.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 74.12 110.86 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.7 tt -43.61 -52.5 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.946 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 94' ' ' GLU . 1.6 t-20 -70.94 -62.63 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.42 110.851 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.704 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 24.2 t70 -55.33 -17.11 4.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 52.35 110.931 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -99.42 -31.54 11.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.04 111.187 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.563 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -105.58 -46.98 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 55.41 111.142 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.64 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -70.72 -39.36 73.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.853 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.704 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 22.3 t80 -81.15 -45.94 15.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 74.24 110.963 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 4.6 t -81.74 -67.07 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 73.11 111.168 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -59.58 -19.92 52.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 61.33 110.843 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -90.3 -19.57 45.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 74.33 112.512 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.85 -51.48 5.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.899 0.381 . . . . 71.11 110.876 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.21 -33.86 58.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.42 111.145 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.67 25.69 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.927 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -116.27 74.26 0.27 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.69 -0.767 . . . . 53.52 112.458 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -78.96 119.51 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 74.05 110.875 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -95.38 10.07 37.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 65.32 110.92 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -51.55 158.44 1.5 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.647 0.737 . . . . 71.43 110.848 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 101.05 0.86 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.704 2.269 . . . . 71.2 112.375 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.7 p -94.35 20.15 8.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 72.35 111.102 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.1 mmmt -89.35 179.31 6.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.4 110.878 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 65.32 110.918 179.852 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.786 0.327 . . . . 63.32 110.88 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 p -142.4 174.42 10.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.54 110.896 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.83 128.25 21.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 54.1 110.838 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.44 -24.61 13.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 71.43 111.127 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.45 143.17 13.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.769 -0.729 . . . . 65.44 112.524 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.54 10.12 23.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 70.42 110.863 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -17.45 59.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 63.45 110.88 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 132.88 -16.92 4.69 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 64.33 112.438 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -86.66 -9.98 54.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.909 0.385 . . . . 63.42 110.842 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.86 -43.28 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 72.24 112.439 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -64.66 -19.86 65.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 74.4 110.894 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HA ' ' HG2' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -94.97 -47.04 6.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 72.2 110.894 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -68.91 -33.98 74.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 65.12 111.114 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 12.7 t -77.83 -32.86 52.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 63.52 110.826 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 15.8 pt-20 -87.73 -25.58 23.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 64.53 110.913 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.69 -30.18 59.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 75.12 111.106 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.562 ' C ' HD12 ' A' ' 17' ' ' LEU . 4.1 pp -96.2 -10.88 27.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 65.4 110.871 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 14' ' ' SER . 6.8 mmtm -39.44 108.76 0.51 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.529 0.681 . . . . 72.41 110.856 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 79.96 0.93 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.644 2.229 . . . . 71.22 112.317 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -90.9 19.85 5.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 72.02 110.925 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 7.9 t -85.89 -19.34 30.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 65.14 110.865 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -114.86 -63.57 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 75.13 110.871 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 27' ' ' GLU . 3.3 ptpt -42.0 -70.24 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 65.23 110.953 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.49 -30.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 64.35 110.799 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.4 m-85 -87.53 -49.02 7.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.957 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.73 -49.46 25.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 61.32 111.118 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.26 -56.82 15.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.89 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -45.66 -35.76 4.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 73.43 110.904 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.98 -34.12 27.87 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 74.15 112.466 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 1.045 ' O ' HG22 ' A' ' 34' ' ' THR . 4.0 ptmm? -72.37 -45.6 59.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.292 . . . . 65.53 110.857 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 13.4 pt-20 -50.29 -27.49 6.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 62.34 110.884 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -76.4 -35.12 58.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 74.4 110.86 -179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.559 HG12 ' N ' ' A' ' 34' ' ' THR . 0.1 OUTLIER -91.68 -59.03 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 71.02 111.146 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 1.045 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.9 t -36.09 -46.97 0.53 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 72.4 111.12 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -56.16 17.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 71.25 110.853 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.78 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -60.42 -47.86 84.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.841 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' O ' HG22 ' A' ' 40' ' ' VAL . . . -55.49 -49.83 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 71.35 111.114 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -49.69 -23.16 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 54.23 110.805 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 tttm -95.42 -39.82 9.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 63.3 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 36' ' ' LYS . 2.2 m -61.95 -5.48 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.236 -0.438 . . . . 62.13 111.135 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' CG1' ' A' ' 44' ' ' VAL . . . -98.49 -11.16 22.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.24 111.14 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.77 -7.5 60.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.813 -0.708 . . . . 54.23 112.544 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.47 -35.57 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.35 110.857 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.4 p -32.77 -48.86 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 55.42 111.121 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 46' ' ' PRO . 7.1 mt-30 -61.89 111.68 4.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 55.33 110.915 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' GLN . 52.7 Cg_endo -69.81 -18.23 36.91 Favored 'Trans proline' 0 CA--C 1.527 0.134 0 C-N-CA 122.684 2.256 . . . . 73.41 112.288 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -89.59 -0.77 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.927 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -90.11 15.4 10.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 54.44 110.916 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' O ' HG22 ' A' ' 52' ' ' VAL . 41.4 t30 -94.67 -18.01 21.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 73.21 110.894 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -91.07 -17.2 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 72.34 110.902 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.07 -29.7 53.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.734 -0.746 . . . . 74.34 112.486 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 53' ' ' PHE . 20.2 m -65.22 -38.57 82.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.363 . . . . 61.43 111.121 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 56' ' ' VAL . 83.4 m-85 -84.11 -6.18 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.88 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -58.97 -24.29 62.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.476 . . . . 71.11 110.887 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.06 -48.81 3.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.787 -0.72 . . . . 45.52 112.475 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.9 m -65.74 -36.7 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.785 0.326 . . . . 72.4 111.116 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -49.35 -59.95 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.865 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.13 -16.26 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 63.15 110.862 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.0 t -84.13 -24.79 30.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 72.24 110.847 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.31 9.83 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 45.22 111.102 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.78 -34.66 28.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 63.43 110.949 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -75.72 -33.39 60.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 73.21 110.905 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.05 12.44 65.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.708 -0.758 . . . . 54.5 112.511 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -116.25 -12.67 11.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.778 0.323 . . . . 75.04 110.935 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -105.87 13.77 29.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.466 . . . . 62.33 110.956 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.49 -24.5 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 71.4 110.823 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -49.91 -31.58 12.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 55.04 111.122 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -57.75 170.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.882 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.46 -83.14 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 72.13 112.504 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -70.52 121.5 17.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 72.43 110.889 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.9 -63.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.711 -0.756 . . . . 54.42 112.46 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 73' ' ' SER . 13.4 mm-40 -100.92 0.95 39.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.822 0.344 . . . . 62.54 110.882 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.24 147.36 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.883 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -57.73 -14.76 6.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 73.2 110.907 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.2 -28.8 42.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.12 111.114 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.6 -41.27 80.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 62.22 110.866 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.579 ' O ' ' N ' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -81.71 -40.84 22.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 64.21 110.899 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.84 -33.42 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 73.34 111.147 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -75.22 -61.6 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.41 110.834 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -74.23 -52.88 11.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 75.41 110.866 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.579 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.6 t80 -42.87 -65.62 0.46 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.455 . . . . 74.44 110.861 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 10.3 ptm -45.8 -35.93 4.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 43.22 110.882 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -73.31 -61.22 3.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.744 -0.741 . . . . 35.41 112.465 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.65 -21.54 4.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.825 0.345 . . . . 72.43 111.102 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.493 ' O ' ' CB ' ' A' ' 89' ' ' LEU . . . -84.47 -75.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 32.33 111.114 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 1.5 tmtp? -50.21 -37.62 36.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.898 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 1.5 t -69.91 -67.33 0.5 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.941 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.621 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -60.9 -53.71 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 73.02 110.901 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 85' ' ' ALA . 5.4 tt -49.37 -54.84 15.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.55 110.976 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 86' ' ' LYS . 4.3 t30 -70.39 -43.87 69.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.901 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.699 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 17.7 t70 -72.08 -14.92 61.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.855 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.9 -24.25 12.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 63.43 111.098 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 97' ' ' SER . 0.5 OUTLIER -106.21 -36.41 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 73.44 111.06 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -92.42 -34.25 14.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 74.2 110.834 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.699 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 16.5 t80 -91.42 -39.17 12.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 73.23 110.918 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.581 HG12 ' N ' ' A' ' 97' ' ' SER . 1.4 t -91.27 -59.85 2.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 74.24 111.12 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.581 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.85 -17.69 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.934 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -87.94 -19.64 52.87 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.747 -0.739 . . . . 74.0 112.447 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.83 -54.88 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.837 0.351 . . . . 51.3 110.85 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.96 -32.34 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 74.14 111.106 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.54 -39.23 85.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.892 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.0 175.77 17.97 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 71.31 112.477 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -95.57 123.44 39.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 74.02 110.83 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -91.35 9.9 29.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 64.33 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -51.57 158.49 1.49 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.6 0.714 . . . . 73.33 110.879 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 92.44 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.678 2.252 . . . . 52.25 112.351 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -52.14 -29.89 24.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 72.03 111.099 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -109.64 -170.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.892 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 70.13 110.892 179.916 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.1 mtm . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 73.15 110.913 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.5 m -133.64 -175.56 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.853 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -137.4 115.11 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 73.4 110.864 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.624 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -53.55 -27.93 28.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 63.3 111.111 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.41 -110.41 1.19 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 52.2 112.507 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -109.69 -23.92 11.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.859 0.361 . . . . 72.13 110.883 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -3.45 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 74.14 110.911 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.624 ' HA3' ' HB1' ' A' ' 4' ' ' ALA . . . -60.57 -17.26 47.83 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.775 -0.726 . . . . 44.35 112.512 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -73.27 -13.39 61.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.003 0.43 . . . . 63.02 110.92 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.33 -42.75 3.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.714 . . . . 72.01 112.449 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -60.53 -20.67 60.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.908 0.385 . . . . 73.35 110.905 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.3 -53.6 3.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 63.15 110.873 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -62.82 -41.77 99.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 45.45 111.092 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.0 t -69.17 -36.52 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 55.32 110.823 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HG2' ' A' ' 18' ' ' LYS . 11.7 pt-20 -83.72 -24.12 31.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 72.54 110.898 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.17 35.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 51.14 111.084 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' C ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -111.01 -19.33 12.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.447 . . . . 72.13 110.942 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -45.49 107.59 0.68 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 75.41 110.928 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 18' ' ' LYS . 53.6 Cg_endo -69.75 63.72 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.686 2.257 . . . . 35.32 112.353 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 46.47 55.71 7.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 72.21 110.948 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 47.8 p -76.8 -18.22 58.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.802 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -115.7 -60.96 1.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 64.35 110.843 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -43.08 -72.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 61.44 110.887 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -37.88 -31.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.843 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 23' ' ' LYS . 3.9 m-85 -84.19 -57.07 3.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 70.41 110.978 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.6 -49.76 44.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 65.22 111.09 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 23' ' ' LYS . 1.2 tp10 -48.4 -56.69 7.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 74.34 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -48.76 -34.53 12.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.23 110.927 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.569 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -76.78 -37.94 32.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.746 -0.74 . . . . 71.22 112.461 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 0.1 OUTLIER -72.9 -48.97 32.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.71 0.29 . . . . 73.22 110.892 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 19.9 pt-20 -45.82 -31.33 2.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 64.3 110.872 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.6 t80 -79.03 -35.83 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 74.22 110.994 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -84.84 -59.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 74.12 111.147 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.6 t -32.56 -47.86 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.193 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -57.23 4.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 73.21 110.87 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 11.1 tptp -59.41 -55.4 35.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 72.34 110.918 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.87 -52.84 13.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.101 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -48.51 -25.07 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.24 110.855 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -96.46 -40.05 9.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 55.32 110.874 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.98 -5.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 75.03 111.057 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.68 -13.8 22.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 43.52 111.061 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.48 -11.97 60.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 74.41 112.468 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.64 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.14 -37.39 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.845 0.355 . . . . 72.34 110.88 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.64 ' C ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -12.18 107.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 73.51 111.125 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -50.19 108.03 0.92 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 74.5 110.934 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -22.31 31.92 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.682 2.255 . . . . 71.24 112.297 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -90.46 -4.02 57.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.893 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -78.09 -1.73 33.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 74.21 110.862 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.49 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.6 t-20 -57.39 -23.7 50.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 65.44 110.899 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -91.03 -21.26 21.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 64.32 110.904 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -74.78 -28.72 62.39 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.744 -0.741 . . . . 71.21 112.506 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 49' ' ' ASN . 25.9 m -63.72 -37.45 79.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.41 111.046 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -83.71 -11.07 57.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.855 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -42.57 90.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 54.32 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.67 -14.91 56.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 54.43 112.524 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 57' ' ' HIS . 2.0 t -90.22 -54.09 8.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 72.05 111.11 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.401 ' N ' HG12 ' A' ' 56' ' ' VAL . 5.4 t-80 -56.82 -47.53 80.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.22 110.808 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -62.32 -19.55 63.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 60.22 110.862 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 t -75.4 -26.39 58.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 62.12 110.86 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.46 60.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 71.15 111.159 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -49.6 -32.5 12.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.895 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -75.92 -49.25 18.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 62.11 110.878 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.97 -10.15 64.42 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.8 -0.714 . . . . 44.53 112.456 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.46 29.68 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.753 0.311 . . . . 74.32 110.882 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.38 13.62 33.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 75.11 110.839 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.446 HD22 ' N ' ' A' ' 67' ' ' ALA . 0.2 OUTLIER -50.06 -22.76 1.75 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.979 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' N ' HD22 ' A' ' 66' ' ' ASN . . . -55.72 -22.93 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 74.55 111.06 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -54.84 167.49 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 52.3 110.926 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.37 -82.13 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 72.33 112.553 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -85.53 124.66 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.899 0.381 . . . . 61.22 110.956 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.27 -64.63 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.677 -0.773 . . . . 70.22 112.42 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 73' ' ' SER . 8.8 mm-40 -100.7 -0.04 38.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.798 0.332 . . . . 54.23 110.863 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.1 t 86.33 147.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 63.14 110.845 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.68 -14.57 8.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 74.22 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.48 -27.48 34.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 61.53 111.083 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -56.23 -43.25 78.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.848 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.594 ' O ' ' N ' ' A' ' 81' ' ' TYR . 5.9 pt20 -79.42 -39.32 32.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 70.55 110.976 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -42.48 -33.06 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 73.4 111.094 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 mtm105 -76.2 -61.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 61.21 110.846 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -75.95 -52.83 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 73.51 110.882 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' A' ' 77' ' ' GLN . 3.0 t80 -42.49 -63.56 0.75 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.936 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -47.46 -37.24 11.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.104 -0.498 . . . . 73.4 110.931 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 87' ' ' SER . . . -71.45 -58.58 5.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.679 -0.772 . . . . 61.21 112.48 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.3 -19.35 8.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 72.51 111.111 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -91.47 -74.89 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 65.52 111.073 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -45.41 -34.32 3.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 52.34 110.886 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -78.64 -67.41 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.244 -0.434 . . . . 60.52 110.887 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -63.19 -59.75 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 72.53 110.887 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' ALA . 6.5 tt -44.64 -54.65 5.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 73.01 110.943 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 94' ' ' GLU . 3.5 t30 -69.16 -55.54 10.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.854 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.679 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 11.0 t70 -62.65 -13.3 30.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 70.24 110.938 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -106.37 -25.72 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 71.12 111.102 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 90' ' ' ASN . 0.8 OUTLIER -106.53 -39.08 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.13 111.168 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 90' ' ' ASN . 2.2 mt-10 -88.89 -33.67 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.922 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.679 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 26.1 t80 -91.58 -40.47 11.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 73.04 110.908 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 97' ' ' SER . 1.3 t -90.02 -59.65 2.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 63.32 111.091 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.607 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -74.29 -16.82 60.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 55.1 110.893 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.7 -19.7 50.6 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.724 -0.75 . . . . 45.33 112.427 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.14 -51.97 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.807 0.337 . . . . 74.24 110.849 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.96 -34.23 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 72.4 111.145 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.5 30.54 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 73.44 110.902 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.31 -103.49 0.54 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 54.44 112.462 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.86 115.74 30.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 74.32 110.896 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.4 10.04 29.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.79 155.69 3.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.579 0.704 . . . . 72.33 110.912 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.74 100.71 0.84 Allowed 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.756 2.304 . . . . 71.21 112.383 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 -31.67 73.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 72.34 111.178 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -63.92 -178.75 0.34 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 75.11 110.88 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 62.4 110.931 179.847 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.716 0.293 . . . . 54.53 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -166.38 170.21 13.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 74.11 110.874 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.86 130.12 18.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 72.05 110.84 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.12 20.06 19.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 53.11 111.096 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.25 -164.15 20.83 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.729 -0.748 . . . . 45.4 112.466 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 9.75 30.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.872 0.368 . . . . 70.14 110.884 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -79.26 -9.99 59.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.95 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.2 103.55 0.21 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 52.34 112.419 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.75 -9.54 58.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.901 0.381 . . . . 51.01 110.911 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.17 -40.67 4.49 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 62.02 112.501 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.74 -20.48 65.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 73.01 110.873 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -95.37 -44.22 7.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.892 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -71.82 -20.86 61.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 70.52 111.131 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 18.5 p -93.49 -29.54 15.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 72.04 110.85 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HG2' ' HA ' ' A' ' 12' ' ' LYS . 13.3 pt-20 -94.46 -26.99 16.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 72.12 110.922 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -86.44 -26.34 24.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 41.14 111.128 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 13' ' ' ALA . 18.3 mt -102.24 -7.39 22.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.878 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -38.76 151.37 0.19 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.657 0.742 . . . . 50.02 110.821 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -9.79 26.94 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.637 2.225 . . . . 61.51 112.347 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.03 26.73 10.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.889 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' O ' ' CD1' ' A' ' 25' ' ' TYR . 1.4 p -88.15 -20.29 25.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 60.34 110.831 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -115.09 -62.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.094 -0.503 . . . . 54.11 110.89 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -42.06 -70.24 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 71.05 110.915 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -37.36 -30.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 64.11 110.865 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLN . 4.6 m-85 -87.23 -49.12 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 75.35 110.976 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.55 -49.39 26.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 44.3 111.09 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -55.18 -56.81 15.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.24 110.879 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' TYR . 10.9 pt20 -46.23 -35.38 5.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 74.5 110.918 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.49 -46.19 26.52 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.733 -0.746 . . . . 44.0 112.409 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.96 ' O ' HG22 ' A' ' 34' ' ' THR . 1.8 mtpp -66.25 -46.01 78.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.788 0.327 . . . . 72.13 110.924 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 3.5 mt-10 -45.16 -31.97 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 64.54 110.828 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.514 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.2 t80 -79.03 -34.51 43.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.52 110.903 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 37' ' ' ALA . 2.1 mp -86.45 -59.76 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 73.01 111.168 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.96 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.5 t -32.03 -48.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 75.34 111.145 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.19 -57.1 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 64.44 110.847 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.767 ' O ' HG13 ' A' ' 40' ' ' VAL . 8.6 tptt -59.95 -55.66 31.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.21 110.961 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -46.37 -52.6 12.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 44.25 111.076 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -48.01 -25.99 1.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 73.12 110.88 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.3 tptt -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.43 110.881 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.3 m -63.21 -5.25 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 73.52 111.136 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.73 -13.65 29.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 71.0 111.119 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.72 -7.83 59.84 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.727 -0.749 . . . . 64.42 112.515 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.635 ' HE2' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.52 -28.35 7.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.35 . . . . 75.13 110.921 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -34.63 -44.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.21 111.133 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -38.35 101.01 0.22 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 54.2 110.935 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -19.06 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.695 2.264 . . . . 71.51 112.391 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -90.8 -3.58 57.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.925 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -91.06 15.68 11.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.487 . . . . 74.51 110.88 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -52.28 -32.07 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 64.12 110.85 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -18.64 13.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.858 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.19 -29.76 16.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 50.31 112.525 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 m -66.18 -34.51 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 71.12 111.117 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 90.8 m-85 -89.91 -5.12 57.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -59.45 -24.78 63.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.91 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.85 -48.25 3.44 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 42.31 112.501 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 35.2 m -66.24 -36.04 76.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.36 . . . . 43.12 111.097 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -50.68 -52.79 36.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.871 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.5 -16.6 62.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 74.31 110.877 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.5 t -84.42 -27.18 27.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 73.32 110.828 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.18 24.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 43.31 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -51.96 -29.86 22.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.904 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -84.55 -32.69 23.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.889 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.38 18.35 57.53 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.723 -0.751 . . . . 64.34 112.496 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.2 tppt? -96.45 28.44 3.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 73.34 110.923 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.01 13.46 23.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 65.23 110.924 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -47.09 -26.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.925 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.03 -70.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 73.22 111.072 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -64.97 141.55 58.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.874 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.39 -63.05 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.761 -0.733 . . . . 75.34 112.467 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -52.27 127.59 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 72.33 110.906 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.9 -71.38 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 74.35 112.555 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -90.98 12.86 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 74.03 110.877 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.684 ' OG ' HD22 ' A' ' 74' ' ' LEU . 7.8 t -63.01 -133.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 63.31 110.912 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.684 HD22 ' OG ' ' A' ' 73' ' ' SER . 1.1 mm? -87.93 -7.18 57.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 62.44 110.882 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.59 -32.25 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 70.04 111.104 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 0.6 OUTLIER -58.64 -41.9 87.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.857 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' TYR . 2.9 mt-30 -81.52 -41.44 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 72.53 110.932 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -41.56 -34.75 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 51.41 111.081 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -73.86 -57.98 3.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 65.23 110.856 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -78.96 -54.91 5.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 74.35 110.855 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 77' ' ' GLN . 2.5 t80 -38.78 -67.52 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.206 -0.452 . . . . 75.14 110.897 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 9.9 mmt -45.04 -60.94 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 74.32 110.875 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -49.54 -62.04 5.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.79 -0.719 . . . . 42.11 112.469 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 88' ' ' LYS . . . -51.0 -32.61 21.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.788 0.327 . . . . 32.0 111.084 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . -67.66 -74.81 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 65.32 111.095 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 9.1 tmtt? -54.93 -31.72 60.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 62.45 110.88 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.505 ' O ' ' CB ' ' A' ' 91' ' ' ASP . 11.0 t -74.57 -52.01 13.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.462 . . . . 71.42 110.902 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 1.094 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 11.6 ttmm -79.04 -15.86 57.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.904 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.592 ' O ' ' HB ' ' A' ' 93' ' ' VAL . 9.0 tp -96.06 -24.01 16.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.875 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 86' ' ' LYS . 6.6 t-20 -107.44 -29.8 9.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.433 . . . . 62.33 110.882 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 3.4 t70 -96.8 -19.37 18.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 71.14 110.9 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 1.094 ' HB3' ' O ' ' A' ' 88' ' ' LYS . . . -108.01 -22.05 12.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 45.23 111.068 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.592 ' HB ' ' O ' ' A' ' 89' ' ' LEU . 1.2 t -106.99 -40.38 5.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.286 -0.415 . . . . 74.45 111.15 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 -33.9 16.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 72.51 110.946 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 19.4 t80 -90.37 -39.95 12.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 54.31 110.915 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 97' ' ' SER . 1.7 t -91.05 -61.23 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.088 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.587 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -71.44 -18.0 62.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 50.14 110.824 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.05 -19.51 53.04 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.783 -0.722 . . . . 63.13 112.496 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -83.38 -53.95 5.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 75.32 110.905 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.8 t -62.92 -27.96 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 64.32 111.137 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -95.82 27.61 3.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 74.21 110.842 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.99 -17.17 69.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.707 -0.759 . . . . 72.34 112.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -60.08 179.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 62.42 110.832 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -89.96 10.11 25.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 44.22 110.905 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.93 160.61 1.1 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.685 0.755 . . . . 73.54 110.847 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 101.42 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.714 2.276 . . . . 72.11 112.374 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -109.84 20.11 18.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.13 111.079 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -132.14 69.84 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 52.5 110.868 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.8 pttm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 64.11 110.908 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.773 0.321 . . . . 73.22 110.915 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.1 p -167.76 -172.4 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 44.33 110.808 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.14 112.29 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 70.54 110.841 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 7' ' ' LYS . . . -57.81 -24.25 56.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 54.44 111.133 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.49 -80.34 0.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 65.04 112.519 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -110.06 10.24 24.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.872 0.367 . . . . 50.45 110.854 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -63.52 -15.81 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 74.13 110.919 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.37 97.38 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.12 112.454 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.37 -7.69 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 63.52 110.827 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.96 -29.74 11.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 21.03 112.45 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 16.4 mm-40 -57.72 -19.98 31.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 71.44 110.902 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -103.88 -46.27 4.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.877 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -68.69 -19.51 64.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.147 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 34.2 t -94.51 -32.28 13.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 71.22 110.818 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 11' ' ' GLU . 23.3 mm-40 -93.87 -22.89 18.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 55.13 110.946 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 12' ' ' LYS . . . -91.0 -27.37 18.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 75.3 111.087 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 13' ' ' ALA . 10.6 mt -104.07 -4.88 22.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.445 . . . . 65.42 110.96 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -38.82 150.54 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.551 0.691 . . . . 72.14 110.87 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -6.98 19.9 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.722 2.281 . . . . 72.53 112.305 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' A' ' 23' ' ' LYS . 2.9 m-20 -137.61 54.98 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 63.43 110.825 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.56 ' HA ' ' CE1' ' A' ' 25' ' ' TYR . 0.4 OUTLIER -101.81 -20.11 15.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 52.34 110.855 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.76 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 12.5 mt-30 -105.24 -12.64 15.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 51.01 110.876 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -102.07 -72.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 75.12 110.879 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.29 -28.87 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.859 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 21' ' ' SER . 4.7 m-85 -89.78 -56.3 3.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.925 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 22' ' ' GLN . . . -71.52 -50.04 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 75.41 111.094 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -51.14 -57.78 7.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 64.23 110.828 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -49.26 -38.68 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.928 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' O ' HD13 ' A' ' 33' ' ' ILE . . . -75.25 -29.94 59.53 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.703 -0.76 . . . . 53.44 112.484 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.95 ' O ' HG22 ' A' ' 34' ' ' THR . 4.6 mtpp -78.64 -49.19 13.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 74.4 110.906 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HA ' ' CG2' ' A' ' 34' ' ' THR . 17.5 pt-20 -46.42 -30.65 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.876 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HD1' HD12 ' A' ' 33' ' ' ILE . 4.5 t80 -79.15 -36.31 40.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 70.53 110.917 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.699 HG23 ' HB2' ' A' ' 37' ' ' ALA . 1.8 mp -84.47 -59.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 75.43 111.171 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.95 HG22 ' O ' ' A' ' 30' ' ' LYS . 1.7 t -32.5 -48.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 74.43 111.118 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -57.27 4.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 61.11 110.879 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.762 ' O ' HG13 ' A' ' 40' ' ' VAL . 14.3 tptt -59.29 -55.24 37.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.893 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 33' ' ' ILE . . . -47.07 -52.72 14.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 50.45 111.107 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -48.65 -24.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.836 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -96.57 -40.16 9.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.872 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 36' ' ' LYS . 1.5 m -61.95 -5.88 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 70.12 111.103 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -95.16 -13.9 24.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.113 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.3 -13.44 60.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.716 -0.754 . . . . 73.11 112.513 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' C ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.77 -39.65 2.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.794 0.33 . . . . 73.24 110.884 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER 26.72 93.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 74.43 111.132 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -48.89 108.22 0.91 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 53.15 110.901 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -22.88 31.39 Favored 'Trans proline' 0 N--CA 1.466 -0.096 0 C-N-CA 122.741 2.294 . . . . 64.51 112.316 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -89.87 0.51 57.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 72.23 110.917 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -88.24 11.32 16.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 71.42 110.844 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 52' ' ' VAL . 16.7 p30 -61.44 -23.11 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 50.24 110.923 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -91.47 -21.21 21.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 72.42 110.859 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.04 73.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 53.45 112.545 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 49' ' ' ASN . 30.1 m -68.04 -39.09 80.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.811 0.339 . . . . 60.5 111.096 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.647 ' HA ' HG22 ' A' ' 56' ' ' VAL . 28.2 m-85 -84.15 -6.83 59.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.921 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -60.05 -23.91 64.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 75.03 110.913 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.07 -47.12 3.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.779 -0.724 . . . . 72.42 112.476 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.647 HG22 ' HA ' ' A' ' 53' ' ' PHE . 32.1 m -68.11 -38.14 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.817 0.341 . . . . 34.23 111.138 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -50.79 -53.83 28.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.902 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -14.61 62.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 45.14 110.871 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 t -86.56 -26.44 24.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 70.11 110.833 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -78.32 -3.44 43.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 73.01 111.105 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -50.31 -32.46 17.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 64.5 110.902 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -49.06 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 64.54 110.859 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.58 -4.51 75.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.799 -0.715 . . . . 54.5 112.476 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.54 7.89 26.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.747 0.308 . . . . 70.55 110.888 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.08 11.7 21.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 71.42 110.873 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -39.54 -37.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.9 -179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.83 -57.99 7.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 61.52 111.111 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -52.08 170.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 73.12 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.28 167.83 0.36 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.794 -0.717 . . . . 71.25 112.474 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.98 179.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.835 0.35 . . . . 60.51 110.937 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.93 -64.71 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.758 -0.734 . . . . 75.44 112.484 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' O ' ' CB ' ' A' ' 73' ' ' SER . 7.1 mm-40 -100.47 1.97 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.44 110.906 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 1.2 m 83.12 148.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 65.34 110.881 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -58.74 -13.86 7.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.913 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.32 -25.77 39.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.51 111.151 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.8 t70 -63.42 -35.2 79.65 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.119 -0.491 . . . . 71.14 110.812 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.648 ' O ' ' N ' ' A' ' 81' ' ' TYR . 18.7 mm-40 -88.93 -39.13 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 72.35 110.886 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.52 -33.24 2.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 63.45 111.113 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' CG ' ' N ' ' A' ' 80' ' ' ASP . 18.8 ptp180 -78.14 -46.09 21.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 63.13 110.877 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' N ' ' CG ' ' A' ' 79' ' ' ARG . 80.6 m-20 -87.58 -56.45 3.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 71.14 110.818 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.648 ' N ' ' O ' ' A' ' 77' ' ' GLN . 4.6 t80 -40.66 -59.68 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.41 110.893 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -59.64 -38.92 82.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.847 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.37 -21.6 70.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.759 . . . . 60.02 112.485 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.38 -40.27 9.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 72.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 89' ' ' LEU . . . -92.91 -77.18 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 73.2 111.119 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASN . 3.9 tmtm? -43.94 -32.43 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 62.14 110.941 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.25 -70.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 52.01 110.917 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -61.07 -60.59 3.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.836 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 8.2 tt -43.88 -52.92 6.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 63.22 110.898 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.696 ' O ' ' N ' ' A' ' 94' ' ' GLU . 7.5 t30 -70.34 -65.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.897 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HB3' ' A' ' 95' ' ' TYR . 69.2 m-20 -51.06 -21.84 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 63.44 110.874 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 96' ' ' VAL . . . -94.04 -38.15 11.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 72.43 111.095 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.538 ' CG1' ' N ' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -98.45 -45.56 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.445 . . . . 75.31 111.146 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 90' ' ' ASN . 4.0 tm-20 -65.23 -42.61 93.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.32 110.841 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.673 ' HB3' ' O ' ' A' ' 91' ' ' ASP . 42.0 t80 -77.71 -46.51 21.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 72.11 110.885 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.614 ' HB ' ' O ' ' A' ' 92' ' ' ALA . 23.4 t -82.39 -68.59 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 75.3 111.184 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -55.98 -20.79 17.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.866 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 94' ' ' GLU . . . -85.62 -34.97 12.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.685 -0.769 . . . . 62.34 112.551 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 96' ' ' VAL . 8.3 ptt180 -75.13 -26.33 59.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 70.33 110.892 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.44 -33.26 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 41.2 111.064 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -85.18 -31.01 23.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 65.35 110.752 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.95 119.41 1.94 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 51.33 112.438 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.52 ' HG3' HG23 ' A' ' 107' ' ' THR . 0.9 OUTLIER -100.06 126.18 46.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.299 . . . . 62.41 110.888 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -71.03 -20.29 62.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 72.0 110.879 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.41 160.5 33.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.589 0.709 . . . . 62.2 110.886 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 101.34 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.677 2.251 . . . . 75.52 112.352 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.52 HG23 ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -51.84 -29.61 20.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 62.4 111.172 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -57.16 138.95 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 64.14 110.944 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 72.5 110.916 179.835 . . . . . . . . 1 1 . 1 stop_ save_